Enzyme-inhibitory secondary metabolites and their exudation in the marine-derived fungus <em>Epicoccum nigrum</em> link by Hufendiek, Peter
ENZYME-INHIBITORY SECONDARY METABOLITES AND 
THEIR EXUDATION IN THE MARINE-DERIVED FUNGUS 
EPICOCCUM NIGRUM LINK 
 
Dissertation 
zur 
Erlangung des Doktorgrades (Dr. rer. nat.) 
der 
Mathematisch-Naturwissenschaftlichen Fakultät 
der 
Rheinischen Friedrich-Wilhelms-Universität Bonn 
 
vorgelegt von 
Peter Hufendiek 
 
  
ENZYME-INHIBITORY SECONDARY METABOLITES AND 
THEIR EXUDATION IN THE MARINE-DERIVED FUNGUS            
EPICOCCUM NIGRUM LINK 
 
Dissertation 
zur 
Erlangung des Doktorgrades (Dr. rer. nat.) 
der 
Mathematisch-Naturwissenschaftlichen Fakultät 
der 
Rheinischen Friedrich-Wilhelms-Universität Bonn 
 
 
vorgelegt von 
Peter Hufendiek 
aus  
Bielefeld 
 
 
Bonn, 2016 
 
 
 
 
 
  
Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der 
Rheinischen Friedrich-Wilhelms-Universität Bonn 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Gutachter: Prof. Dr. G. M. König 
2. Gutachter: Prof. Dr. V. Gieselmann 
 
Erscheinungsjahr: 2017 
Tag der Promotion: 30.03.2017 
 
In advance publications of the dissertation 
 I 
IN ADVANCE PUBLICATIONS OF THE DISSERTATION 
 
Parts of this study have been published in advance by permission of the Mathematisch-
Naturwissenschaftlichen Fakultät, represented by the supervisor of this study: 
Research papers: 
Hufendiek, P.; Stölben, S. S. M; Kehraus, S.; Merten, N.; Harms, H.; Crüsemann, M.; Arslan, 
I.; Gütschow, M.; Schneider, T.; König, G. M. Biosynthetic studies on acetosellin and 
structure elucidation of a new acetosellin derivative. Planta Medica 2017. Advance online 
publication. doi: 10.1055/s-0042-124493. 
*Dávila-Céspedes, A.; *Hufendiek, P.; *Crüsemann, M.; Schäberle, T. F.; König, G. M. 
Marine-derived myxobacteria of the suborder Nannocystineae: An underexplored source of 
structurally intriguing and biologically active metabolites. Beilstein Journal of Organic 
Chemistry 2016, 12, 969–984. 
*These authors contributed equally.  
Harms, H.; Kehraus, S.; Nesaei-Mosaferan, D.; Hufendiek, P.; Meijer, L.; König, G. M. Aβ-42 
lowering agents from the marine-derived fungus Dichotomomyces cejpii. Steroids 2015, 104, 
182–188. 
Harms, H.; Rempel, V.; Kehraus, S.; Kaiser, M.; Hufendiek, P.; Müller, C. E.; König, G. M. 
Indoloditerpenes from a Marine-Derived Fungal Strain of Dichotomomyces cejpii with 
Antagonistic Activity at GPR18 and Cannabinoid Receptors. Journal of Natural Products 
2014, 77, 673–677. 
 
Research presentations: 
Hufendiek, P.; Kehraus, S.; König, G.M. Chemical and pharmacological investigation of 
metabolites from the marine-derived fungus Epicoccum nigrum LINK.             Poster 
presentation at the ´14th International Symposium on Marine Natural Products joint with the 
8th European Conference on Marine Natural Products 2013´, September 15-20, 2013, La 
Toja Island, Spain. 
Hufendiek, P.; Kehraus, S.; Gütschow, M.; König, G.M. Epipyrones from the marine-derived 
fungus Epicoccum nigrum LINK inhibit the proteases cathepsin K and S. Poster presentation 
In advance publications of the dissertation 
 II 
at the ´2nd European Conference on Natural Products 2015´, September 6-9, 2015, Frankfurt, 
Germany. 
Schrör, J.; Hufendiek, P.; Kehraus, S.; Gütschow, M.; König, G.M. Secondary metabolites of 
the fungus Stemphylium globuliferum and their biological activity. Poster presentation at the 
´2nd European Conference on Natural Products 2015´, September 6-9, 2015, Frankfurt, 
Germany. 
Hufendiek, P.; Kehraus, S.; Gütschow, M.; König, G.M. Epipyrones from the marine-derived 
fungus Epicoccum nigrum LINK inhibit the proteases cathepsin K and S. Poster presentation 
at the ´9th conference of Marine Natural Products 2015´, August 30 - September 2, 2015, 
Glasgow, Scotland. 
Hufendiek, P.; Kehraus, S.; Gütschow, M.; König, G.M. Epipyrones from the marine-derived 
fungus Epicoccum nigrum LINK inhibit the proteases cathepsin K and S.  Poster presentation 
at the ´1st International Conference of the Marine Fungal Natural Products Consortium joint 
with the 14th International Marine and Freshwater Mycology Symposium 2015´, July 21-24, 
2015, Nantes, France. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
 III 
ACKNOWLEDGEMENTS 
 
I am deeply indebted to my supervisor, Prof. Dr. G. M. König, who guided and supported me 
throughout this work. She left a lot of freedom to me in my research and always had an open 
ear for problems or scientific discussions. 
I also want to express my gratitude towards Prof. Dr. E. Gieselmann (Institute for 
Biochemistry and Molecular Biology, University of Bonn) for officiating as a second referee 
and for the fruitful cooperation during my work. Assays on cerebroside sulfotransferase were 
carried out in his working group by himself and by Dr. Isabell Zech, who did the main work on 
this target.  
I also want to thank Prof. Dr. M. Gütschow and Prof. Dr. A. Schieber for participating in the 
examination committee. 
Special thanks go to Dr. S. Kehraus for conducting 2D-NMR experiments, checking 
analytical data and proofreading parts of this dissertation. 
Prof. Dr. M. Gütschow and Anna Schulz-Fincke (Institute for Pharmaceutical Chemistry I, 
University of Bonn) for carrying out assays on cysteine  and serine proteases. 
Prof. Dr. T. Schneider and Michaele Josten (Institute for Pharmaceutical Microbiology, 
University of Bonn)  for providing antimicrobial assays.  
Dr. N. Merten (Institute for Pharmaceutical Biology, University of Bonn) for providing a 
cytotoxicity assay. 
Dr. A. van Diepeningen (CBS-KNAW fungal biodiversity centre, Utrecht) for carrying out 
assays on the antifungal activity of epipyrones. 
Prof. Dr. G. Bendas and H. Falkenstein-Paul (Institute for Pharmaceutical Chemistry II, 
University of Bonn) for performing assays on the binding of epipyrones to a model membrane 
and for in-depth discussions on the results.  
Dr. Marcus Helfer (Institute for Virology, Helmholtz Zentrum München) for carrying out 
assays on anti-HIV activity. 
Dr. Steinar Paulsen (University of Tromsø, MabCent, Tromsø, Norway) for performing the 
assays on nuclear receptors.  
Acknowledgements 
 IV 
Dr. L. Meijer (Protein Phosphorylation & Disease, CNRS, Roscoff, France) for providing the 
protein kinase assays and Aß-42 production assay. 
Dr. Marc Sylvester (Institute for Biochemistry and Molecular Biology, University of Bonn) for 
performing some of the HR-MS measurements and professional help in data analysis. 
Max Crüsemann (Institute for Pharmaceutical Biology, University of Bonn) for providing LC-
HRMS measurements and for proofreading a part of this dissertation. 
E. Egereva who performed LC-MS measurements and introduced me to the  fermentation of 
fungi. E. Neu, who carried out agar diffusion assays. 
Dr. C. Drewke and the other colleagues whom I worked with in the course ´Pharmaceutical 
Biology III´, for the great working atmosphere. Dr. R. Schröder for helping with administrative 
´challenges´. 
Simon Stölben, who was working with me as a Master student.  
I especially want to thank my office members, Antonio Dávila Céspedes, Raphael Reher 
(also for proofreading a part of my thesis) and Jan Schrör for the great atmosphere and 
(scientific) discussions.  
All the other lab members for the discussions, nice atmosphere, especially Paul Barac-
Poponut, Sarah Bouhired, Fayrouz El-Maddah (also for proofreading a part of my thesis), 
Emilie Goralski, Till Schäberle; Henrik Harms, who also helped me in my first weeks at the 
institute.  
Finally, I am grateful for the funding and the scientific workshops from the graduate research 
school Biotech-Pharma during my first years at the institute. I also want to thank Dr. E. Mies-
Klomfass, who coordinated the program. 
 
 
 
 
 
 
 
Abbreviations 
 V 
ABBREVIATIONS 
 
°C   degree Celsius 
[1-13C]acetate  acetate enriched with 13C at position C-1 
1H-NMR  proton NMR 
13C-NMR  carbon-13 NMR 
α   optical rotation 
 TDα   specific optical rotation; T = temperature; D = D-line of sodium   at 589 
nm 
δ   chemical shift in NMR spectroscopy [ppm] 
Δδ   difference of chemical shifts 
λ   wavelength [nm] 
µ   micro = 10-6 
µL   microliter 
µm   micrometer 
A   adenine 
Ac2O   acetic anhydride 
ACN   acetonitrile 
ACP   acyl carrier protein (domain of polyketide synthases) 
ARSA or ASA  Arylsulfatase A 
Asp   L-aspartic acid 
ASW   artificial sea water 
Å   Ångström = 0.1 nm 
BGC   biosynthetic gene cluster 
Abbreviations 
 VI 
C   cytosine 
13C   carbon-13 isotope  
C18 silica  octadecylsilylated silica gel (= ODS, RP-18 silica) 
CD   Circular dichroism 
CDA   Czapek-Dox agar 
CDA+Cu2+  Czapek-Dox agar supplement with CuSO4 
CDA+Zn2+  Czapek-Dox agar supplement with ZnSO4 
CDT   Czapek-Dox agar with TMS 
CMeT   C-methyl transferase (domain of polyketide synthases) 
CoA ≡ CoASH coenzyme A 
(h)CST  (human) cerebroside sulfotransferase 
Cys   L-cysteine 
MeOH-d4  fully deuterated MeOH 
DMSO-d6  fully deuterated DMSO 
DAD   diode array detector 
DEPT-135  distortionless enhancement by polarization transfer   
 (flip angle 135°) 
DMSO   dimethyl sulfoxide 
e.g.   for example 
ELSD   evaporative light scattering detector 
ESI   electrospray ionization (in mass spectrometry) 
EtOAc   ethyl acetate  
EtOH   ethanol  
FAS   fatty acid synthase 
FC   flash chromatography 
Abbreviations 
 VII 
g   gram 
G   guanine 
H,H-COSY  homonuclear correlation spectroscopy 
His   L-histidine 
HMBC   heteronuclear multiple bond correlation spectroscopy 
HPLC   high pressure liquid chromatography 
HSQC   heteronuclear single quantum coherence spectroscopy 
Hz   Hertz (frequency) 
i.e.   that is to say (id est) 
IR   infrared  
ITS   Internal transcribed spacer (gene region) 
J   coupling constant [Hz] 
keV   kiloelectron volt 
L   liter 
LC   liquid chromatography 
LC-MS   HPLC or UPLC coupled to a mass spectrometer 
log D Distribution coefficient (pH-dependent) 
log P Partition coefficient  
m/z   mass to charge ratio (in mass spectrometry) 
mAU  milli absorption units  
MAzP   Monascus azaphilone pigment 
mg   milligram 
MEA   malt extract agar 
MEN   MEA supplemented with ASW and NaOAc 
MES   MEA supplemented with ASW 
Abbreviations 
 VIII 
MeOH   methanol 
MHz   Megahertz 
min   minutes 
mL   milliliter 
mol   mole (unit) 
mmol   millimole 
MPLC medium pressure liquid chromatography (syn. flash chromatography) 
Mr   molecular weight 
ms   milliseconds 
MS   mass spectrometry 
MS/MS ≡ MS2  Tandem mass spectrometry 
NADPH  nicotinamide dinucleotide phosphate (reduced form)  
NaOAc  sodium acetate 
nL   nanoliters 
nm   nanometer 
NMR   nuclear magnetic resonance  
NOESY  Nuclear Overhauser enhancement spectroscopy 
NP   normal phase (in chromatography) 
NR-(f)PKS  non-reducing (fungal) polyketide synthase 
OSMAC  one strain many compounds 
(f)PKS   (fungal) polyketide synthase 
ppm   parts per million 
R2   correlation coefficient 
ROESY  rotating frame Nuclear Overhauser effect spectroscopy 
RP   reversed phase (in chromatography) 
Abbreviations 
 IX 
S   Svedberg unit (sedimentation rate of ribosomal subunits) 
SAM   S-adenosyl methionine 
SAW   surface acoustic wave (type of biosensor) 
sec   seconds 
SEC   size exclusion chromatography 
Ser   L-serine 
SM   secondary metabolite 
SPE   solid phase extraction 
T   thymine 
TM   melting point [°C] 
tR   retention time [min] 
TFA   trifluoroacetic acid 
TIC   total ion chromatogram (in mass spectrometry) 
TMS   trace metal solution (as defined in section 3.1.3) 
TWC   total wavelength chromatogram (in mass spectrometry) 
UPLC ≡ UHPLC ultrahigh pressure liquid chromatography 
UV   ultraviolet 
VLC   vacuum liquid chromatography 
vol%   percentage by volume (v/v) 
wt%   percentage by mass (w/w) 
 
 
 
 
 
Abbreviations 
 X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contents 
 XI 
CONTENTS 
In advance publications of the dissertation ............................................................................. I 
Acknowledgements ...............................................................................................................III 
Abbreviations ........................................................................................................................ V 
Contents ............................................................................................................................... XI 
1 Introduction .............................................................................................................. 1 
1.1 Why fungi? Secondary metabolism and its relevance in drug discovery .................. 1 
1.2 Plant-associated fungi as sources of secondary metabolites ................................... 4 
1.3 Marine fungi - algicolous strains and their potential as producers of lead structures 6 
1.4 Introduction to the enzymatic targets and their role in human diseases ................... 8 
1.5 Exudation in fungi and its significance ....................................................................12 
2 Aim of the present study .........................................................................................14 
3 Materials and methods............................................................................................15 
3.1 The fungal strains ...................................................................................................15 
3.1.1  Early examination of isolated fungal strains ....................................................16 
3.1.2  Identification and taxonomy ............................................................................16 
3.1.3  Culture conditions and media for large scale fermentation .............................20 
3.1.4  Extraction of the cultivated fungi .....................................................................22 
3.1.5  Cultivation and extraction conditions for the ´time course experiments´ and 
isotopic labeling ..............................................................................................22 
3.2 Chromatography .....................................................................................................23 
3.2.1  Size exclusion chromatography (SEC) ...........................................................23 
3.2.2.  Vacuum liquid chromatography (VLC) ............................................................23 
3.2.3.  Solid phase extraction (SPE) ..........................................................................24 
3.2.4.  Flash chromatography (FC) ............................................................................24 
Contents 
 XII 
3.2.5.  High performance liquid chromatography (HPLC) ..........................................24 
3.2.6  Isolation protocols ..........................................................................................25 
3.3 Structure elucidation ...............................................................................................29 
3.3.1.  NMR ...............................................................................................................29 
3.3.2.  Mass spectrometry .........................................................................................30 
3.3.3.  UV-spectroscopy ............................................................................................31 
3.3.4  CD-spectroscopy ............................................................................................32 
3.3.5  IR-Spectroscopy .............................................................................................32 
3.3.6  Optical rotation ...............................................................................................32 
3.4 Chemical derivatization ...........................................................................................33 
3.5 Evaluation of the biological activity .........................................................................34 
3.5.1  Cell viability assays ........................................................................................34 
3.5.2  Antimicrobial activities ....................................................................................35 
3.5.3 Inhibition of human cerebroside sulfo-transferase (hCST) ...............................38 
3.5.4  Inhibition of cysteine- and serine-proteases ...................................................39 
3.5.5  Luciferase-based transient reporter system for agonists on nuclear receptors .. 
  ........................................................................................................................40 
3.5.6  Extracellular Aβ-42 peptide production, cell survival and inhibition of protein    
kinases ...........................................................................................................41 
3.5.7  Binding of epipyrones (1-3) to a model membrane .........................................43 
3.6 Guttation fluids – cultivation and analysis ...............................................................44 
3.7 Chemicals and solvents ..........................................................................................47 
4 Results ...................................................................................................................48 
4.1 Identification of the fungal strains ............................................................................48 
4.2 Secondary metabolites obtained during this study ..................................................50 
Contents 
 XIII 
4.3 Epipyrones (1-3) .....................................................................................................54 
4.3.1  Cultivation experiments and fermentation conditions ......................................54 
4.3.2   Acetylation products (5-6)..............................................................................59 
4.4 Acetosellin (4) and 5´,6´-dihydroxyacetosellin (7)....................................................63 
4.4.1  Isolation procedure .........................................................................................65 
4.4.2  Structure elucidation of acetosellin .................................................................66 
4.4.3  5´,6´-Dihydroxyacetosellin ..............................................................................70 
4.4.4   Studies on the biosynthesis of acetosellin (4) ................................................72 
4.5 Other secondary metabolites found in this study .....................................................77 
4.5.1.  Polyketides ......................................................................................................77 
4.5.2   Terpenoids .....................................................................................................82 
4.5.3.  Flazin (15) .......................................................................................................85 
4.6 Bioactivities of the isolated metabolites ...................................................................86 
4.6.1  Inhibition of cerebroside-sulfotransferase (CST) .............................................86 
4.6.2  Inhibition of cysteine and serine proteases .....................................................89 
4.6.3  Other bioactivities ...........................................................................................92 
4.7 Guttation fluids – qualitative and quantitative analysis ............................................98 
4.7.1  Introduction ....................................................................................................98 
4.7.2  Cultivation and phenotype ..............................................................................99 
4.7.3 Secondary metabolite content in E. nigrum strain 749 ................................... 101 
5 Discussion ............................................................................................................ 107 
5.1 Chemical structures and bioactivities .................................................................... 107 
5.1.1  Epipyrones (1-3) ........................................................................................... 107 
5.1.2  Acetosellin (4) .............................................................................................. 111 
5.1.3  Other polyketides ......................................................................................... 120 
Contents 
 XIV 
5.1.4  Isoprenoids - Tricinonoic acid and epicaronic acid ....................................... 123 
5.1.5  Beta-carbolines – artefacts from the medium ............................................... 126 
5.2 Guttation – patterns of production and metabolite content .................................... 127 
6 Summary .............................................................................................................. 136 
7 References ........................................................................................................... 139 
8 Appendix .............................................................................................................. 161 
 
 
Introduction 
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1 INTRODUCTION 
 
1.1 WHY FUNGI? SECONDARY METABOLISM AND ITS RELEVANCE IN 
DRUG DISCOVERY 
 
As pointed out by Newman and Cragg [1], secondary metabolites are an indispensable 
source for drugs in medicine. Of the therapeutic agents, which were approved from 1981 – 
2014, 51% were derived from natural products. 4% of all introduced drugs were unmodified, 
original natural products. The long evolutionary history of metabolic adaption may be the 
reason, why natural products in general often lead to positive hits in drug screening 
programs. It was hypothesized by Kellenberger et al. that there are similar recognition sites 
in the biosynthetic proteins and in human protein targets used in drug discovery [2]. For the 
search of new chemical entities, mainly plants, bacteria and fungi, but also vertebrates and 
invertebrates have been employed as sources [3]. Among the mentioned groups, fungi are 
highly diverse, with ca. 100.000 known species and an estimated 1.5 - 5.1 million species [4]. 
They colonize virtually any substrate, ranging from exposed rocks and deserts to freshwater 
and marine habitats. Most importantly, they interact with other organisms as parasites, 
symbionts or decomposers and thus remineralize decaying organic material [5].  
However, the vast diversity of metabolic scaffolds from fungi cannot only be explained by the 
number of species. In their natural environments, they are exposed to often harsh conditions, 
e.g., intense sun light, low nutrient availability or osmotic stress in saline habitats [6–8]. What 
may be even more important is the close contact to other, often concurring organisms (e.g., 
in soil or on plant surfaces). In soil, up to 1011-1012 prokaryotic cells can be found per gram 
dry sample via microscopic methods [9,10]. Adaption to the numerous different ecological 
niches is of course also reflected by a variety of morphological and physiological 
characteristics. Consequently, fungi developed a vast array of specific enzymes and 
metabolic capabilities. Therefore they are a prolific source of primary and secondary 
metabolites [11–18]. This applies mainly to the Ascomycota and the Basidiomycota, which 
comprise more than 90% of the known fungal species (see fig. 1.1) and are also the most 
productive producers of secondary metabolites  [19]. 
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Fig. 1.1: A phylogenetic tree, showing the fungi as a distinct group. The picture is taken from Stajich et 
al. [5]. 
 
In order to exploit the metabolic potential of fungi, the so called OSMAC (one strain many 
compounds) approach was developed and used over the last decades [20–22]. The simple, 
yet efficient idea behind this method is to stimulate the biosynthesis of a wide range of 
secondary metabolites by applying different cultivation conditions.  
This can be done by offering completely different sets of nutrients: Fermentation on nutrient-
rich complex media (e.g., yeast extract or malt extract) versus cultivation on nutrient-limited, 
defined media like Czapek-Dox agar (CDA). 
Another variant of this approach is to provide the fungus with different supplements or abiotic 
factors while cultivating it on the same substrate. Variations can be the addition of trace 
metal ions [23] as well as altered physical variables: temperature, lighting, oxygen 
concentration, to name just a few. These slight modifications can lead to major changes in 
the metabolic profile [24,25]. In recent years, co-cultivation and the addition of epigenetic 
modifiers emerged as powerful tools in this field [26]. 
Thus, the chemical diversity and strong bioactivities of different fungal natural products led to 
the development of a number of drugs and drug candidates for the medicinal use. Fig. 1.2 
shows one examples of a fungal meroterpenoid, namely fumagillin, which was first isolated 
from Aspergillus fumigatus (Trichocomaceae, Eurotiales). Biosynthetically, it is composed of 
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a sesquiterpenoid unit and a polyenic polyketide moiety [27]. The epoxy group is the 
pharmacophore, which irreversibly binds to a histidine residue of methionine aminopeptidase 
type 2 (MetAP2) [28]. Methionine aminopeptidases are cytosolic enzymes, which cleave 
terminal methionine residues from nascent proteins. They are therefore essential for the 
activation of newly synthesized proteins and cell survival [29]. While higher eukaryotes have 
two isoforms, MetAP1 and MetAP2, microsporidia only produce MetAP2. Microsporidia (e.g., 
Enterocytozoon bieneusi) are obligate intracellular parasites of vertebrates and invertebrates, 
which presumably form an ancient clade of the fungi (see fig. 1.1). In rare cases, 
immunocompromised patients get infected and suffer ocular infections, chronic 
gastrointestinal symptoms and weight loss. Therefore, fumagillin is used against 
microsporidiosis in the USA and France [3,30,31]. Since MetAP2 also has a crucial function 
in angiogenesis, fumagillin is further investigated for the treatment of different types of cancer 
[29]. 
                
Fig. 1.2: Structure of fumagillin from Aspergillus fumigatus. 
 
ASP2397 (see fig. 1.3) is a recent example of a fungal hydroxamate siderophore, which is 
being developed as antifungal agent [32]. It was isolated from Acremonium persicinum 
(Hypocreales), growing on leaf litter and shows strong inhibitory activity on different 
Aspergillus spp. While the exact mechanism is not known, data from A. fumigatus show that 
the efficacy relies on the chelated metal ions (i.e., Al3+ or Ga3+), since Fe3+ abandons the 
activity [33]. ASP2397 is taken up by hyphae through the siderophore transporter Sit1. Since 
humans do not express this protein, fungi are selectively inhibited. Currently, a phase I 
clinical trial is undertaken in order to assess its application in invasive pulmonary 
aspergillosis. This is a life-threatening infectious disease in immunocompromised patients 
[34–36]. 
Introduction 
 4 
 
Fig. 1.3: Molecular structure of ASP2397 from Acremonium persicinum, a hydroxamate siderophore 
with antifungal activity. It is currently in phase I clinical trials. M(III) = Al
3+
. 
 
1.2 PLANT-ASSOCIATED FUNGI AS SOURCES OF SECONDARY 
METABOLITES 
 
As mentioned earlier, fungi are highly adaptable organisms, able to thrive autonomously or in 
different relationships. These relationships involve symbiotic or parasitic ties with plants, 
bacteria or animals [5,37–42]. Regarding symbiotic relationships with plants, a distinction 
between mycorrhizal fungi and endophytic fungi is important: The term mycorrhiza is used to 
characterize specifically a fungal association with plant roots, where significant parts of the 
fungus still live outside of the plant tissue [43]. Microorganisms (including bacteria and even 
unicellular algae [44,45]) living asymptomatically in plant tissue are commonly referred to as 
endophytes. Endophytes can infect different plant parts and live exclusively inside of the 
plant during the association. They were found in all large groups of plants, including mosses, 
ferns, gymnosperms, angiosperms and algae. Finally, epibionts live on plant surfaces [46].  
Endophytes are usually regarded as a means to strengthen the competitiveness of the host 
plant. They influence the resistance against abiotic (e.g., light stress, drought/ salt/ oxidative 
stress) and biotic stress factors (e.g., herbivores, pathogens) [47]. Different mechanisms are 
involved in the mentioned effects. Drought stress and salt stress can be alleviated by the 
production of compatible solutes [48]. Oxidative stress, resulting from different abiotic and 
biotic stressors, was also found to be reduced in infected plants. Barley roots (Hordeum 
vulgare, Poaceae), associated with the fungal endophyte Piriformospora indica 
(Sebacinales), exhibited higher levels of antioxidant metabolites, i.e., glutathione and 
ascorbic acid [49].  
The association of different grasses with fungi from the family Clavicipitaceae (Hypocreales, 
Ascomycota; the so-called clavicipitalean endophytes) is the subject of numerous studies. 
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This is due to its agricultural and economic importance for livestock farming and crop 
growing [50]. On the one hand, clavicipitalean fungi can act as parasites on grasses, e.g., the 
ergot fungus (Claviceps purpurea). It produces different ergoline alkaloids, of which 
ergotamine is one of the main constituents (see fig. 1.4). Due to its agonist activity on 
serotonin- (5-HT1B-/5-HT1D-)receptors, it is in use against migraine (Ergo-Kranit
®). On the 
other hand, clavicipitalean fungi also form symbiotic relationships with plants, as epibionts or 
endophytes. In those cases, the fungal partner produces antioxidant phenolic substances as 
well as insecticidal and antifeedant alkaloids, which can be toxic to grazing cattle (e.g., loline 
or ergoline alkaloids) [51,52].   
From a pharmaceutical perspective, another finding may even be more intriguing: A couple 
of secondary metabolites from terrestrial plants are actually produced by fungal endophytes 
or by both symbiotic partners, plant and fungus. The discovery of plant-derived drugs being 
produced by fungal endophytes spurred the search for fungal strains, which could be 
exploited for the large-scale production of these compounds. Industrial production of plant 
secondary metabolites by plant cell cultures can be cumbersome. Thus, the replacement of 
plant cells by fungal biomass is a promising field of current research projects [53]. Examples 
include the microtubule-stabilizing anticancer drug paclitaxel from Taxus brevifolia (see fig. 
1.4). It is most likely produced by the host plant together with different endophytic fungi (e.g., 
Taxomyces andreanae or Paraconiothyrium sp. SSM001) [54], though there has been some 
controversy over the real capabilities of the endophytes to produce taxane alkaloids [55]. 
Furthermore, some of the flavonolignans (e.g., silybin A, see fig. 1.4) from the fruits of the 
milk thistle (Silybum marianum) have also been produced in axenic culture by an endophytic 
fungus, i.e., Aspergillus iizukae (Trichocomaceae, Eurotiales) [56]. A complex of at least 
seven flavonolignans, called silymarin, is used as hepatoprotective agent and antidote 
against poisoning by hepatotoxic compounds, e.g., amatoxins. Silymarin presumably acts by 
preventing lipid peroxidation in the plasma membrane and by regulating the membrane 
permeability of liver cells, thus inhibiting absorption of the toxic agents [57]. 
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Fig. 1.4: Structures of approved drugs, which are produced by fungi associated with vascular plants:  
Ergotamine is produced by the parasitic fungus Claviceps purpurea. Paclitaxel and silybin A were first 
isolated from vascular plants and are now thought to be produced additionally by fungal endophytes. 
Ph = Phenyl ring. 
 
1.3 MARINE FUNGI - ALGICOLOUS STRAINS AND THEIR POTENTIAL AS 
PRODUCERS OF LEAD STRUCTURES 
 
Though most of our planet is covered by oceans, fungi were mainly sampled or studied from 
terrestrial biotopes. Nevertheless, they are also frequently isolated from marine and 
freshwater habitats [58,59]. Some fungi even specialized on freshwater environments. These 
are commonly referred to as ´Ingoldian fungi´, though they do not form a monophyletic group 
[60]. Instead, they are defined by their ecophysiological and morphological traits. Similar to 
the Ingoldian fungi, obligate marine species belong to different phylogenetic groups mainly 
within the Ascomycota and Basidiomycota (according to the current state of knowledge). 
Thus, adaptation to marine habitats may have occurred multiple times independently during 
evolution [61,62]. Apart from that, common terrestrial lineages make up the majority of 
samples from marine habitats, thus highlighting the high adaptability of certain fungi to 
different ecological niches and degrees of salinity. Many of them live on the surface of algae 
or in their tissue as endophytes. Those species are referred to as algicolous fungi [63]. To 
Paclitaxel Ergotamine 
Silybin A 
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date, macroalgae from the Chlorophyta (green algae), Rhodophyceae (red algae) and 
Phaeophyceae (brown algae) were found to harbor fungal endophytes [64]. 
Similar to marine-derived fungi in general, secondary metabolites from marine sources have 
long been neglected due to the difficulty in sampling. Since it is becoming increasingly harder 
to find new chemical entities in terrestrial strains, marine-derived fungi are an advancing 
research area [65,66]. As mentioned before, a number of studies on terrestrial endophytes 
focus on the ability of fungi to produce plant secondary metabolites. However, research on 
marine endophytes or epibionts concentrates more on the discovery of new chemical 
entities. Clinical studies already have been undertaken with fungal metabolites from marine 
sources. Unfortunately, however, none has been approved yet [67]. 
A promising example for a marine-derived lead structure is (-)-phenylahistin (syn. halimide, 
see fig. 1.5), which is produced by an Aspergillus sp., isolated from a green alga near the 
Philippine Islands. Chemically, it is a diketopiperazine derivative with cytotoxic activity. In 
order to improve its bioactivity, it was semi-synthetically modified to yield plinabulin [68,69]. 
The mechanism of action of plinabulin is believed to be the induction of caspase- and JNK 
(c-Jun N-terminal kinase)-dependent apoptosis. Additionally, it leads to microtubule 
depolymerization in vascular endothelial cells in the tumor [70]. Currently, a phase III clinical 
trial is under way in order to assess its efficacy in combination with docetaxel against 
advanced NSCLC (non-small cell lung cancer) [71]. 
 
 
 
 
Fig. 1.5: Structures of (-)-phenylahistin (syn. halimide) and the semi-synthetic derivative plinabulin 
(syn. NPI-2358). 
 
 
 
 
(-)-Phenylahistin 
Plinabulin 
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1.4 INTRODUCTION TO THE ENZYMATIC TARGETS AND THEIR ROLE IN 
HUMAN DISEASES 
 
Cerebroside sulfotransferase: 
Human cerebroside sulfotransferase (hCST) catalyzes the sulfonation of galactose residues 
of glycolipids. One of the major substrates is galactosyl ceramide, a glycosphingolipid, which 
is converted by hCST into sulfatide (see fig. 1.6) [72–74]. The enzyme is located in the 
membrane of the Golgi apparatus with the catalytic domain localized to the lumen. To date, 
neither the crystal structure of the hCST was published, nor is the exact catalytic mechanism 
known [72].  
Arylsulfatase A (ASA or ARSA) is the physiological opponent of hCST, since it recycles 
sulfatide into cerebroside, thereby preventing the accumulation of sulfatide in healthy 
individuals [75]. Mutations in the gene, which codes for ASA, can lead to ASA deficiency and 
subsequently to increased concentrations of sulfatide in lysosomes of different cell types, 
especially in the central (CNS) and peripheral nervous system (PNS), where the myelin 
sheath is most affected. As a consequence, the accumulation of sulfatide leads to a 
degradation of the myelin sheath (´demyelination´) and to lesions of the white matter in the 
brain [76]. This observation led to the name for this disease - metachromatic leukodystrophy 
(MLD). It is a rare, autosomal recessive disorder [75,77]. Based on the lysosomal location of 
sulfatide accumulation, it is grouped into the lysosomal storage diseases. Symptoms mostly 
include neurological signs like seizures, paresis, movement disorders, speech disorders and 
a dramatically decreased expectancy of life. Patients often die during childhood. 
While ASA deficiency is usually responsible for the development of MLD, in a few cases ASA 
activity seems to be normal. Instead, the putative cofactor of ASA is affected. This 
glycoprotein - saposin-B and its precursor prosaposin – stimulates ASA activity [78]. In rare 
cases, mutations in the gene coding for prosaposin (psap) lead to symptoms, which 
resemble those of the metachromatic leukodystrophy. The difference is that ASA activity is 
normal in those cases [79].  
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Fig. 1.6: Reaction scheme, showing the sulfonation reaction catalyzed by hCST and sulfatide 
breakdown by ASA [72,76].  
R = fatty acyl substituent with different chain lengths. 
A: Galactosyl ceramide ≡ cerebroside  
B: Sulfatide 
PAPS = 3´-Phosphoadenosine-5´-phosphosulfate 
hCST = Cerebroside sulfotransferase  
 
Currently, there is no causal therapy or cure available for MLD, regardless of whether ASA 
activity is affected or the activity of saposin-B [75]. Recent attempts to introduce new 
treatments include the intrathecal application of a recombinant human arylsulfatase A 
(enzyme replacement therapy, ERT) [80] or hematopoietic stem cell transplantation [81]. 
None of these methods was approved for clinical use, yet. A third approach would be 
substrate reduction therapy [72,82], which  requires an inhibitor of hCST in order to prevent 
the accumulation of sulfatide. For other lysosomal storage diseases, this approach is already 
in clinical use: Miglustat (n-butyldeoxynojirimycin) was approved for use against Morbus 
Gaucher (type I) and Niemann-Pick disease (type C) [83], while migalastat (1-
deoxygalactonojirimycin) was approved recently (in 2016) in the EU for use against Morbus 
Fabry [84,85]. The latter was isolated from the actinomycete Streptomyces lydicus [86]. 
However, no inhibitor of hCST was known at the beginning of this study [72]. But the last 
example shows that it is worth searching for lead structures against lysosomal storage 
diseases in microorganisms.  
 
 
 
A 
B 
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Cysteine and serine proteases: 
Proteases can be found in every domain of life, including viruses [87]. More than 2% of the 
human genome consist of sequences coding for proteases or protease inhibitors, which 
points to their physiological importance [88]. Based on functionally important amino acids in 
their active site, they were subdivided into six broad subgroups, amongst them are cysteine- 
and serine-proteases. These subgroups are further subdivided into clans and families 
according to catalytic mechanism and ancestry [89]. A common trait of cysteine and serine 
proteases is that they employ a nucleophile – either a Cys or a Ser residue – to attack the 
carbonyl function of the substrate and thereby cleave the peptide bond.  
Serine proteases make up more than one third of the known proteases. Most serine 
proteases are endoproteases, which are involved in blood coagulation, cell development, 
digestion [90]. They also contribute to inflammatory diseases, like lung emphysema [91]. In 
plants, serine proteases were proven to have important functions in defense against 
pathogens [92]. The active site is usually formed by a catalytic triad of Asp, His, Ser. The 
hydroxyl group of serine is deprotonated by a histidine  residue and thereby activated. Asp 
has the role of stabilizing the protonated His residue [93]. This is especially true of 
chymotrypsin-like peptidases, of which some representatives were assayed for this study, 
i.e., chymotrypsin, trypsin, neutrophil elastase (human leukocyte elastase, HLE). 
Chymotrypsin and trypsin are both part of the digestive system, where they break down 
proteins. Both are synthesized in the pancreas as proenzymes and activated later in the 
small intestine [94]. HLE is secreted by neutrophil granulocytes and is connected with 
degradation of pathogens under physiological conditions [95]. 
Like serine proteases, cysteine proteases are distributed among all domains of life [96]. The 
common property of cysteine proteases is a catalytic dyad, formed by a Cys and a His 
residue. Similar to serine proteases, the His residue deprotonates the thiol group of Cys, the 
resulting thiolate ion acts as a nucleophile on the carbonyl bond of the peptide substrate. 
Among the members of papain-like proteases (clan CA, according to the MEROPS-database 
[89]), which encompasses the cysteine cathepsins, Gln and Asn (or Asp) have supportive 
roles in the active site [97]. Papain-like proteases are distributed widely, e.g., in plant latices, 
where they are supposed to play a role against herbivores [98]. In contrary, human 
cathepsins are predominantly located in the lysosomes [99]. Regarding the physiological and 
pathological relevance of serine and cysteine proteases, please refer to table 1.1. 
In recent years, a few reports were published about inhibitors of cysteine and serine 
proteases from natural origin, especially against cathepsins B, L and K or HLE [100–105]. 
Among them are also fungal metabolites, like the anthraquinone chrysophanol isolated from 
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Penicillium citrinum, which is active against cathepsin B [101]. HLE inhibitory activity was 
found for a tetramic acid derivative (Sch210972) from a Microdiplodia sp. [106] and for two 
enantiomeric phthalimides from a Stachylidium sp. [107]. In both cases, activities are in a low 
micromolar range, underlining the high potential of natural products of fungal origin for novel 
drug leads.  
 
Tab. 1.1: Main physiological functions and pathological relevance of the tested enzyme types.   
Enzyme Main physiological functions Main pathological relevance 
Trypsin Proenzyme produced in pancreas, 
activation in small intestine;  
involved in digestion of food proteins 
Pancreatitis through premature 
activation already in the pancreas 
[108] Chymotrypsin 
HLE 
Secretion by neutrophil granulocytes                 
(degradation of pathogens) 
COPD (chronic obstructive 
pulmonary disorder), rheumatoid 
arthritis [109,110] 
Cathepsin B 
In different cell types, involved in 
degradation of extracellular matrix 
(ECM) 
Cancer [111,112] 
Cathepsin L 
In different cell types involved in protein 
turnover 
Cancer and metastasis [113] 
Cathepsin K 
Mainly found in osteoclasts; responsible 
for resorption of non-mineral bone 
matrix 
Osteoporosis [111] 
Cathepsin S 
Antigen presentation in antigen 
presenting cells; endothelial cells 
Different chronic inflammatory 
diseases (rheumatoid arthritis, 
psoriasis, asthma,…), [114]; 
neuropathic pain [115]; psoriasis 
[116] 
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1.5  EXUDATION IN FUNGI AND ITS SIGNIFICANCE 
 
Fungi in general follow an ´absorptive lifestyle´: They secrete enzymes in order to break 
down organic macromolecules and subsequently ingest the products. Additionally, small 
organic acids (e.g., oxalic acid) and different siderophores are employed for the supply with 
inorganic nutrients (e.g., trace metals and phosphate) [43,117]. Moreover, the buildup of the 
fungal cell wall depends on the vesicular secretion of chitinases and β-1,3-D-glucan 
synthases for the formation of cell wall components [118]. Thus it becomes evident that fungi 
rely heavily on different secretory mechanisms for their growth. By means of exudation or 
secretion of metabolites into their surrounding space, fungi also change their environment 
and may thereby control the community structure in the respective ecological niche [119]. For 
this purpose, fungi can either secrete primary metabolites, e.g., trehalose, which can be used 
as substrate by certain bacteria [120]. Toxic secondary metabolites may, in turn, be used as 
defense weapons. Furthermore, secreted chemical signals may also induce symbiotic or 
parasitic relationships to plants or even humans [121]. Cryptococcus neoformans, a 
basidiomycete causing life-threatening infections in immunocompromised patients, releases 
virulence factors into the host tissue via exocytosis. The vesicles presumably pass the cell 
wall through preformed pores [122]. 
Since fungi produce a large number of highly bioactive metabolites, secretion can also serve 
as a detoxification mechanism for toxic metabolic end-products [123]. The secreted 
compounds can further act as virulence factors or defense substances. Such a dual role for 
secretion, i.e. for waste disposal and defense or host invasion, was shown for gliotoxin and 
aflatoxin [124,125].  
Apart from exocytosis, two types of transporters are used for the secretion of specific 
secondary metabolites. MFS (major facilitator superfamily) transporters use the 
electrochemical gradient at the plasma membrane as the driving force. Their role was proven 
for the expulsion of cephalosporin and gliotoxin [124,126]. ABC (ATP-binding cassette) 
transporters hydrolyze ATP. They were proposed to carry out the secretion of penicillin in 
Aspergillus nidulans [127].  
Guttation (Latin gutta = drop) is a special means for the exudation of solutes from the cell. It 
occurs widely in plants, bacteria and fungi, i.e., Basidiomycota, Ascomycota and 
Mucoromycotina [128,129]. Originally, it was described for plants, which are able to exude 
liquid water actively onto the leave surface. Guttation droplets are commonly  observed 
under conditions of high humidity, when the capacity of the transpiration-driven water flow 
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from the roots up to the leaves cannot be exploited sufficiently [130]. Among the 
Basidiomycota, guttation is also frequently observed in the wild on fruiting bodies, while in 
the Ascomycota guttation droplets in axenic culture have been used as taxonomic markers 
[131–133]. In contrary to plants, only little is known about the reasons for guttation and the 
underlying cellular structures in fungi [133]. Guttation droplets can be regarded as exudates, 
which form droplets on the mycelium due to the highly hydrophobic cell wall of the fungal 
hyphae [134]. These droplets were shown in a few cases to harbor reasonable amounts of 
primary (e.g., carbohydrates, amino acids, enzymes) and secondary metabolites, both, in 
plants and in fungi [133,135,136].  
Hypotheses on the role of guttation in fungi include the relevance for storage or disposal of 
primary and secondary metabolites. Fungi, especially at the hyphal tip, do not have extensive 
storage capacities such as plants, which usually form a large central vacuole [119]. Guttation 
droplets were also shown to exert antifeedant or antimicrobial activity and to mediate plant 
cell wall degradation [136–138]. Finally, a role in the growth of hyphae was proposed, 
specifically as a water reservoir to keep up the intracellular turgor [139]. These observations, 
together with the fact that guttation droplets can be analyzed without extensive processing, 
renders guttation droplets interesting subjects to assess their ecological significance and 
their usability during drug discovery projects.   
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2 AIM OF THE PRESENT STUDY 
 
The main goal of the present study is to identify bioactive metabolites from marine-derived 
fungi, which could serve as lead structures for the development of medicinal drugs. For this 
purpose, two fungal strains, Epicoccum nigrum strain 749 and 800, were chosen based on 
preliminary screening results to be cultivated under different conditions in order to search for 
inhibitors of human cerebroside sulfotransferase as well as against serine- and cysteine 
proteases.  
First, the two fungal strains are to be subjected to different substrates and cultivation 
conditions, in order to examine their ability to produce secondary metabolites. Besides the 
medium, abiotic factors like light and trace element supplementation are included in the 
fermentation experiments. The most promising cultivation conditions are then chosen for 
large scale fermentation.  
In the next step, preparative analytical methods are employed for the fractionation of 
promising crude extracts and isolation of secondary metabolites, which will be characterized 
via different analytical techniques.  
One of the known metabolites from polyketide origin – acetosellin – will be investigated 
regarding its biosynthesis through feeding of labeled precursors. Thus, its construction from 
two separate polyketide units shall be proven.   
Second, the isolated secondary metabolites will be subjected to different pharmacological 
assays for the assessment of their biological effects with an emphasis on the aforementioned 
targets.  
In the end, guttation droplets, which are formed by E. nigrum strain 749 under certain 
conditions, are to be examined for their content in secondary metabolites. The metabolic 
pattern will be compared between the guttation droplets and the fungal crude extracts. In this 
way, their applicability for drug discovery during the screening for bioactive metabolites shall 
be assessed. Therefore, a thorough qualitative and quantitative chemical examination will be 
carried out, taking into account the effect of different cultivation conditions on the constituent 
levels.  
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3 MATERIALS AND METHODS 
 
3.1 THE FUNGAL STRAINS 
 
During this study, two fungal strains of the species Epicoccum nigrum LINK were cultivated 
and studied for their chemical constituents: 
Strain 749 was isolated from the surface of an unspecified green alga on water agar (WA, 
see below). The alga was collected at Cabrera (Spain).  
Strain 800 was isolated as an endophyte from a Fucus sp. (Fucaceae, Phaeophyceae [≡ 
brown algae]) on chitin malt extract agar (CM, see below). The alga was collected at Büsum, 
Germany. 
Collection of the algae, isolation of fungal strains and early examinations (see section 3.1.1) 
were carried out by Ekaterina Egereva (Institute of Pharmaceutical Biology, University of 
Bonn). For the isolation of fungal samples, following procedure was applied: 
The algal samples were first sterilized with 70 vol% EtOH, then rinsed with sterile water and 
pressed onto sterile agar surfaces (control samples). Viable spores or hyphae on the surface 
of the alga were to be detected through incubation of these agar plates. The remaining 
sterilized algal samples were then cut into pieces and incubated on agar separately 
(´endophyte-revealing samples´). Mycelia growing out of the cut surface were deemed as 
endophytes. Mycelial mats, which were also observed on the control samples, were marked 
as ´non-endophytic´, i.e., epibionts or contaminants. Promising fungal colonies were 
separately transferred onto new plates containing MES medium. The media, which were 
used during the isolation process are the following. Each isolation medium was 
supplemented with 250 mg/L benzylpenicillin (= penicillin G) and 250 mg/L streptomycin 
sulfate. 
Water agar (WA): 15 g agar, 1 L ASW. 
Glucose yeast agar (GYA): 15 g agar, 1 g glucose, 0.1 g yeast extract, 1 L ASW. 
Chitin malt extract agar (CM): 15 g agar, 2 g chitin, 10 g malt extract, 1 L ASW. 
Cellulose agar (CA): 15 g agar, 20 g cellulose, 1 L ASW. 
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3.1.1  EARLY EXAMINATION OF ISOLATED FUNGAL STRAINS  
 
The isolated strains were subjected to medium scale fermentation on solid agar media. The 
resulting extracts were used for the investigation of promising chemical  bioactivities. 
Following media were employed for the cultivation (see section 3.1.3 for media composition): 
MEA (malt extract agar) 
MES (malt extract agar with addition of artificial sea water) 
 
3.1.2  IDENTIFICATION AND TAXONOMY 
 
Microscopy was carried out using an Olympus BX51 microscope. Pictures were recorded 
with CellA 2.4 software (CellA Soft Imaging Systems GmbH, Münster). 
 
3.1.2.1 MOLECULAR IDENTIFICATION 
 
For the molecular identification of the two strains, the ITS (internal transcribed spacer) region 
was employed. ITS sequences are linker regions within the rDNA (ribosomal DNA), which 
codes for the ribosomal RNA (rRNA). Typically, high copy numbers of rDNA occur as tandem 
repeats on one DNA molecule. These repeats are connected by linker regions, which are 
divided into a NTS (non-transcribed spacer, harboring the promotor) and the ETS (external 
transcribed spacer). Transcription of rDNA is carried out by RNA-polymerase I in eukaryotes 
[140].  
Each transcription unit consists of an external transcribed spacer (ETS), a small (SSU, 18S), 
a large (LSU, 28S) and a 5.8S subunit. The linker sequences – ITS1 and ITS2 – between 
these subunits are called ITS sequences, whereas the ITS1, 5.8S subunit and ITS2 taken 
together are referred to as ITS region. Due to the high variability and copy number, the ITS 
region is frequently used for the molecular identification of fungi and was proposed as a 
universal barcode marker [141,142].   
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Fig. 3.1: Schematic drawing of the eukaryotic rDNA. The arrow represents the hybridization region of 
the ITS4 primer, with the head being the 3´-end. The interrupted orange lines stand for the NTS (non-
transcribed spacer, including the promoters) and the ETS. SSU = Small subunit; LSU = Large subunit.                                                                            
(Picture modified from: Schmidt-Stohn, G.; Oertel, G. “DNA-Analysen in der Pilz-Taxonomie.” Journal 
Des Journee Europeennes Du Cortinaire, 11 (2009): 10–19.) 
 
During this study, the ITS4 primer, described by White et al. [143] was used. The primer was 
provided by Eurofins MWG Operon (Ebersberg, Germany):   
Sequence (5´ → 3´):  
TCCTCCGCTTATTGATATGC (TM = 55.3°C, according to the manufacturer) 
 
The identification process included following six steps: 
1) For the extraction of fungal DNA, static liquid cultures, grown in 100 ml MEB (malt extract 
broth: 2g malt extract, 100 ml demineralized water) under artificial light for two weeks 
were chosen. At the end of the cultivation, the fungal biomass was separated from the 
liquid medium and dried in a freeze drier. The DNA was then extracted with the E.Z.N.A.® 
SP Fungal DNA Mini Kit (Omega Bio-tek, Norcross, USA).  
 
2) Polymerase chain reaction: PCR was performed applying a T3-thermocycler. For PCR 
amplification of template DNA, PCR-buffers supplied with the GoTaq® Flexi DNA 
Polymerase were applied.  
 
 
 
 
 
3´ 5´ 
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Tab. 3.1: PCR reaction mixture: 
5x GoTaq® Flexi Buffer   10.0 μl 
MgCl2  (25 mM) 2.5 μl 
dNTP  (each 10 mM) 1.0 μl 
GoTaq-Polymerase  (5 unit/μl) 0.5 μl 
Primer  (100 μM) 1.0 μl 
DMSO  2.5 μl 
Template   2.0 μl 
H2O (nuclease-free)  ad 50.0 μl 
 
A modified version of the thermocycling sequence described in [143] was applied: 
Tab. 3.2: Thermocycling sequence 
 Step Temperature [°C] Duration [s] 
 Initial denaturation 95 120 
35 cycles of: Denaturation 95 30 
 Annealing 55 30 
 Extension 72 60 
 Final extension 72 600 
 
3) After amplification, the fragments were separated through agarose gel electrophoresis 
and the bands with a size of ca. 450 – 600 bp were excised. Agarose gel electrophoresis 
was employed for the purification of the PCR products. Gels consisted of 1% peqGOLD 
Agarose in 1 x TBE buffer. Simple gels were usually run for 20 min at a voltage of 120 V 
in Life Technologies Horizon® 58 chambers. Nucleic acid probes were mixed with gel 
loading dye before loading them into the slots. DNA standards were applied to each gel 
for size estimation.  
 
The gels were stained subsequently to the separation run. The dye bath contained 100 
ml ethidium bromide solution (10 mg/ml), the gels were stained for 1-3 min, followed by a 
washing step in water for another 3-5 min. Bands containing nucleic acids were 
visualized in under UV light (254 nm).  
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Detected PCR fragments were directly cut out from the gel and purified using the 
Wizard® SV Gel and PCR Clean-up System (Promega, Mannheim, Germany), following 
the manufacturer’s protocol. 
 
4) DNA sequencing was carried out by GATC Biotech AG (Konstanz, Germany) using a 454 
pyrosequencing method [144].  
 
5) The obtained sequence data were checked for errors and edited using Geneious® Basic 
5.6.7 (www.geneious.com, [145]), then analyzed with other sequences obtained in this 
lab and from Genbank [146], using the blastn suite of BLAST (Basic Local Alignment 
Search Tool; http://blast.ncbi.nlm.nih.gov/Blast.cgi; [147]).  
 
6) The first four hits in the nucleotide search were used for phylogenetic analysis (for each 
strain), together with three further sequences of fungi (Phoma exigua strain PB5, Phoma 
betae strain 815, Gliomastix murorum strain 469), which were isolated before in our lab 
(see appendix for sequences or accession numbers). The two Phoma species were 
chosen for their close relationship (both belong to the order Pleosporales), whereas 
Gliomastix murorum is distantly related (order Hypocreales). 
The evolutionary history was inferred by using the Maximum Likelihood method based on 
the Tamura-Nei model [148]. The tree with the highest log likelihood (-1237.5214) is 
shown. The percentage of trees in which the associated taxa clustered together is shown 
next to the branches. Initial tree(s) for the heuristic search were obtained automatically by 
applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated 
using the Maximum Composite Likelihood (MCL) approach, and then selecting the 
topology with superior log likelihood value. The tree is drawn to scale, with branch 
lengths measured in the number of substitutions per site. The analysis involved 12 
nucleotide sequences. All positions with less than 95% site coverage were eliminated. 
That is, fewer than 5% alignment gaps, missing data, and ambiguous bases were 
allowed at any position. There were a total of 423 positions in the final dataset. 
Evolutionary analyses were conducted in MEGA6 [149]. 
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3.1.3  CULTURE CONDITIONS AND MEDIA FOR LARGE SCALE 
FERMENTATION 
 
In this section, the constituents for the media used in this study will be given. If nothing else 
is mentioned, all ingredients were added and mixed on a magnetic stirrer before autoclaving 
the media. Each preculture was prepared by cultivating the respective strain at 25°C in an 
incubation chamber in darkness. After autoclaving, either ca. 100 mL of the respective 
medium was poured into each petri dish (145 x 20 mm), or 250 mL were used in Fernbach 
flasks for large scale cultivation. Inoculation was carried out using 3 agar plugs of precultures 
per plate. After inoculation, the plates were sealed with parafilm and incubated at 26°C under 
constant artificial illumination (white light). Cultures grown in darkness were stored in the 
same room in a closed box.  
Malt extract agar (MEA):  20 g malt extract, 16 g agar (Sigma-Aldrich), 1000 mL 
demineralized water. 
MES (MEA + ASW): 20 g malt extract, 16 g agar, 500 mL ASW stock solution, 500 
mL demineralized water.  
MEN (MEA + ASW + NaOAc): 20 g malt extract, 16 g agar, 1 g NaOAc, 500 mL ASW 
stock solution, 500 mL demineralized water.  
MPY (malt extract – peptone – yeast extract agar): 20 g malt extract, 2.5 g 
peptone from animal tissue (Roth), 2.5 g yeast extract (Roth). 
Czapek-Dox agar (CDA): 35 g Czapek-Dox broth, 16 g agar, 1000 mL demineralized water.  
For the preparation of CDA and CDT, Difco Czapek-Dox broth was used. The constituents 
are as follows [g/L medium]: 
Tab. 3.3: Constituents of Difco Czapek-Dox broth: 
Compound Amount [g] 
Sucrose 30.0 
NaNO3 3.0 
K2HPO4 1.0 
MgSO4 0.5 
KCl 0.5 
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Czapek-Dox agar + TMS (CDT): 35 g Czapek-Dox broth, 16 g agar, 1 mL TMS stock 
solution, 1000 mL demineralized water.  
Czapek-Dox agar + Cu2+ (CDA+Cu2+): 35 g Czapek-Dox broth, 16 g agar, 1 mL 
CuSO4 stock solution, 1000 mL demineralized water. 
Czapek-Dox agar + Zn2+ (CDA+Zn2+): 35 g Czapek-Dox broth, 16 g agar, 1 mL 
CuSO4 stock solution, 1000 mL demineralized water. 
Artificial seawater (ASW): Artificial seawater was prepared by dissolving defined salts in 
demineralized water. It was mixed as a stock solution in double concentration. Per Liter agar 
medium, 500 mL of ASW were added and filled up with 500 ml of demineralized water. The 
stock solution contains following salts: 
 
Tab. 3.4: Constituents of artificial sea water (ASW) stock solution (per Liter demineralized water): 
Constituent amount [g] 
KBr 0.2 
NaCl 46.96 
MgCl2 x 6 H2O 21.22 
CaCl2 x 2 H2O 2.94 
KCl 1.32 
SrCl2 x 6 H2O 0.08 
Na2SO4 7.84 
NaHCO3 0.38 
H3BO3 0.06 
 
Trace metal solution (TMS): According to Frisvad [20], 1 g ZnSO4 x 7 H2O and 0.5 g CuSO4 
x 5 H2O were dissolved in 100 ml demineralized water. Of this solution 1 ml was taken for the 
preparation of 1 L CDT or any other TMS-supplemented medium. The final concentration in 
the medium was: c(Zn2+) = 35 µM; c(Cu2+) = 20 µM. 
 
CuSO4 stock solution: 0.5 g CuSO4 x 5 H2O was dissolved in 100 ml demineralized water. 
Of this solution 1 ml was taken for the preparation of 1 L Cu2+-supplemented medium 
(CDA+Cu). 
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ZnSO4 stock solution: 1 g ZnSO4 x 7 H2O was dissolved in 100 ml demineralized water. Of 
this solution 1 ml was taken for the preparation of 1 L Zn2+-supplemented medium (CDA+Zn). 
 
3.1.4  EXTRACTION OF THE CULTIVATED FUNGI 
 
When nothing else is stated, the fermented cultures – containing mycelium and agar medium 
– were harvested after 4 weeks and minced using a blender. Aliquots were transferred to 1L 
round flasks and covered with 300 – 400 mL EtOAc. The saturated solution was decanted 
and exchanged for pure EtOAc. Decanting was carried out successively four times during 
two days, in order to exhaustively extract the secondary metabolites. The collected four 
aliquots were then unified, dried in a rotary evaporator to dryness and stored under -18°C. 
 
3.1.5  CULTIVATION AND EXTRACTION CONDITIONS FOR THE ´TIME 
COURSE EXPERIMENTS´ AND ISOTOPIC LABELING 
 
3.1.5.1 STRAIN 800 – TIME COURSE EXPERIMENT 
 
To determine the optimal cultivation time for the labeling experiment with sodium [1-
13C]acetate, a large scale culture of Epicoccum nigrum strain 800 on MEN (6.25 L, divided 
into 25 Fernbach flasks; continuous illumination with artificial white light; 26 °C) was prepared 
and divided into five equal parts. Extraction was carried out in time intervals of 1 week, 
starting at week 1 and ending at week 5.  
For each time point, five cultures, equal in size (total volume of medium: 1.25 L), were 
extracted three times with ca. 400 mL EtOAc, a sufficient amount to cover the agar pieces. 
The solvent was evaporated at 40 °C, using a rotary evaporator. For the yields of extracts 
see fig. 3.2.  
 
 
Fig. 3.2: Yields for the extractions of the time cultures of E. nigrum strain 800. 
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3.1.5.2 STRAIN 749 – ISOTOPIC LABELING EXPERIMENT 
 
Since E. nigrum strain 749, grown on CDA, proved to be a superior production system than 
strain 800 on MES, labeling cultures were prepared using following protocol: 
Strain 749 was cultivated for 3 weeks on 500 mL of CDA under continuous illumination with 
artificial white light at 26 °C.  
A solution was prepared containing 55.6 mg/mL sodium[1-13C,99%]acetate (Cambridge 
Isotope Laboratories Inc.) in demineralized H2O.  
3 mL of this solution were added to each Fernbach flask during the cultivation period on days 
4, 7 and 10, respectively. The solution was spread evenly on the agar surface in order to 
enable every part of the mycelium to get in contact to the labeled precursor. The total amount 
of added precursor was 500 mg sodium[1-13C,99%]acetate per flask, which equals a 
concentration of 2 g/L medium. 
After 21 days, the labeling culture underwent the same extraction procedure as described in 
section 3.1.5.1, yielding 111 mg of crude extract (´749-13C-EtOAc´). 
 
3.2 CHROMATOGRAPHY 
 
3.2.1  SIZE EXCLUSION CHROMATOGRAPHY (SEC) 
 
The sorbent used for SEC was Sephadex® LH-20 (Sigma Aldrich), pure MeOH served as the 
mobile phase. The stationary phase was swollen overnight in the eluent prior to packing of 
the column. The column was packed with the sorbent being suspended in the eluent. The 
flow was set to ca. 2-4 drops/second. 
 
3.2.2.  VACUUM LIQUID CHROMATOGRAPHY (VLC) 
 
Separations were performed using either silica gel 60 (0.063-0.2 mm, Merck), silica gel 60M 
(0.04-0.063 mm, Macherey-Nagel) or Polygoprep 60 C18 (0.05 mm, Macherey-Nagel). 
Columns were packed under vacuum with the sorbent being suspended in the eluent, using 
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PE or dichloromethane for normal-phase, and MeOH for RP separations. Each column was 
equilibrated prior to the separation with the first designated eluent. Vacuum was applied 
using a water-jet vacuum pump. 
 
3.2.3.  SOLID PHASE EXTRACTION (SPE) 
 
For solid phase extraction, a Bakerbond C18 column (2000 mg/6ml; column A) or Bakerbond 
C18 (1000 mg/3 ml, column B) was used. Separations were performed using a water-jet 
vacuum pump. Columns were equilibrated with the first designated eluent. 
 
3.2.4.  FLASH CHROMATOGRAPHY (FC) 
 
A Reveleris X2 Flash Chromatography System with UV-detector and ELSD was used. 
Software: Navigator. For the introduction of samples, either a 3 g- or a 12 g-solid loader was 
used. Packing of the solid loaders was achieved through adsorption of the sample onto silica 
gel 60 (0.063–0.200 mm, Merck) or Polygoprep 60 C18 (0.05 mm, Macherey-Nagel), 
respectively. The dried material was then filled into the solid loader. Reveleris® flash 
cartridges, prefilled either with 4 g or 12 g of silica or C18-silica, were used (with 40 µm 
particle size).  
3.2.5.  HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
 
Following systems were used: 
System A: Waters 1525µ binary pump with Waters 2998 diode array detector (DAD). 
Software: Breeze 2 (© 2008 Waters Co.). 
System B: Waters HPLC system equipped with a 2695 separations module, a 996 DAD and 
QuickStart Empower 2 software (© 2005 Waters Co.). 
System C: HPLC system composed of a Waters 515 pump with a Knauer K-2300 differential 
refractometer. 
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System D: Merck-Hitachi system equipped with an L-6200A pump, an L-4500A photodiode 
array detector and a D-6000 interface. 
 
Columns: 
Column A: Macherey-Nagel Nucleodur C18 ec (250 x 8 mm, 5 µm). 
Column B: Kinetex C18 column (Phenomenex, 250 mm x 4.6 mm, 5 µm). 
Column C: Kinetex PFP column (Phenomenex, 250 mm x 4.6 mm, 5 µm). 
Column D: Macherey-Nagel Nucleoshell RP18 plus column (250 mm x 4.6 mm, 5 µm).  
Column E: Atlantis T3 RP18 column (250 x 4.6 mm, 5 µm). 
Column F: Phenomenex Aqua C18 (250 x 4.6 mm, 5 µm, 125 Å). 
Column G: YMC-Triart C18 (250 x 4.6 mm, 5 µm). 
Column H: Macherey-Nagel Nucleodur PFP (250 mm x 4.6 mm, 5 µm). 
 
3.2.6  ISOLATION PROTOCOLS  
 
3.2.6.1 ISOLATION OF EPIPYRONES (1-3), EPICOCCONE (11) AND 1F4-1-6 
(12) 
 
E. nigrum strain 749 was cultivated under continuous illumination for 5 weeks on 7 L of MES 
medium, distributed among 28 Fernbach flasks. The collected medium and mycelium were 
extracted together five times successively, using EtOAc, yielding 2.66 g of crude extract. 
VLC on NP (70 g of silica gel 60, 0.063-0.2 mm, Merck) was employed for the first separation 
step. The step gradient involved the use of DCM, acetone, MeOH  (DCM/acetone/MeOH, 
90:10:0  90:10:0  70:30:0  50:50:0  30:70:0  0:100:0  0:70:30  0:50:50  
0:30:70  0:0:100  0:0:100; 100 ml for each step), yielding eleven fractions. The polar 
fractions 6-11 were pooled (= 1F12) for further fractionation, since they showed strong 
signals for epipyrones (1-3) in the LC-MS. Fraction 1F12 was then subjected to SEC (see 
section 3.2.1) with 250 g of Sephadex® LH-20. Fractions were taken with a volume of 50 mL, 
the total number of fractions being 39. Fractions 12-18 showed strong signals for epipyrones 
(1-3) in the LC-MS. Therefore, they were again pooled and purified employing RP-VLC 
(column packed with 100 g of Polygoprep 60 C18 silica gel) and isocratic elution with 
MeOH/water(0.2% TFA) 80:20. The volume of each fraction was ca. 150 mL (fractions 1-10) 
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or ca. 250 mL (fractions 11-16). Fraction 5 proved to be purified epipyrones (1-3; 79 mg, 11.3 
mg/L), while fractions 4, 6, 7, 8, 9 also contained epipyrones (1-3) in a semi-pure form. 
Fraction 5 was used throughout this work for bioactivity testing.  
The aforementioned fractions from the NP-VLC separation were also employed for the 
isolation of further compounds:  
Compound 12 was isolated from VLC-fraction 4 via successive use of RP-SPE on C18-silica 
gel (MeOH/H2O 50:50  100:0 in 10 steps; column A; 30 mL per fraction). SPE-fraction 
number 1 was purified employing HPLC (system C, column A, MeOH/water 60:40, 1.5 
mL/min), with compound 12 eluting after 16 min (m = 2.4 mg).  
Epicoccone (11) was isolated from VLC-fraction 5 via successive use of RP-SPE (column A, 
MeOH/water 60:40; 50 mL per fraction, 7 steps), fraction 1 was again subjected to RP-SPE 
(column B; MeOH/water 10:90; 30 mL per fraction, 4 steps) and fraction 1 of the latter 
fractionation was purified by HPLC system B [column F, ACN/water 5:95 (t = 0-15 min), 5:95 
 10:90 (t = 15-30 min), 10:90  80:20 (t = 30-40 min)], with epicoccone (11, 2.7 mg) 
eluting after 26 min (8% ACN).  
 
3.2.6.2 ISOLATION OF ACETOSELLIN (4) 
 
The crude extract of E. nigrum strain 749 (m = 576 mg), grown on Czapek-Dox agar (CDA) 
under continuous illumination for four weeks, was first defatted using liquid-liquid extraction. 
For this purpose, the sample was dissolved in 100 ml MeOH/water (80:20) and successively 
shaken three times with 100 ml petrol ether in a separation funnel. The defatted fraction (321 
mg) was subjected to flash chromatography (see fig. 4.13). For this procedure, the sample 
was dissolved in MeOH and adsorbed onto 3.5 g C18 silica gel (Polygoprep 60 C18, 50 µm, 
Macherey-Nagel) using a solid loader. Separation was carried out using a C18 column (40 µm 
particle size, 12 g). For the mobile phase MeOH (solvent A) was used in combination with 
0.1% aqueous TFA (solvent B).  A step gradient with a constant flow of 30 mL/min was 
applied starting at 20% solvent A (t = 0-5 min), rising up to 100% solvent A (t = 5-17 min), 
finishing the run with 100% solvent A (t = 17-22 min). The separation process was observed 
using ELSD and UV-detection (220 nm, 254 nm, 340 nm). Acetosellin (4) eluted after 14 min 
(80% solvent A). In fraction 6, an oxidation product of acetosellin (4) in a semi-pure form was 
detected, 5´,6´-dihydroxyacetosellin (7, tR ≈ 10 min, 6 mg). Epipyrones (1-3) were found to be 
a minor constituent eluting at ca. 95% solvent A (tR ≈ 16.5 min). 
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3.2.6.3  ISOLATION OF 13C-LABELED ACETOSELLIN (4) 
 
In order to purify the 13C-enriched acetosellin (4), the crude extract was subjected to RP 
Flash chromatography (30 mL/min, Reveleris® C18
 column, 4 g, particle size 40 µm), starting 
with H2O:MeOH 80:20 (min 0-5) and then switching to gradient elution (MeOH 20 %  100 
%, min 5-15), ending up with 34.5 mg of semi-pure compound (tR = 12 min, 70% MeOH).  
 
3.2.6.4 FRACTIONATION OF CRUDE EXTRACT FROM ´TIME COURSE 
CULTURES´ OF STRAIN 800  
 
The five ´time course´ cultures (for cultivation details see section 3.1.5.1) were pooled, 
resulting in 934 mg of crude extract (800Z-total). The extract was then defatted using liquid-
liquid extraction (n-hexane/MeOH:H2O [90:10]). This resulted in 509 mg of defatted crude 
extract (800Z).The defatted crude extract 800Z was subjected to fractionation via RP flash 
chromatography (FC, flow: 30 mL/min, column: Reveleris® C18-silica, 12 g, 40 µm), starting 
with H2O:MeOH 80:20 (min 0-7) and then switching to linear gradient elution (MeOH 20 %  
100 % min 7-15; t = 15-20 min: 100% MeOH). Ten fractions were obtained. 
The so obtained fractions were further separated using HPLC system B (see section 3.2.5). 
FC-Fraction 4 (eluting after 10.5 min) was separated with RP-HPLC (H2O:ACN 80:20; 
column D; flow: 0.7 mL/min), fraction 1 giving purified (3R,4S)-4-hydroxymellein (10, 2.0 mg).  
The same compound was isolated from fraction 5 of flash chromatography by HPLC 
(H2O:ACN 76:24, column E, 0.7 mL/min). 
 
FC-Fraction 7 (eluting after 14 min) was separated with RP-HPLC (H2O:ACN 70:30, column 
D, 1.0 mL/min) into 7 fractions (F7-1 – F7-7), of which fraction 6 proved to be the new 
compound epicaronic acid (13, 2.7 mg). 
 
FC-Fraction 8 (eluting after 15 min) was separated with RP-HPLC (H2O:ACN 62:38, column 
D, 1.0 mL/min) into 8 fractions, of which fraction 5 yielded tricinonoic acid (14, 1.5 mg).  
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3.2.6.5 ISOLATION OF EPICOCCOLIDE B (9), FLAZIN (15) AND 
EPICARONIC ACID (13) FROM STRAIN 800 
 
Two cultures of E. nigrum strain 800 were used:  
1) The first culture was prepared on 10 L of MEN medium and fermented for four weeks. 
Extraction with EtOAc afforded 1.35 g of crude extract (see section 3.1.4 for the 
protocol), which was subjected to NP VLC on silica gel (200 g  silica gel 60M, 0.04-
0.063 mm, Macherey-Nagel) with a step gradient (n-hexane-EtOAc-MeOH: 100:0:0 
 80:20:0  60:40:0  40:60:0  20:80:0  0:100:0  0:80:20  0:60:40  
0:40:60  0:20:80  0:0:100  0:0:100, each step 200 ml), yielding 12 fractions.  
Fractions 6-12 (fraction 6 eluted with 100% EtOAc, fraction 12 eluted with 100% 
MeOH) were pooled to give 608 mg. This crude material was separated via RP-VLC 
(using 50 g of Polygoprep 60 C18, 0.05 mm, Macherey-Nagel) with following step 
gradient: MeOH/aqueous TFA (0.1%) 40:60  100:0 (8 steps with 200 mL, 
respectively). Fractions 4 and 5, eluting at 70-80% MeOH, were again pooled (m = 
177 mg) and subjected to SEC (packed with 25 g of Sephadex LH-20), employing 
100% MeOH as eluent.  
Eight fractions were obtained, fraction 4, eluting as a red solution, was purified on 
HPLC system D with column G (see section 3.2.5 for details) with a flow of 0.9 
mL/min and a gradient of MeOH/water 60:40 (t = 0-23 min)  75:25 (t = 24-50 min). 
Fraction 4 of this HPLC-separation, eluting after 24 min, proved to be epicaronic acid 
(13, 2.2 mg), which was also found in another extract of E. nigrum strain 800 (see 
section 3.2.6.4).  
Fraction 6 of the separation using size exclusion chromatography, eluting as a yellow 
solution, was purified on HPLC system D with column G. A gradient was used with a 
flow of 0.9 mL/min, starting with MeOH/water 60:40 (t = 0  t = 30 min), ending up 
with 100% MeOH (t = 31-60 min). From this HPLC-separation, fraction 2 proved to be 
flazin (15, tR = 25 min; 1.2 mg).  
2) The next culture of E. nigrum strain 800 was grown on 500 mL of malt extract agar 
with trace metal solution in darkness, yielding 0.2 g of crude extract through 
extraction with EtOAc (see section 3.1.4). This extract was subjected to NP FC (15 
mL/min, Reveleris® flash cartridge, with 4 g of silica, 40 µm particle size), using a  
linear gradient starting with petrol ether (t = 0 min: 80%, t = 5 min: 0%), with 
increasing amounts of EtOAc (t = 0 min: 20%  t = 5-8 min: 100%) and  MeOH (t = 8 
Materials and methods 
 29 
min: 0%  t = 16-18 min: 100%). Fraction 2, eluting at = 3.5-7 min, was purified on 
HPLC system A with column D, a following gradient was applied:  ACN/water 20:80 (t 
= 0-10 min)  30:70 (t = 12-21 min)  100% MeOH (t = 22-26 min), the flow was set 
to 1.0 mL/min. Epicoccolide B (9, 1.3 mg) eluted after 20 min with 30% ACN.  
This compound was later again isolated, in order to get a larger amount of substance. 
For this purpose, four exploratory crude extracts from E. nigrum strain 800 were 
pooled to give a total mass of 0.4 g (see section 3.1.3 for media composition): 
 800 MES (grown under continuous illumination) 
 800 MEA+TMS (grown in darkness) 
 800 MEA+TMS (grown under continuous illumination) 
 800 MES+TMS (grown under continuous illumination) 
Fractionation was achieved through successive use of RP FC(flow: 30 mL/min, 
column: Reveleris® C18-silica, 12 g, 40 µm, ACN/water 10:90  80:20 and HPLC with 
ACN/water (system A, column B, gradient: t = 0-4 min: 20:80  t = 5-16 min: 30:70  
t = 17-20 min: 100:0, 1.0 mL/min), with compound 9 eluting after 14.5 min (m = 4.8 
mg). 
 
3.3 STRUCTURE ELUCIDATION 
 
3.3.1.  NMR 
 
All NMR spectra were recorded in acetone-d6, methanol-d4, or in DMSO-d6 using either a 
Bruker Avance 300 DPX spectrometer operating at 300 MHz (1H) and 75 MHz (13C),  a 
Bruker Avance 500 DRX spectrometer operating at 500 MHz (1H) and 125 MHz (13C) and a 
Bruker Ascend 600 spectrometer operating at 600 MHz (1H) and 150 MHz (13C). Spectra 
were referenced to residual solvent signals with resonances at δH/C 2.04/29.8 (acetone-d6), 
δH/C 3.35/49.0 (methanol-d4) and δH/C 2.50/39.51 (DMSO-d6) respectively. Spectra were 
processed using Bruker XWIN-NMR version 3.5 software and Mestrenova version 8.0.1-
10878 (Mestrelab Research S.L.). ChemSketch version 11.02 (ACD/Labs 2012) was used to 
compare characteristic chemical shifts of isolated compounds to calculated values. The 
following NMR experiments were performed: 1H-NMR, 13C-NMR, DEPT-135, COSY, 1H-13C-
HSQC, 1H-13C-HMBC and 1H-1H-ROESY, 1H-1H-NOESY. 
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3.3.2.  MASS SPECTROMETRY 
 
Mass spectrometry was performed on the following four systems: 
1) LC-ESI-MS using an HPLC coupled to a quadropole analyzer (system A) 
LC-ESI-MS measurements were conducted by E. Eguereva (Institute for Pharmaceutical 
Biology, University of Bonn). The samples were diluted with MeOH to a concentration of 1 
mg/mL and were analyzed using an Agilent 1100 system including a diode array detector 
(DAD) and an API 2000 Triple Quadrupole LC/MS/MS with ESI source (Applied 
Biosystems/MDS Sciex, Analyst Software). An RP-18 column (Macherey-Nagel Nucleodur 
100, 125 x 2mm, 5 µm) served as stationary phase. Gradient elution was used with following 
parameters: It started at MeOH/H2O (10:90) and was ramped up to 100% MeOH in 20 min, 
followed by isocratic elution with 100% MeOH  for 10 min, NH4OAc was added as a buffer (c 
= 2 mM); flow rate: 0.25 mL/min. Experiments were recorded only in positive mode using a 
declustering potential of either 30 V (experiment 1) or 70 V (experiment 2).  
 
2) LC-MS using a UPLC system coupled to an Orbitrap (system B) 
Spectra were recorded by Dr. Marc Sylvester (Institute for Biochemistry and Molecular 
Biology, University of Bonn). The dried samples were dissolved in 50 µl water per vial. 2µl of 
this solution were then diluted in an Eppendorf vial using 18 µl of 0.1% formic acid. The 
resulting solution was centrifuged for several minutes at 12,000 g to separate precipitates.  
2 µl (≡ 0.4% of the original sample) were injected onto a C18 trap column (20 mm length, 100 
µm inner diameter) coupled to a C18 analytical column (200 mm length, 75 µm inner 
diameter), made in house with 1.9 µm ReproSil-Pur 120 C18-AQ particles (Dr. Maisch, 
Ammerbuch, Germany). Solvent A was 0.1% formic acid. Analytes were separated during a 
linear gradient from 1% to 35% solvent B (90% ACN, 0.1% formic acid) within 40 min and 
35% to 50% B within 7 min at a flow rate of 320 nL/min.  
The nanoHPLC was coupled online to an LTQ Orbitrap Velos mass spectrometer using a 
nanoESI ion source (Thermo Fisher Scientific, Bremen, Germany). Precursor ions between 
180 and 700 m/z were scanned in the Orbitrap detector with a resolution of 30,000 
(maximum fill time 400 ms, AGC target 106, lock mass 445.12003 Da). The 10 most intense 
precursor ions (threshold intensity 5000) were subjected to collision induced dissociation and 
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fragments also analyzed in the linear ion trap. Fragmented ions were excluded from repeat 
analysis for 15 s. 
 
3) LC-MS using a UPLC System coupled to Qq-TOF with ESI-source (system C) 
Spectra were recorded by Dr. Max Crüsemann (Institute of Pharmaceutical Biology, 
University of Bonn). A micrOTOF-Q  mass spectrometer ( Bruker) with ESI-source coupled to 
a HPLC  Dionex Ultimate 3000 (Thermo Scientific)  and a EC10/2 Nucleoshell C18 2.7 µm 
column (Macherey-Nagel) was used. The column temperature was set to 25°C. 
MS data were acquired over a range from 100-3000 m/z in positive mode. Auto  MS/MS 
fragmentation was achieved with rising collision energy  (35-50 keV over a gradient from 
500-2000 m/z) with a frequency of 4 Hz for all ions over a threshold of 100. 
HPLC started with 90 % H2O containing 0.1% HOAc. The gradient starts after 1 min ending 
up with 100% Acetonitrile (0.1% acetic acid) in 20 min. The flow was set to  0.3 mL/min. 5 µL 
per  sample solution (1mg/mL) was injected for each run. 
 
4) High resolution ESI-MS (system D) 
Dr. M. Engeser (Kekulé Institute of Organic Chemistry and Biochemistry, University of Bonn) 
conducted HR-ESI-MS measurements on a Bruker Daltonik (Bremen)  micrOTOF-Q Time-
Of-Flight mass spectrometer for exact mass determination of purified compounds. 
 
3.3.3.  UV-SPECTROSCOPY 
 
UV spectra were obtained using a Perkin Elmer Lambda 40 UV/Vis spectrometer with UV 
WinLab Version 2.80.03 software, using 1.0 cm quartz cell. The molar absorption coefficient 
ε was determined in accordance with the Lambert-Beer-Law: 
   )/( bcAbcA    
ε: molar absorption coefficient [L·mol-1·cm-1]; A: absorption at peak maximum; c: 
concentration [mol/L]; b: layer thickness of solution [cm] 
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3.3.4  CD-SPECTROSCOPY 
 
CD spectra were recorded in MeOH at room temperature using a JASCO J-810-150S 
spectropolarimeter. The CD (circular dichroism) is measured as ellipticity Θ (in mdeg, 
millidegrees) and subsequently converted into the molar ellipticity [Θ]M and finally into Δε in 
accordance to the following equation: 
[θ]M = θ · M / 10 · C · d 
[Θ]M = molar ellipticity [degrees · cm
2/dmol]; θ = ellipticity [degrees]; Mr = molecular weight 
(g/mol); C = concentration (mg/ml); D = path length (0.1 cm) 
Results presented as ε =[θ]M / 3300 
 
3.3.5  IR-SPECTROSCOPY 
 
IR spectra were recorded as film, using a Perkin-Elmer FT-IR Spectrum BX spectrometer. 
Analysis and reporting were performed with Spectrum v3.01 software. 
 
3.3.6  OPTICAL ROTATION 
 
Optical rotation was measured on a Jasco DIP 140 polarimeter (1 dm, 1 cm3 cell) operating 
at wavelength λ=589 nm corresponding to the sodium D line at room temperature. Specific 
optical rotation  TDα  was calculated using following equation: 
 
lc
α



100T
D          
T = temperature [°C]; D = sodium D line at λ = 589 nm; c = concentration [g/100 ml];  l = cell 
length [dm]; α = optical rotation 
Compounds were dissolved in methanol and the average optical rotation α was calculated 
based on 5 measurements. 
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3.4 CHEMICAL DERIVATIZATION 
 
Acetylation of epipyrones (1-3) 
For the first attempt, 26 mg (≡ 4.1825·10-5 mol) of epipyrones (1-3) were dissolved in 1 mL 
pyridine and the reaction started with an excess of Ac2O (60 µL). The mixture was stirred at 
room temperature for 2.5 h under inert gas (argon). TLC was used to monitor the reaction 
process [C18-silica, MeOH/water(TFA 0.1%) 85:15]. The reaction was stopped by adding 300 
µL water and evaporating the solvent in a rotary evaporator to yield 34.5 mg of crude 
product. The crude product was purified in two successive steps using column A on HPLC 
system B (step 1) or column D and HPLC system A (step 2): For step 1, a gradient with 
MeOH/water (TFA 0.1%) with a constant flow of 1.5 mL/min was used: t=0 min: 80% MeOH; 
t=5 min: 85% MeOH; t=20 min: 87% MeOH; t=30 min: 87% MeOH; t=40 min: 95% MeOH.  
Fraction 5, eluting after 22 min, showed the strongest signals in 1H-NMR and thus was used 
for purification in step 2 with following gradient (MeOH/water (0.1% TFA)): t=0 min: 75% 
MeOH; t=3 min: 75% MeOH; t=10 min: 80% MeOH; t=20 min: 80% MeOH; t=21 min: 100% 
MeOH; t=27 min: 100% MeOH. Peak 4 (compound 6, 1.4 mg; 5.4% yield) was the main 
product and was subsequently used for structure elucidation and bioactivity testing. 
For the second acetylation approach, the reaction time and amount of Ac2O was increased in 
order to get the tetraacetate as the main product:  
29 mg (≡ 4.71677·10-5 mol) of epipyrones (1-3) were dissolved in 1.3 mL pyridine and the 
reaction started with the addition of 134 µL Ac2O. The reaction was again monitored via TLC 
[silica gel, DCM/acetone/MeOH (0.1% TFA) 80:15:5]. The reaction was stopped after 48 h by 
the addition of 5 mL water under cooling with iced water. The solution was extracted seven 
times successively with 1.5 mL DCM. The pooled DCM phases were washed once with 
NaHCO3-solution in water (39 mg/mL), then twice with 3 mL water. The organic phase was 
then evaporated to dryness in the rotary evaporator to yield 39 mg of crude product. 
Purification was carried out on HPLC system B with column G, using isocratic elution with 
78% MeOH/22%water (0.1% TFA) and a constant flow of 1.5 mL/min. Compound 5 eluted 
after 18 min (compound 5, 11.8 mg; 40.7% yield). 
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3.5 EVALUATION OF THE BIOLOGICAL ACTIVITY 
 
3.5.1  CELL VIABILITY ASSAYS 
 
3.5.1.1 RESAZURIN-BASED ASSAY WITH HEK293-CELLS 
This assay was carried out by Nicole Merten (working group of Prof. Kostenis, Institute for 
Pharmaceutical Biology, University of Bonn). Cell viability was assessed using a fluorimetric 
detection of resorufin (CellTiter-Blue Cell Viability Assay, Promega; see fig. 3.3). HEK293 
cells were seeded at a density of 25,000 cells per well into black 96-well poly-D-lysine–
coated plates with clear bottom. 3h after seeding cells were treated with 0.3% dimethyl 
sulfoxide (DMSO) or compound dissolved in medium for 24h. To detect cell viability, 
CellTiter-Blue reagent was added and cells were incubated for 1h at 37°C according to the 
manufacturer’s instructions. Fluorescence (excitation 560nm, emission 590nm) was 
measured using a FlexStation 3 Benchtop Multimode Plate Reader and data were expressed 
as percentage of cell viability relative to DMSO control (The cytotoxic anticancer drug 
etoposide was used as a positive control.). 
 
Fig. 3.3: Reaction scheme showing the reduction of resazurin by mitochondrial oxidoreductases. 
Resazurin itself is only weakly fluorescent, while resorufin shows strong emission at wavelengths 
above 550 nm upon exposure to green light [150,151].  
 
 
Materials and methods 
 35 
3.5.1.2  MTT-ASSAY 
 
This colorimetric assay was used to assess the effect of epipyrones (1-3) on viability of 
different cell lines according to Zapol´skii et al. [152]. In living cells, MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by reductases to yield 
purple formazan. This color change is used as an indicator of cell viability. 
The assay was performed by Galina Sergeev in the working group of Prof. Sasse 
(Helmholtz-Zentrum für Infektionsforschung, Braunschweig). Epipyrones (1-3) were applied 
in serial dilutions in MeOH, with a maximum concentration of 60.4 µM. Metabolic activity was 
determined after 24 h in order to assess acute cytotoxicity with following cell line: 
FS4-LTM (immortalized human fibroblasts) 
Three additional cell lines were assessed for cell proliferation, using the above mentioned 
assay. Metabolic activity was determined after 120 h (5 days): L929 (immortalized murine 
fibroblasts), KB-3-1 (human cervical cancer), MCF-7 (human breast cancer). 
  
3.5.2  ANTIMICROBIAL ACTIVITIES 
 
3.5.2.1 INHIBITION OF BACTERIA AND YEASTS 
 
Agar diffusion assays were provided by Michaele Josten (working group Prof. Schneider, 
Institute of Pharmaceutical Microbiology, University of Bonn). The following protocol was 
applied as published before [153].  
Culture plates (5% sheep blood Columbia agar, BD) were overlaid with 3 mL Tryptic soy soft 
agar, inoculated with TSB (Tryptic soy broth, Oxoid) growth suspension of the bacteria to be 
tested. Compounds were diluted to a concentration of 1mg/mL  with DMSO and 3 µL of this 
dilution were placed on the surface of the agar. Compounds diffused into the agar and the 
size of the inhibition zone was measured after 24 hours incubation at 37 °C. 
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Tab. 3.5: Bacterial and yeast strains used to assess antimicrobial activity: 
  Strain No. 
1 MSSA 5185 
2 MSSA I-11574 
3 MRSA LT-1334 
4 MRSA LT-1338 
5 MRSE LT-1324 
6 Candida albicans I-11301 
7 Candida albicans I-11134 
8 Citrobacter freundii I-11090 
9 Klebsiella pneumoniae subsp. ozeanae I-10910 
10 Enterococcus faecium I-11305b 
11 Enterococcus faecium I-11054 
12 Escherichia coli I-11276b 
13 Escherichia coli O-19592 
14 Stenotrophomonas maltophilia O-16451 
15 Stenotrophomonas maltophilia I-10717 
17 Pseudomonas aeruginosa I-10968 
18 KNS I-10925 
19 Staphylococcus simulans 22 
20 Micrococcus luteus ATCC 4698 
21 Mycobacterium smegmatis ATCC 70084 
22 Bacillus subtilis 168 
23 Bacillus megaterium ATCC 13632 
24 Arthrobacter crystallopoietes DSM 20117 
25 Listeria welchimeri DSM 20650 
26 Bacillus cereus  
28 Corynebacterium xerosis Va167198 
29 Staphylococcus aureus  
30 Staphylococcus aureus 133 
MSSA = methicillin-sensitive Staphylococcus aureus 
MRSA = methicillin-resistant S. aureus 
MRSE = methicillin-resistant S. epidermidis 
KNS = coagulase-negative Staphylococci 
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3.5.2.2 INHIBITION OF FILAMENTOUS FUNGI AND YEASTS 
 
The agar diffusion assay using the following set of filamentous fungi and yeasts was 
provided by Dr. Anne van Diepeningen (CBS-KNAW Fungal Biodiversity Centre, Utrecht, 
The Netherlands). Paper disks were soaked with 50 µL DMSO (control) or 50 µL of the 
dissolved compound (1mg/mL DMSO) and placed onto the fungal colonies grown on agar 
medium. The size of the halo (no growth zone) around the filter paper at two time points was 
measured, after 2-3 days and after 6-7 days.  
 
Tab. 3.6: Fungal strains used to assess antifungal activity of epipyrones (1-3): 
No. Strain Strain number 
 Ascomycota:  
1 Arthroderma obtusum CBS 633.82 
2 Arthroderma otae CBS 282.63 
3 Arthroderma racemosum CBS 633.82 
4 Arthroderma vanbreuseghemii CBS 449.74 
5 Aspergillus fumigatus CBS 418.64 
6 Candida albicans CBS 6431 
7 Candida albicans CBS 8758 
8 Cladophialophora carionii CBS 160.54 
9 Exophiala jeanselmii CBS 507.90 
10 Exophiala phaeomuriformis CBS 131.80 
11 Fusarium andiyazi CBS 134430 
12 Fusarium petroliphilum CBS 135955 
13 Fusarium verticillioides CBS 135801 
14 Fusarium sp. WLD1-6 
15 Meyerozyma guillermondii 18.6AIII 
16 Microsporon gypseum CBS 130939 
17 Penicillium chrysogenum 18.6FII 
18 Pleospora sp.  CBS 134305 
19 Sporothrix schenckii CBS 340.35 
20 Trichophyton erinacei CBS 344.79 
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Tab. 3.6 continued 
21 Trichophyton mentagrophytes CBS 101546 
22 Trichophyton mentagrophytes CBS 120357 
23 Trichophyton verrucosum CBS 134.66 
24 Trichophyton violaceum CBS 119447 
 Basidiomycota:  
25 Rhodotorula glutinis CBS 20 
 ´Zygomycetes´:  
26 Actinomucor elegans CBS 100.13 
27 Mucor indicus CBS 120585 
28 Cunninghamella elegans WLD1-4 
   
3.5.2.3 ANTI-HIV ACTIVITY 
Anti-HIV activity of epipyrones (1-3) was assessed by Dr. Markus Helfer (Institute of Virology, 
Helmholtz Zentrum München) following the procedure described by Kremb et al. [154].  
 
3.5.3 INHIBITION OF HUMAN CEREBROSIDE SULFO-TRANSFERASE 
(HCST) 
 
Isolated and purified hCST was used for the inhibition assay, which was conducted by Isabell 
Zech (working group Prof. Gieselmann, Institute for Biochemistry and Molecular Biology, 
University of Bonn), following the modified procedure of Jungalwala et al. [155] as reported in 
[72]. In principle, the assay measures the activity of hCST by detecting the amount of 
radioactively labeled sulfatide on a HPTLC plate. Radioactively labeled PAP[35S] (3´-
phosphoadenosine-5´-phosphosulfate) was used to monitor the activity of the hCST.  
 
Reaction mixture: 
20 µg galactosyl ceramide were dissolved in 10 µl 1% Triton X-100 solution (CHCl3/MeOH 
2:1), dried and following solutions added: 
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3 µl of diluted tested compounds (stock solution: 1 mM in 10 % aqueous DMSO). For positive 
controls 3 µL 10% DMSO without inhibitor was taken. 
16 µl Reaction buffer consisting of: 
 Tris-HCl pH 7.1 (final concentration: 80 mM) 
 MgCl2 (final concentration: 16 mM) 
 PAPS (final concentration: 20 µM; ratio of PAPS and PAP[35S] = 2-10:1) 
15 µl shCST solution in Tris-HCl, pH 7.1 (shCST = soluble hCST) 
Reaction conditions: 37°C, 700 rpm, 60 min 
Termination of the reaction was achieved by addition of 1 ml CHCl3/MeOH (2:1). 
After addition of 150 mM NaCl, the mixture was vortexed, centrifuged, the organic phase was 
transferred into a new vial and washed with 100 µl MeOH/NaCl (150 mM)/CHCl3 (48:47:3). 
The dried sample was then dissolved in 20 µl CHCl3/MeOH (2:1) und chromatographed 
using HPTLC (Silica gel 60, Merck, eluent: CHCl3/MeOH/H2O, 65:25:4). Spots with different 
amounts of reaction buffer served as standards for quantification of the detected signals. 
After drying the plate, a bioimager screen was applied and incubated for several hours in the 
dark. The signals were detected using a bioimager screen scanner.  
 
3.5.4  INHIBITION OF CYSTEINE- AND SERINE-PROTEASES 
 
The assays were performed by the working group of Prof. Dr. M. Gütschow (Pharmaceutical 
Institute, Pharmaceutical Chemistry I, University of Bonn) using the following methods. The 
tested proteases were used in isolated and purified form. 
The panel of tested enzymes involved: 
1. Lysosomal cysteine-proteases: Cathepsins B, L, S, K 
2. Serine-proteases:  HLE (human leukocyte elastase)  
bovine trypsin 
bovine chymotrypsin 
 
The assays for cathepsins B and L were based on a method described before [156,157]. 
Cleavage of the chromogenic substrates was observed spectrophotometrically at 405 nm. 
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For cathepsin B, Z-Arg-Arg-pNA served as the substrate. Cathepsin L was tested using Z-
Phe-Arg-pNA. 
The assay against cathepsin S employed the method elsewhere [157].  It employed a 
spectrophotometric determination of the chromogenic substrate Z-Phe-Arg-pNA (Z-Phe-Arg-
para-nitroanilide), which is cleaved by cathepsin S, the detection wavelength was 405 nm. 
Inhibitory activities on HLE were performed according to the described method [158]. The 
spectrophotometric assay employed the chromogenic substrate MeOSuc-Ala-Ala-Pro-Val-
pNA, cleavage was monitored at 405 nm. 
For bovine trypsin, the method reported in [159] was used. Cleavage of the chromogenic 
substrate Suc-Ala-Ala-Pro-Arg-p-NA was observed at 405 nm. Bovine chymotrypsin was 
assayed according to the described method [160]. 
 
3.5.5  LUCIFERASE-BASED TRANSIENT REPORTER SYSTEM FOR 
AGONISTS ON NUCLEAR RECEPTORS 
 
Activities on α-/γ-/δ-PPAR and α-/δ-LXR were assessed by Dr. Paulsen Steinar (The 
Norwegian Structural Biology Centre and Department of Chemistry, University of Tromsø) 
using the method described by Tzameli et al. and Ciocoiu et al. [161,162]. Cos-1 cells (cell 
line from monkey kidneys [163], ATCC no. CRL-1650) were maintained in a humidified 
atmosphere at 37°C with 5% CO2, in DMEM (Dulbecco´s Modified Eagle Medium, Invitrogen, 
CA) containing gentamicin (10 μg/mL) and fetal bovine serum (10%). Prior to sub-culturing or 
transfection, cell confluence was not more than 80%. 1.7 µg of the expression plasmids and 
8.5 µg reporter construct per 1 x 107 cells were employed in order to transiently transfect the 
Cos-1 cells. Transient transfection was achieved using the Neon electroporation system 
(Invitrogen, Carlsbad, CA). Prior to the addition of the test compound, the cells were seeded 
(2 x 104/well) in 96-plates (white F96 microwell, Nalge Nunc Int., Rochester, NY) and 
allowed to attach for 5 h. The transfected cells were treated with compounds for 19 h 
(compound solutions made in dilution series in the medium). The values are relative to the 
luciferase activity obtained by activating the reporter gene system with a known agonist. Luc 
protein expression was developed (final concentration of D-luciferin: 0.4 mM) in a 30 mM 
HEPES buffer supplemented with ATP (0.5 mM) and MgSO4 (1 mM) and quantified on a 
luminometer (Envison, Perkin-Elmer, MA, US).  
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The pSG5-Gal4-hPPAR-LBD (α, γ and δ isotypes) and pSG5-Gal4-hLXR-LBD (α and δ 
isotypes) expression constructs were made by Dr. Hilde Nebb, University of Oslo. The pGL3-
5xUAS-SV40 luciferase reporter construct was purchased from Promega Corporation (USA). 
 
3.5.6  EXTRACELLULAR AΒ-42 PEPTIDE PRODUCTION, CELL 
SURVIVAL AND INHIBITION OF PROTEIN KINASES 
 
The assays were performed with epipyrones (1-3) by ManRos Diagnostics (Centre de 
Perharidy, 29680 Roscoff, France), applying following protocols: 
MTS survival assay 
This assay is a means to assess cytotoxic effects of the tested compounds, i.e., epipyrones 
(1-3). MTS  [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium] is reduced by reductases in living cells to a formazan (see section 3.5.1). The 
latter is detected via colorimetry.  
N2a cells (= Neuro2a cells, murine neuroblastoma cell line) were transfected with human 
APP695 and maintained in DMEM in a humidified atmosphere (37°C, 5% CO2). The medium 
was supplemented with 5% fetal bovine serum (FBS), 1% penicillin-streptomycin solution 
and G418 (Sigma, USA) (0.1 mg/mL).  
N2a-APP695 cells were cultivated at a density of approximately 10,000 cells per well on 96-
well plates in DMEM, supplemented with 0.5% FBS. The media were replaced by new media 
containing the test compounds after 24 h of incubation. For the initial screen, a 10 µM final 
concentration was applied. As a control, medium without cells (= blanks) and untreated cells 
were used. The viability of the cells was measured by the formation of a formazan from MTS, 
using CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega, Madison, WI, 
USA) at 18 h post treatment. Incubation was carried out for 1h30 (37°C, 5% CO2 and 95% 
humidity). Optical density (OD) was measured at 490 Δ 630 nm using a microELISA reader. 
Cell viability (%) =    OD of treated cell – OD of blanks 
 OD of controls (vehicle treated cells) – OD of blanks 
 
 
· 100 Cell viability (%) = 
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Ability of epipyrones (1-3) to induce extracellular production of Amyloid β-42  
This assay was performed following the method described by Hochard et al. and Bettayeb et 
al. [164,165]. It investigates a stimulatory effect of the test substance on the formation of 
amyloid β-42, which is seen as a causal agent of Alzheimer´s disease.  
The effect of epipyrones was tested at a final concentration of 10 µM. Following controls 
were used: (1) Blank (without cells), (2) Vehicle treated cells; (3) cells + 100 µM Aftin-5 (Aftin-
5 is a reference compound for the induction of extracellular Aβ-42 production [164]). Aftin-5 
was produced by ManRos Reagents.   
Inhibition of Amyloid β-42 production induced by Aftin-5 
In addition to the previous assay, this method measures the effect of compounds on the 
production of extracellular Amyloid β peptides induced by a pre-treatment with 100 µM of 
Aftin-5. Thus, an inhibitory effect of the test substance on the formation of amyloid β-42, 
which is seen as a causal agent of Alzheimer´s disease, is investigated. The effect of 
epipyrones was tested at a final concentration of 10 µM. The following controls were used (1-
4): (1) Blank (no cells); (2) vehicle treated cells; (3) cells + 100 µM Aftin-5, the reference 
activator of extracellular Aβ-42 production [2]. Aftin-5 was produced by ManRos Reagents; 
(4) cells + 10 µM DAPT (N-[(3,5-difluorophenyl)acetyl]-Lalanyl-2-phenyl]glycine-1,1-
dimethylethyl ester), a ɣ-secretase inhibitor, which inhibits the production of extracellular 
Amyloid β peptides induced by a pre-treatment with 100 µM Aftin-5. 
N2a cells were transfected with human APP695 and cultivated as described for the MTS-
assay (see above). The N2a-APP695 cells were cultivated with a density of approximately 
10,000 cells per well in DMEM/optiMEM with 0.5% FBS. After 18 h incubation, the media 
were replaced by new media containing the test compounds. After 1 h incubation, Aftin-5 
was added (100 µM 1% DMSO final). The cultured media were taken for Amyloid β-42 
determination by ELISA assay after 18 h of incubation. 
Protein kinase assays 
The assays were performed using following protocols: The assays were performed in buffer 
A or C (see below), with their corresponding substrates, in the presence of 15 μM [γ-33P] 
ATP (3,000 Ci/mmol; 10 mCi/mL, PerkinElmer, France) in a final volume of 30 μL. The 
reaction was stopped by harvesting on a FilterMate harvester (Packard) onto P81 
phosphocellulose papers (GE Healthcare) after 30 min of incubation at 30°C. Filters were 
washed in 1% phosphoric acid. 20 µL of scintillation fluid were added and the incorporated 
radioactivity was measured in a Packard counter. Blank values were subtracted and activities 
calculated as pmoles of phosphate incorporated during the 30 min incubation. The activities 
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were expressed in % of the maximal activity, i.e., in the absence of inhibitors. Controls were 
performed with appropriate dilutions of DMSO. CDK1/cyclin B  was prepared as previously 
described [166]. Kinase activity was assayed in buffer A, with 1 mg histone H1/mL. 
CDK2/cyclin A (human, recombinant, expressed in insect cells) was tested as described for 
CDK1/cyclin B. CDK5/p25 (mammalian, recombinant, expressed in E. coli) was tested as 
described for CDK1/cyclin B. CDK9/cyclin T (human, recombinant, expressed in insect cells) 
was tested as for CDK1/cyclin B using the Tide 7/9 substrate 
(YSPTSPSYSPTSPSYSPTSPSKKKK, Proteogenix, France) (500 µM). CK1δ/ε (porcine 
brain, native, affinity purified on axin-2 beads [6]) was tested as described for CDK1 but in 
buffer C and using the CK1-specific peptide substrate (CKs: RRKHAAIGSpAYSITA, 
Proteogenix, France) (1 mM). CLK1 (Human, recombinant, expressed in E. coli as GST 
fusion protein) was tested in buffer A (+ 0.15 mg BSA/ml) with RS peptide 
(GRSRSRSRSRSR, Proteogenix, France) (1 μg/assay). DYRK1A (human, recombinant 
expressed in E. coli as a glutathione S-transferase fusion protein) were purified by affinity 
chromatography on glutathione-agarose and tested as described for CDK1/cyclin B using 
Woodtide (KKISGRLSPIMTEQ, Proteogenix, France) (1.5 µg/assay) as a substrate, a 
residue of transcription factor FKHR. GSK-3α/β (porcine brain, native, affinity purified on 
axin-1 beads [7]) was tested as described for CDK1 using a GSK-3–specific substrate (GS-1: 
YRRAAVPPSPSLSRHSSPHQSpEDEEE; Sp = phosphorylated serine, Proteogenix, France) 
(250 µM). 
Two protein kinase assay buffers were used during this assay: Buffer A : 10 mM MgCl2, 1 
mM EGTA (MW 380.4), 1 mM DTT (MW 154.2), 25 mM Tris/HCl (MW 121.1) and 50 µg/ml 
Heparin. Buffer C : 20 mM ß-glycerophosphate, 10 mM p-nitrophenylphosphate, 25 mM 
MOPS, 5 mM EGTA, 15 mM MgCl2, 1 mM DTT and 0.1 mM sodium vanadate.  
 
3.5.7  BINDING OF EPIPYRONES (1-3) TO A MODEL MEMBRANE 
 
Binding of epipyrones (1-3) to a model membrane consisting of POPC (1-palmitoyl-2-oleoyl-
phosphatidylcholine) was studied using a SAW (surface acoustic wave) sensor (S-sens® K5, 
Biosensor GmbH, Bonn) by Hildegard Falkenstein-Paul in the working group of Prof. Bendas 
(Pharmaceutical Institute, Pharmaceutical Chemistry II, University of Bonn). The method 
described by Schmitz [167] was used.  
Briefly, a solution of the tested substance is injected into the SAW sensor setup (surface 
acoustic wave, a piezoelectric crystal element), which is loaded with an artificial membrane 
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bilayer consisting of POPC (1-palmitoyl-2-oleoyl-phosphatidylcholine). During the 
measurements, an alternating current is applied. This current leads to a rhythmic deformation 
of the piezoelectric crystal with specific frequency and amplitude. The type of wave, which is 
observed, is named ´Love shear wave´. It is a surface wave with horizontal polarization. 
Adsorption of particles onto the surface leads to an altered oscillation of the crystal.  
The membrane surface is separated into five single chambers, in which parallel 
measurements can be performed. It is continuously flushed with buffer (PBS buffer, pH 7.4). 
In defined intervals, increasing concentrations of a test compound are injected into the buffer 
flow. According to phase shift and amplitude of the detected Love shear wave, conclusions 
can be drawn on whether the tested substance binds to the membrane, whether it is inserted 
into the membrane or whether it does not show any affinity towards the membrane. During 
the delay period following each injection, the test compound is allowed to elute from the 
membrane. The next injection cycle can proceed with an increased concentration of the test 
compound. For further descriptions and theory, see following literature [167–169].  
 
3.6 GUTTATION FLUIDS – CULTIVATION AND ANALYSIS 
 
Fungal cultures of E. nigrum strain 749 were grown on Czapek-Dox agar with and without 
trace metals. 4 – 5 L of each medium were prepared. Ca. 100 mL were filled into each petri 
dish (145 x 20 mm; see section 3.1.3 for media composition and section 3.1.4 for 
extraction).  
Tab. 3.7: Experimental setup of the cultivation of E. nigrum strain 749 on Czapek-Dox medium for the 
induction of guttation droplet formation. For each experiment, 10-25 petri dishes with agar medium 
were prepared and inoculated with three agar plugs from precultures. 
 
No additives 
Trace metals (Cu
2+
, 
Zn
2+
) 
Without illumination Experiment 1 Experiment 2 
Continuous 
illumination 
Experiment 3 Experiment 4 
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Fungal cultures on each medium were divided into two groups, respectively: One half was 
grown in darkness, while the other half was grown under continuous illumination with artificial 
white light over the whole fermentation period (see table 3.7). In this way 10-25 petri dishes 
were prepared for each of the four conditions. Each plate was inoculated with three agar 
plugs (three-point inoculation) from fungal precultures grown on agar medium (either malt 
extract agar or Czapek-Dox agar). The whole experiment was performed three times. Each 
culture was fermented at 26 °C for 30 days. On day 14 and 28, cultures were checked for 
production of guttation droplets. Droplets were drawn with a syringe (10 µl, Hamilton, USA) 
and collected in glass vials. Each vial was supplemented with 20 µL of MeOH (LC-MS grade, 
Merck, Germany) as an antifoam agent. Volumes of the samples were measured with an 
HPLC-syringe (100 µL, Hamilton, USA). The solution was then dried under nitrogen gas flow 
and stored under -18 °C until further use.  
On day 30, the fermented cultures – containing mycelium and agar medium – were extracted 
four times successively during two days using EtOAc. The collected four aliquots were then 
unified, dried in a rotary evaporator to dryness and stored under -18 °C.  
Guttation droplets were analyzed qualitatively using LC-HRMS (with systems B and C, see 
section 3.3.2). Crude extracts of the fungal cultures were measured via 1H-NMR (in MeOH-
d4) and LC-HRMS (with system C) for qualitative analysis.  
Quantitative determination of epipyrones (1-3) and acetosellin (4) in guttation droplets and 
crude extracts was performed on LC-MS system A in one single run, using the peak area in 
the TWC (total wavelength chromatogram) of the diode array detector for quantification. For 
this purpose, the dried guttation fluid was dissolved in 180 µl MeOH/water (50:50), 
centrifuged (13g, 2 min) and the supernatant was taken for analysis. The crude extracts were 
defatted prior to quantification using VLC [the column was packed with 10 g C18-silica and 
repeatedly used for every sample (see section 3.2.2; eluent: 50 mL MeOH/water (90:10)]. 
The crude extract samples were then dried at 40 °C using a rotary evaporator and resolved 
in 100% MeOH (LC-MS grade, Merck, Germany) to a final concentration of 1 mg/mL. 
Following standards were prepared for acetosellin (4) and epipyrones (1-3) in ascending 
concentrations using 100% MeOH (LC-MS grade, Merck, Germany; values given in mg/mL): 
0.002; 0.01; 0.05; 0.1; 0.5; 1.0. 
From the peak area of standard solutions (expressed in [mAU·sec]) a standard curve was 
prepared and the concentration values of each sample was calculated on basis of the 
standard curves (see figures 3.4a and 3.4b). Statistical evaluation was performed on Prism 
5 (GraphPad Software Inc.), including the SEM (standard error of the mean) and statistical 
evaluation employing the Mann-Whitney test (one-tailed). Concentration values for the 
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guttation fluid refer to the concentration in the original fluid prior to processing. Concentration 
values for the crude extracts refer to the original, non-defatted, extracts.  
 
 
Fig. 3.4a: Linearity for the LC-MS results of standard solutions for acetosellin (4) (concentration given 
in mmol/L), inferred by linear regression. Peak areas, expressed in mAU·sec, were taken from the 
diode array detector. 
 
 
Fig. 3.4b: Linearity for the LC-MS results of standard solutions for epipyrones (1-3) (concentration 
given in mmol/L), inferred by linear regression. Peak areas, expressed in mAU·sec, were taken from 
the diode array detector.   
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3.7 CHEMICALS AND SOLVENTS 
 
Acetic anhydride (99.6%)   VWR International (France) 
Acetone-d6 99.8%    Deutero GmbH (Germany) 
Acetonitrile (HPLC grade)   VWR International (France) 
Agar      Sigma-Aldrich (USA) 
Benzylpenicillin    Fluka (Switzerland) 
Chitin from crab shells   Fluka (Switzerland) 
Chloroform-d1     Deutero GmbH (Germany) 
Copper sulfate pentahydrate (p.a.)  Merck (Germany) 
Difco Czapek-Dox broth    Becton Dickinson (USA) 
DMSO-d6, 99.8%    Deutero GmbH (Germany) 
Malt extract     Villa Natura GmbH (Germany 
Methanol (HPLC grade)   Avantor (Poland) 
Methanol (LC-MS grade)   Merck (Germany) 
Methanol-d4 99.8%    Deutero GmbH (Germany) 
Peptone (from animal tissue)   Roth (Germany) 
Pyridine (99%)    Roth (Germany) 
Sodium[1-13C,99%]acetate    Cambridge Isotope Laboratories Inc. (USA) 
Streptomycin sulfate    Fluka (Switzerland) 
Trifluoroacetic acid (TFA), 99.9%  Roth (Germany) 
Yeast extract (micro-granular)  Roth (Germany) 
Zinc sulfate heptahydrate (p.a.)  Roth (Germany) 
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4 RESULTS 
 
4.1 IDENTIFICATION OF THE FUNGAL STRAINS 
  
As of 2011, nearly 100,000 fungal species have been described [170]. Ascomycota make up 
the largest group with 68,000 species. The major characteristic of this phylum is the 
formation of asci, which harbor the ascospores, i.e., meiospores that are built after genetic 
recombination in a sexual process. Among these fungi are the Pleosporales, which form a 
large group with 4705 species, according to Moore et al. [170]. Typically, they live as 
epiphytes, endophytes, plant parasites, saprobes on dead plant matter or on dung [171]. 
Inside the order Pleosporales, the family Didymellaceae, which was delineated by genetic 
methods, harbors the genus Epicoccum. Currently, eight species are accepted for this 
genus, all of which are highly variable anamorphic fungi, i.e., sexual reproduction has not 
been observed [172,173]. Specifically, the herein described species – Epicoccum nigrum – 
has been the subject of some recent phylogenetic studies [14,174]. Remarkable variability, 
together with frequent occurrence and the importance for agriculture, may be the reasons.  
The two fungal strains, which are the basis of this work, were identified based mainly on their 
ITS sequences. Additionally, microscopic evaluation was performed. According to Chen et al. 
[173], the genus Epicoccum is characterized by the formation of unicellular or multicellular, 
smooth or verrucose chlamydospores, which can vary in size (5 – 35 µm) and pigmentation 
(subhyaline to dark brown). This was confirmed through microscopical examination of 
mycelium grown on Czapek-Dox agar with trace metal solution (see fig. 4.1 and 4.2). 
However, pycnidia or sporodochia, which were also described for the genus, could not be 
observed on the cultures.  
For the confirmation of the microscopical data and to further narrow down the identity of the 
strains to species level, molecular identification via the ITS sequence was used. This 
approach has already been applied successfully for this genus [14]. Comparison of the 
obtained genetic sequences with the top hits in blastn revealed the identity of both strains to 
be Epicoccum nigrum with a sequence identity of 100% compared to the strains obtained 
from Genbank [146] (see fig. 4.3).  
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Fig. 4.1: Branched vegetative mycelium of E. nigrum strain 749 grown in MEB (malt extract broth), 
imaged by phase-contrast microscopy. Magnification: 200x. 
 
Fig. 4.2: Chlamydospores of E. nigrum strain 749 grown on Czapek-Dox agar with trace metal solution 
in darkness. Spores were imaged through phase-contrast microscopy after 4 weeks culture. 
Magnification: 200x. Spore sizes are included in the picture. 
100 µm 
21 µm 
17 µm 
23 µm 
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Fig. 4.3: Evolutionary relationships of the herein described taxa. ITS sequences for E. nigrum strains 
obtained in this study are highlighted. Gliomastix murorum strain 469 (Hypocreales, Sordariomycetes) 
was chosen as the outgroup, all of the remaining taxa belong to the Pleosporales (Dothideomycetes). 
Calculation of the phylogenetic tree was carried out with Mega6 [149]. The evolutionary history was 
inferred by using the Maximum Likelihood method based on the Tamura-Nei model. The tree with the 
highest log likelihood (-1237.5214) is shown. The percentage of replicate trees in which the associated 
taxa clustered together (1000 replicates) are shown next to the branches. The tree is drawn to scale, 
with branch lengths measured in the number of substitutions per site (scale bar: 5 substitutions per 
100 nucleotides; see section 3.1.2 for the method and references).  
 
4.2  SECONDARY METABOLITES OBTAINED DURING THIS STUDY 
 
During the initial screening of E. nigrum strain 749, carried out by Ekaterina Egereva, an 
inhibitory activity of crude extracts against human leukocyte elastase (HLE) (see table 4.1). 
Consequently, a large scale fermentation of strain 749 was attempted on MES  medium (malt 
extract agar with artificial sea water) first. During this work, an additional strain of E. nigrum 
was isolated (see section 4.1), the strain 800. The latter was initially envisaged as the 
producing strain for acetosellin in order to elucidate its biosynthesis, since it initially produced 
a higher amount of this compound (see section 4.4). Later, strain 749 proved to be the 
superior producer of acetosellin (4) during cultivation experiments. Therefore, strain 800 was 
only used for the isolation of additional bioactive secondary metabolites (see fig. 4.5).  
 Epicoccum nigrum JX4021941 
 Epicoccum nigrum JX4021821 
 Epicoccum nigrum JX4021911 
 Epicoccum nigrum KC3051601 
 Epicoccum nigrum strain 800 
 Epicoccum nigrum KF1644041 
  Epicoccum nigrum KF5748771 
 Epicoccum nigrum strain 749 
 Epicoccum nigrum KC5682891 
 Phoma exigua strain PB5 
 Phoma betae strain 815 
 Gliomastix murorum  
 strain 469 
96 
99 
64 
0.05 
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Table 4.1: Inhibitory activity on human leukocyte elastase (HLE) of extracts from cultures of E. nigrum 
strain 749 grown under continuous illumination.  
Growth medium  
Residual enzyme activity [%] at a 
concentration of 10 µg/ml
*
 
MES
** 
33.3 
 MEA
*** 
9.9 
*Experiments performed in the working group of Prof. Gütschow.  
**MES = Malt extract agar with artificial sea water. ***MEA = Malt extract agar.  
 
Both strains – 749 and 800 – were fermented under different conditions, in order to change 
the secondary metabolism (OSMAC approach, see section 1.1 for the definition). 
Strain 749 was cultivated first on MES (malt extract agar with artificial sea water) under 
continuous illumination with artificial light. From this extract, epipyrones (1-3) were isolated 
using size exclusion chromatography and RP-VLC in high yields (78.8 mg). Two 5-methyl 
orsellinic acid derivatives, 1F4-1-6 (12) and epicoccone (11), were obtained via further 
purification by RP-SPE and RP-HPLC. For details see section 3.2.6.1 and fig. 4.4.  
Later, acetosellin (4) and its dihydroxy derivative (compound 7) were isolated from a culture 
of strain 749 on CDA (Czapek-Dox agar), grown under continuous illumination with white 
light, again in a high yield (104 mg). 
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Fig. 4.4: Separation scheme for E. nigrum strain 749 grown on MES (malt extract agar with artificial 
sea water) and on CDA (Czapek-Dox agar). Both cultures were grown under continuous illumination. 
For details on cultivation conditions and media see section 3.1.3, for details on extraction and 
fractionation see section 3.2.6.1. 
 
Strain 800  
E. nigrum strain 800 was cultivated three times on different media:  
1) The first culture was prepared on MEN medium (malt extract agar with artificial sea 
water and sodium acetate) under continuous illumination with white light. Separation 
of this first extract by successive use of NP VLC, SPE and HPLC afforded two 
metabolites (see section 3.2.6.5 and fig. 4.5): Epicaronic acid (13, also found in the 
third culture extract of strain 800 mentioned below) and flazin (15).  
2) Epicoccolide B (9) was isolated from a second culture on MEA+TMS (malt extract 
agar with trace metal solution), grown in darkness, through successive use of NP 
flash chromatography and RP-HPLC (see fig. 4.5 and section 3.2.6.5).  
3) The third culture (´time course´ culture) was initially prepared for studies on the 
biosynthesis of acetosellin (4) (section 4.3.4). Isolation of metabolites was achieved 
by successive use of RP flash chromatography and RP-HPLC (see section 3.2.6.4 
and fig. 4.6). Three compounds were isolated: Epicaronic acid (13), tricinonoic acid 
(14) and (3R,4S)-4-hydroxymellein (10).  
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Fig. 4.5: Separation scheme for the first two fermentations of E. nigrum strain 800 on MEA+TMS (malt 
extract agar with trace metal solution, grown in darkness) and on MEN (malt extract agar with artificial 
sea water and sodium acetate, grown under continuous illumination). For details on cultivation 
conditions and media see section 3.1.3.  
 
Fig. 4.6: Separation scheme for the third cultivation of strain 800. These ´time course´ cultures of E. 
nigrum strain 800 were grown on MEN (malt extract agar with artificial sea water and sodium acetate). 
The culture was grown under continuous illumination. For details on cultivation conditions and media 
see section 3.1.5, details on fractionation are given in section 3.2.6.4. 
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4.3  EPIPYRONES (1-3) 
 
4.3.1  CULTIVATION EXPERIMENTS AND FERMENTATION 
CONDITIONS 
 
As indicated in the last section, different culture conditions were used to alter the secondary 
metabolism of E. nigrum strains 749 and 800 (for basic cultivation techniques, see section 
3.1.3). For this purpose, two of the aforementioned procedures (see section 4.2) were 
chosen: Variation of the substrate and of abiotic factors, including trace metal 
supplementation and growth under continuous illumination with white light or darkness. 
Concerning strain 749, following observations were made: The metabolic pattern proved to 
be remarkably stable, concerning the experiments on malt extract agar medium (MEA)  (see 
table 4.2 and appendix: fig. 8.1). Epipyrones (1-3, fig. 4.7) can be distinguished as the main 
metabolites on different growth conditions, with a retention time of ca. 18.4-19.5 min in the 
UV trace of the LC-MS-DAD chromatogram (see table 4.2 and fig. 8.1 in appendix). The 
striking exception is an extract prepared from strain 749 grown on malt extract agar with 
trace metal solution under continuous illumination (No. 5 in table 4.2). In this case, only 
minute amounts of epipyrones (1-3) could be detected, probably due to the artificial light 
applied during the whole cultivation period. It can be concluded from the depicted data that – 
during fermentation on MEA – either darkness is needed to induce production of epipyrones 
(1-3) or a (osmotic) stress-inducing supplement. This can be ASW (artificial sea water) or 
NaOAc.  
The second major compound found in strain 749 is acetosellin (4) (see fig. 8.1 in appendix 
for a comparison of chromatograms from crude extracts) with a retention time of 
approximately 18 min. This compound is a polyketide with a partly reduced azaphilonoid core 
structure. It will be further discussed in section 4.4. In contrary to strain 749, production of 
epipyrones (1-3) was not observed for strain 800 (see fig. 8.2 in appendix) with neither of the 
cultivation conditions. Production of acetosellin (4), however, is upregulated during growth on 
malt extract agar with ASW (artificial sea water) and sodium acetate. Also, addition of trace 
metals causes a marked decrease in acetosellin (4) production in both strains. As will be 
mentioned in section 4.7, production of acetosellin (4) on Czapek-Dox agar (CDA) in strain 
749 relies mainly on the absence of trace metal solution (TMS). More details on the 
metabolism of strain 749 on CDA will be given in section 4.7.  
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Fig. 4.7: Major secondary metabolites found in E. nigrum strain 749. Epipyrone A (1), epipyrone B (2), 
epipyrone C (3), acetosellin (4). 
Table 4.2: Relative abundance of the major metabolites from extracts fermentation experiments (each 
strain was cultivated on five petri dishes under each condition). The data were calculated from the 
peak area in the TWC in relation to epipyrones (1-3) or acetosellin (4) standard solution (1 mg/ml), 
respectively. Shown are the data from extracts of two strains (strains 749 and 800).  
 Relative abundance of major metabolites in crude extract [wt%] 
epipyrones acetosellin 
No. Culture conditions strain 749  strain 800  strain 749  strain 800  
1 MEA + ASW  16 n.d. 9 2 
2 
MEA + ASW +NaOAc
 
38 n.d. 3 8 
3 
MEA + TMS +ASW  
 
50 n.d. 3 1 
4 
MEA + TMS 
 
24 n.d. n.d. 0 
5 MEA + TMS  1 n.d. 0 1 
6 
CDA + TMS 
 
58 n.d. n.d. n.d. 
n.d. = not detected, MEA = malt extract agar, ASW = artificial sea water 
TMS = trace metal solution (containing Zn
2+
 and Cu
2+
, see section 3.1.3 for details), CDA + TMS = 
Czapek-Dox agar with trace metal solution. Lightbulbs indicate continuous illumination of the fungal 
cultures with artificial white light. 
1 
2 
3
 2 
4
 
 2 
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4.3.1.1 ISOLATION AND STRUCTURE ELUCIDATION OF EPIPYRONES (1-3) 
 
As described in section 3.2.6.1, epipyrones (1-3) were isolated from strain 749 grown on 
MEA + TMS via successive use of NP-VLC, SEC and RP-VLC. Structure elucidation was 
achieved by comparison of the exact mass measurement, 1D-/2D-NMR data, as well as of 
the UV and IR data with data from the literature [175,176]. In this way the configuration of the 
side chain and the identity of the C-glycosyl moiety could be confirmed. The signals in the 
1H-NMR and 13C-NMR also point to the presence of isomers B (2) and C (3), which arise 
from 1 by rearrangement of the glycosidic part (see tables 4.3a-c). Integration of the signals 
also confirms that epipyrone A (1) accounts for ca. 70% of the mixture, which was reported 
before [175]. 
 
Fig. 4.8: Structure of epipyrone A (1) with numbering. 
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Table 4.3a: NMR-data of epipyrone A (1), measured in MeOH-d4, at 300 MHz (
1
H-NMR) and 75 MHz  
(
13
C-NMR), respectively.  
Carbon No. δC [ppm]
 a,c
       δH [ppm]
c
; (J [Hz])           COSY HMBC
b,c
 
2 166.1, qC -     
3 101.7, qC -    
4 170.4, qC -     
5 102.3, CH 6.12 (1 H, s)   3,6,7 
6 160.6, qC -     
7 122.4, CH 6.20 (1 H, br d, 15.0) 8   
8 137.6, CH 7.13 (1 H, dd, 11.3; 15.0) 7   
9 132.2, CH 6.45
†
     
10 140.6, CH 6.61 (1 H, br d, 11.3)     
11 134.1, CH 6.44
†
     
12 133.6, CH 6.40
†
     
13 137.0, CH 6.44
†
     
14 130.1, CH 6.44
†
     
15 138.1, CH 6.47
†
     
16 140.3, CH 6.44
†
     
17 136.6, qC -     
18 131.4, CH 6.18 (1 H, s) 20,29 20,21,28 
19 132.2, qC -     
20 149.1, CH 5.65 (1 H, d, 10.3) 18,21 18,28 
21 33.1, CH 3.08 (1 H, m) 22,27   
22 45.8, CH2 1.16 (1 H, m
†
) 1.40 (1 H, m
†
)   21 
23 33.8, CH 1.36 (1 H, m
†
) 22,24 25 
24 31.2, CH2 1.21 (1 H, m
†
) 1.36 (1 H, m
†
)   22 
25 11.7, CH3 0.915 (3 H, t
†
) 24 23 
26 19.5, CH3 0.90 (3 H, d
†
)   22,24 
27 21.8, CH3 1.07 (3 H, d, 6.6) 21 21,22 
28 172.0, qC  -     
29 13.8, CH3 1.92 (3 H, s)     
30 76.2, CH 4.58 (1 H, d, 9.5) 31 2,3,4 
31 70.2, CH 4.28 (1 H, t, 9.5) 30,32   
32 76.5, CH 3.57 (1 H, dd, 2.9; 9.5) 31,33   
33 71.1, CH 3.97 (1 H, br d, 2.9) 32,34   
34 80.9, CH 3.67 (1 H, m) 33,35   
35 62.7, CH2 3.80 (1 H, m) 34   
referenced in Mestrenova using MeOH-d4 signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances  
c
 measured in MeOH-d4 
†
 overlapped 
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Table 4.3b: NMR-data of epipyrone B (2), measured in MeOH-d4, at 600 MHz (
1
H-NMR) and 125 MHz  
(
13
C-NMR), respectively. 
Carbon No. δC [ppm]
 a,c
       δH [ppm]
c
; (J [Hz])           
30 83.0, CH 5.27 (1 H, d, 2.5) 
31 78.8, CH 4.23
†
 
32 80.6, CH 4.27
†
 
33 87.3, CH 4.09
†
 
34 72.5, CH 3.82
†
 
35 64.5, CH2 3.69
†
 
referenced in Mestrenova using MeOH-d4  signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances 
c
 measured in d4-MeOH 
†
 overlapped 
 
Table 4.3b: NMR-data of epipyrone C (3), measured in MeOH-d4, at 600 MHz (
1
H-NMR) and 125 MHz  
(
13
C-NMR), respectively. 
30 78.3, CH 5.16
†
 
31 79.5, CH 4.69
†
 
32 71.0, CH 4.17
†
 
33 83.6, CH 4.12
†
 
34 72.4, CH 3.82
†
 
35 62.7, CH2 3.71
†
 
referenced in Mestrenova using MeOH-d4  signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances 
c
 measured in d4-MeOH 
†
 overlapped 
 
Epipyrones (1-3): Red-orange amorphous powder (79 mg, 11.3 mg/L).  20D  +121.0 (c 
0.04, MeOH). UV (CH3OH) λmax (ε), 239 (1990) nm, 427 (69346); IR (νmax) 3261, 2961, 1664, 
1538, 1421, 1138, 1003 cm-1. 1H-/13C-NMR-data see table 4.3. HR-ESI-MS m/z 635.2780 
[M+Na]+ (calcd. for C34H44NaO10
+, 635.2827).  
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4.3.2   ACETYLATION PRODUCTS (5-6) 
 
Acetylation of epipyrones (1-3) was attempted according to the protocols mentioned in 
section 3.4 in order to determine the structure-activity relationships for the C-glycosyl moiety 
and to inhibit isomerization of the pyranosyl isomer into the two furanosyl isomers. 
Isomerization reportedly happens spontaneously in solution [175]. However, for purification, 
chemical analysis and biological activity testing, a defined substance is preferable. The 
desired compound 5 (see fig. 4.9) was obtained in 40.7% yield, while the yield for compound 
6 (see fig. 4.9) was 5.4%. Structure elucidation involved comparison of the 1D- and 2D-NMR 
data with the data obtained from epipyrones (1-3), high accuracy mass measurements, as 
well as IR- and UV-data. For compound 5, the 1H-NMR (see table 4.4) already showed the 
presence of four additional signals between δ 1.93 and δ 2.22, typical for methyl protons in α-
position of an acetyl unit. The 1H-NMR coupling constants of the C-glycosyl moiety further 
confirmed the presence of a pyranose ring. HMBC correlations, together with the changed 
chemical shift values of methine and methylene groups in the 1H-NMR, served to elucidate 
the acetylation pattern of the pyranosyl moiety. 
Remarkably, the signal for H-20 was shifted downfield (Δδ = 0.95), which pointed to an 
isomerization from Z- to E-configuration at the terminal double bond, which is especially 
prone to isomerization. This was confirmed by the ROESY correlation between H-18 and H-
21. Additional evidence for isomerization was obtained from the lower UV-maximum at 422 
and the lower molar absorptivity compared to epipyrones (1-3) (Δλ = 5 nm, Δε = 39840).  
The 1H-NMR of compound 6 (see table 4.5) revealed the presence of three acetyl units (δ 
1.93 – 2.11). Again, the 1H-NMR coupling constants for the C-glycosyl moiety confirmed the 
presence of a pyranose partial structure and HMBC correlations provided evidence for the 
acetylation pattern. The chemical shift value of H-20 pointed to the fact that the original Z-
configuration of the terminal double bond was retained.  
Finally, high resolution mass spectrometry confirmed the acetylation rate for both compounds 
5 and 6 (see fig. 4.9).   
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Table 4.4: NMR-data of epipyrone tetraacetate (5), measured in MeOH-d4, at 600 MHz (
1
H-NMR) and 
150 MHz  (
13
C-NMR), respectively.  
Carbon No. δC [ppm]
 a,c
       δH [ppm]
c
; (J [Hz])           COSY HMBC
b,c
 
2 165.3, qC -     
3 99.1, qC -     
4 170.7, qC -     
5 101.4, CH 6.09 s     
6 161.2, qC -     
7 122.3, CH 6.24 (1H, d, 15.0)     
8 138.1, CH 7.21 (1 H, dd, 11.2; 15.0)     
9 132.2, CH 6.49
†
     
10 140.8, CH 6.72 (1 H, dd, 11.4; 14.5)     
11 134.3, CH 6.48
†
     
12 133.6, CH 6.45
†
     
13 136.9, CH 6.53
†
     
14 130.3, CH 6.51
†
     
15 138.2, CH 6.59
†
     
16 138.9, CH 6.53
†
     
17 139.8, qC -     
18 127.0, CH 6.14 (1 H, s) 20   
19 130.1, qC -     
20 152.1, CH 6.60 (1 H, br d, 10.5) 18 19,28 
21 32.9, CH 2.57 (1 H, br m)     
22 45.3, CH2 1.18 (1 H, m
†
)  1.40 (1 H, m
†
)     
23 33.6, CH 1.27 (1 H, m
†
)     
24 31.1, CH2 1.18 (2 H, m
†
)     
25 11.6, CH3 0.90 (3 H, t, 7.5)     
26 19.6, CH3 0.84 (3 H, d, 6.4)     
27 20.3, CH3 1.06 (3 H, d, 6.4)     
28 170.6, qC -     
29 14.7, CH3 1.78 (3 H, br s) 18 19 
30 73.6, CH 4.88 (1 H, d, 9.9)     
31 68.2, CH 6.04 (1 H, t, 9.9)   36 
32 74.2, CH 5.20 (1 H, dd, 3.4; 9.9)   38 
33 69.3, CH 5.50 dd (1 H, dd, 0.7; 3.4)   40 
34 75.6, CH 4.15 (1 H, m
†
)     
35 63.1, CH2 4.17 (2 H, m
†
, 5.5; 10.1)   42 
36 171.4, qC -     
37 20.6
†
, CH3 1.93 (3 H, s)   36 
38 171.7, qC -     
39 20.6
†
, CH3 2.00 (3 H, s)   38 
40 172.3
†
, qC -     
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Tab. 4.4 continued 
41 20.6
†
, CH3 2.22 (3 H, s)   40 
42 172.2
†
, qC -     
43 20.6
†
, CH3 2.06 (3 H, s)   42 
referenced in Mestrenova using MeOH-d4 signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances 
c
 measured in MeOH-d4 
†
 overlapped 
 
Table 4.5: NMR-data of epipyrone triacetate (6), measured in MeOH-d4, at 600 MHz (
1
H-NMR) and 
150 MHz  (
13
C-NMR), respectively.  
Carbon No. δC [ppm]
 a,c
       δH [ppm]
c
; (J [Hz])           COSY HMBC
b,c
 
2 166.6, qC -     
3 99.0, qC -     
4 n.d.       
5 104.2, CH 6.02 (1 H, br s)     
6 160.3, qC -     
7 122.8, CH 6.21 (1 H, d, 15.2)     
8 137.2, CH 7.17 (1 H, br t)     
9 132.3, CH 6.47
†
     
10 140.2, CH 6.69 (1 H, br t, 11.9)     
11 134.0, CH 6.45
†
     
12 133.6, CH 6.45
†
     
13 136.9, CH 6.47
†
     
14 130.0, CH 6.45
†
     
15 137.8, CH 6.55
†
     
16 140.3, CH 6.45
†
     
17 136.5, qC -     
18 131.5, CH 6.16 (1 H, s) 20   
19 n.d.       
20 148.3, CH 5.61 (1 H, d, 10.3) 18   
21 33.1, CH 3.05 (1 H, br m)     
22 45.9, CH2 1.16 (1 H, m
†
) 1.40 (1 H, m
†
)     
23 33.8, CH 1.37
†
     
24 31.2, CH2 1.21 (2 H, m
†
)     
25 11.7, CH3 0.91 (3 H, br s)     
26 19.5, CH3 0.91 (3 H, s
†
)     
27 21.8, CH3 1.07 (3 H, br d)     
28 172.6, qC -     
29 13.7, CH3 1.93 (3 H, s
†
)     
30 74.1, CH 4.83 (1 H, d
†
, 8.8)     
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Tab. 4.5 continued 
31 69.0, CH 5.94 (1 H, br t, 9.7)   36 
32 76.7, CH 5.03 (1 H, d
†
, 9.7)   38 
33 68.7, CH 4.14 (1 H, br s)     
34 77.7, CH 3,96 (1 H, br s)     
35 64.7, CH2 4.28 (2 H, br m)   40 
36 171.6, qC -     
37 20.6, CH3 1.93 (3 H, s
†
)   36 
38 172.1, qC -     
39 20.8, CH3 2.11 (3 H, br s)   38 
40 172.6, qC -     
41 20.7, CH3 2.08 (3 H, br s)   40 
referenced in Mestrenova using MeOH-d4 signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances 
c
 measured in MeOH-d4 
†
 overlapped 
 
 
Fig. 4.9: Acetylation products 5 and 6 obtained from reaction of epipyrones (1-3) with Ac2O in pyridine. 
Epipyrone tetraacetate (5): Red-orange amorphous solid (11.8 mg).  20D  -46.0 (c 0.20, 
MeOH). UV (CH3OH) λmax [nm] (ε [L·mol
-1·cm-1), 219 (16299), 330sh (12976), 422 (29506); 
IR (νmax) 3385, 2924, 1745, 1682, 1541, 1420, 1368, 1223 cm
-1. 1H-/13C-NMR-data see table 
4.4. HR-ESI-MS m/z 781.3359 [M+H]+ (calcd. for C42H53O14
+, 781.3430), 803.3232 [M+Na]+ 
(calcd. C42H52NaO14
+, 803.3249).  
Epipyrone triacetate (6): Red-orange amorphous solid (1.4 mg).  20D  +9.0 (c 0.10, 
MeOH). UV (CH3OH) λmax [nm] (ε [L·mol
-1·cm-1) 345sh (9134), 424 (34163); IR (νmax) 3395, 
5
 
 2 
6
 
 2 
ROESY correlation 
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2922, 1728, 1639, 1538, 1440, 1370, 1240 cm-1. 1H-/13C-NMR-data see table 4.5. HR-ESI-
MS m/z 739.3284 [M+H]+ (calcd. for C40H51O13
+, 739.3324).  
 
4.4  ACETOSELLIN (4) AND 5´,6´-DIHYDROXYACETOSELLIN (7) 
 
Acetosellin (4) is believed to be a polyketide-derived secondary metabolite, which belongs to 
the widespread fungal subgroup of azaphilonoid compounds [177,178]. A highly oxygenized 
pyran-quinone core structure is characteristic. A remarkable feature of acetosellin (4) is the 
reduced pyran moiety, since the usually present double bond at C-1 is responsible for the 
high reactivity regarding primary amines (see fig. 4.10 and 4.11) [177,179–181]. The enone 
partial structure usually acts as a Michael acceptor for the nucleophilic amine group. 
Depending on the degree of unsaturation in the pyran moiety, either a pyridylidene- or an 
enamine formation is favored. In the case of epicocconone (8), it was shown that reaction 
with amines only leads to a reversible enamine formation. Though the reactivity of acetosellin 
(4) with regard to amines has not been studied to the best of my knowledge, it can thus be 
assumed that acetosellin (4) is not as reactive under physiological conditions. 
Compound 4 was discovered in an extract of the ascomycete Pseudocercospora acetosellae 
(syn. Cercospora acetosellae, Mycosphaeraceae, Capnodiales), though only weak 
bioactivities were reported against Micrococcus luteus and Saccharomyces cerevisiae, as 
well as phytotoxic activity [182]. In 2013, a report about the occurrence in an Epicoccum sp. 
CAFTBO, endophytically growing in Theobroma cacao, was published [183]. The authors 
confirmed moderate antibacterial activity. 
The biosynthesis of acetosellin (4) was subject of a dissertation published in 2007 [184]. 
However, since the employed strain lost the ability to produce acetosellin (4)  during these 
studies,  the biosynthetic origin could not be clarified.  
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Fig. 4.10: Generic azaphilonoid scaffold (modified from [177]), in comparison with acetosellin (4) and 
epicocconone (8). The characteristic core structure is shown in bold for compounds 4 and 8. 
 
Fig. 4.11: Reactivity of different azaphilonoid scaffolds with ammonia and primary amines (A + B) and 
proposed diminished reactivity of acetosellin (4). Reactions: A = generic azaphilonoid scaffold, e.g., 
(+)-sclerotiorin; B = epicocconone (8) core structure; C = acetosellin (4) core structure. 
In early cultivation experiments during this study, acetosellin (4) was only found as a 
byproduct in strain 749 grown on different cultivation media. Different approaches to isolate 
this compound, proved to be cumbersome, yielding minute amounts, which were not 
sufficient for structure elucidation. Unfavorable chromatographic properties during HPLC and 
chemical instability are the likely reasons. During the studies on the guttation droplets (see 
section 4.7), a major change in the metabolic pattern was observed: By omitting the TMS 
supplementation and incubation under constant illumination with artificial light, the fungus 
was influenced to produce acetosellin (4) as major metabolite rather than epipyrones (1-3) 
(see fig. 4.12, appendix: fig. 8.3 and fig. 8.4). The acetosellin (4) concentration reached ca. 
4 8 
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43 wt% in the exploratory crude extract as deduced from the LC-ESI-MS measurement. 
Additionally, acetosellin (4) was found in the agar medium (see appendix: fig. 8.25) and in 
the guttation droplets (also see section 4.7). 
For the isolation of acetosellin (4) this crude extract was harnessed, named 749CDA-h(1). As 
a consequence, feeding studies on the biosynthesis of acetosellin (4) were also carried out 
under the aforementioned conditions. 
 
 
Fig. 4.12: Relative abundance of the main metabolites as calculated from the TWC from LC-MS 
measurements. Shown are values for acetosellin (4) and epipyrones (1-3) in the exploratory crude 
extracts of E. nigrum strain 749 on either CDA (Czapek-Dox agar) under continuous illumination with 
white light or on CDT (Czapek-Dox agar with trace metal solution), grown in darkness. On CDT, 
acetosellin could not be detected during this cultivation experiment.  
 
4.4.1  ISOLATION PROCEDURE 
 
E. nigrum strain 749 was fermented on 2.5 L of CDA, distributed on 25 petri dishes (for the 
cultivation and extraction conditions see sections 3.1.3 and 3.1.4). 576 mg of a yellow-
brown crude extract were separated using flash chromatography (see section 3.2.6.2), 
yielding 15 fractions (see fig. 4.13). Fraction 10 (tR ≈ 14 min, 80% MeOH/ 20% TFA) proved 
to be purified acetosellin  (4, 104 mg, orange solid). In fraction 6, an oxidation product of 
acetosellin (4) in a semi-pure form was detected, dihydroxyacetosellin (7, tR ≈ 10 min, 6 mg). 
Epipyrones (1-3) were found to be a minor constituent eluting with approximately 95% MeOH 
(fraction 13, tR ≈ 16.5 min).  
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Fig. 4.13: Flash chromatogram from the separation of the defatted crude extract of E. nigrum strain 
749. Fractions 6 (fraction containing compound 7), 10 (acetosellin,  4) and 13 (epipyrones 1-3) are 
highlighted.  Detectors used during this run: ELSD and UV. UV-wavelengths: UV1 = 220 nm, UV2 = 
254 nm, UV3 = 340 nm. The solvent gradient is indicated as gray line (AB = composition of the eluents 
in vol% MeOH). For details see sections 3.1.3 and 3.2.6.1. 
 
4.4.2  STRUCTURE ELUCIDATION OF ACETOSELLIN  
 
Comparison of the NMR-data with 1D-NMR values given by Nasini et al. [182] proved to be 
cumbersome. On the one hand, spectroscopic data were reported without direct assignment 
to the regarding atoms. On the other hand, deviations of 13C-NMR values for C-10 (Δδ = 3.3), 
C-13 (Δδ = 9.5), C-14 (Δδ = 3.3) and C-1´ (Δδ = 5.8) were higher than expected.  
Consequently, the structure of acetosellin (4) was deduced from extensive NMR-
measurements, using 1H-/13C-NMR, DEPT-135, as well as 2D-NMR-data (see table 4.6 and 
4.7, fig. 4.14). Confirmation of the absolute configuration was achieved by optical rotation 
measurements and the CD spectrum.  
 
Fig. 4.14: Structure of acetosellin (4) showing COSY and key HMBC correlations.  
COSY 
HMBC 
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Table 4.6: 
13
C-NMR data of acetosellin (4): Comparison of literature values with data from this study. 
Data were obtained in DMSO-d6 in both cases. Values with a deviation of Δδ > 2 ppm are marked in 
bold. 
Carbon No. 
δC [ppm]* 
according to Nasini et al. 
[182] 
δC [ppm] 
own data 
1 63.77 63.8, CH2 
3 74.21 74.1, CH 
4 32.04 32.0, CH2 
5 146.50 145.2, qC 
6 117.72 116.5, qC 
7 157.78 156.0, qC 
8 84.79 84.7, qC 
9 196.71 195.7, qC 
10 130.51 127.2, qC 
11 164.21 165.6, qC 
12 109.03 109.0, qC 
13 146.84 156.3, qC 
14 119.19 115.9, CH 
15 144.94 144.6, qC 
16 28.78 28.1, CH3 
17 63.77 63.6, CH2 
1´ 124.24 129.0, CH 
2´ 134.21 135.4, CH 
3´ 130.51 130.1, CH 
4´ 135.44 136.3, CH 
5´ 131.50 131.7, CH 
6´ 131.88 132.4, CH 
7´ 18.18 18.4, CH3 
*
: Assignment of the data from the given publication was done for this thesis according to best fitting of 
the values found in this study.  
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Table 4.7a: NMR-data of acetosellin (4), measured in MeOH-d4, at 300 MHz (
1
H-NMR) and 75 MHz  
(
13
C-NMR), respectively.  
Carbon No. δC [ppm] 
a,c
 δH [ppm] 
c
, (J [Hz]) COSY
c
 HMBC
b,c
 
1 65.5, CH2 
4.73 (1Hb, dd, 17.2; 2.4);                                             
4.35 (1Ha, dt, 17.2; 3.0) 
1a,4b        
1b 
3,9,10,15          
15 
3 75.4, CH 3.73 (1 H, m
†
) 17   
4 33.3, CH2 
2.84 (1 Hb, m);                                             
2.67 (1 Ha, d, 17.6) 
3,4a,17
1a,4b 
                               
15 
5 146.7, qC       
6 118.2, qC       
7 157.4, qC       
8 86.6, qC       
9 197.3, qC       
10 128.8, qC       
11 168.3, qC       
12 110.3, qC       
13 157.5, qC       
14 117.2, CH 6.85 (1 H, s)   1´,5,6,11,12,13 
15 146.9, qC       
16 28.6, CH 1.83 (3 H, s)   7,8,9 
17 65.3, CH2 3.74 (2 H, m
†
) 3,4   
1´ 129.7, CH 6.99 (1 H, d, 15.0) 2´ 3´,13,14,15 
2´ 137.2, CH 6.69 (1 H, dd, 9.9; 15.0) 1´,3´ 4´,15 
3´ 131.1, CH 6.33  (1 H, dd
†
, 9.9; 15.0) 4´,2´ 3´ 
4´ 137.9, CH 6.42 (1 H, dd
†
, 9.9; 15.0) 3´,5´ 5´ 
5´ 132.9, CH 6.17 (1 H, dd, 9.9; 15.0) 4´,6´ 4´ 
6´ 133.3, CH 5.86 (1 H, dq, 15.0; 6.8) 5´,7´ 4´ 
7´ 18.6, CH3 1.81 (3 H, br d, 6.8) 6´ 5´,6´ 
Data referenced in Mestrenova using MeOH-d4 signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances 
c
 measured in MeOH-d4 
†
 overlapped 
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Table 4.7b: NMR-data of acetosellin (4), measured in DMSO-d6 or acetone-d6, at 300 MHz (
1
H-NMR) 
and 75 MHz  (
13
C-NMR), respectively. 
Carbon 
No. 
δC [ppm] 
a,d
        δH [ppm] 
d
; (J [Hz])           δH [ppm] 
e
; (J [Hz])           
1 63.8 CH2 
4.57 (1H, d, 16.5)                        
4.28 (1H, d, 16.5) 
4.65 (1H, d, 15.7)                       
4.33 (1H, dt, 16.9; 3.5) 
3 74.1 CH 3.60 (1H, m 
†
) 3.71 (H, m) 
4 32.0 CH2 2.68 (2H, m) 
2.89 (1H, m)                         
2.74 (1H, br d, 18.0) 
5 145.2 qC     
6 116.5 qC     
7 156.0 qC     
8 84.7 qC     
9 195.7 qC     
10 127.2 qC     
11 165.6 qC     
12 109.0 qC     
13 156.3 qC     
14 115.9 CH 6.91 (1H, s) 7.01 (1H, s) 
15 144.6 qC     
16 28.1 CH3 1.79 (3H, s 
†
) 1.83 (3H, s) 
17 63.6 CH2 3.57 (2H, m 
†
) 3.71 (2H, m) 
1´ 129.03 CH 7.11 (1H, d, 15.0) 7.14 (1H, d, 15.0) 
2´ 135.4 CH 6.68 (1H, dd, 10.0; 15.0) 6.75 (1H, dd, 10.0; 15.0) 
3´ 130.1 CH 6.41 (1H, dd, 10.0, 15.0 
†
) 6.38 (1H, m) 
4´ 136.3 CH 6.47 (1H, dd, 10.0, 15.0
†
) 6.45 (1H, m) 
5´ 131.7 CH 6.20 (1H, dd, 10.0; 15.0) 6.16 (1H, dd, 10,0, 15.0) 
6´ 132.4 CH 5.88 (1H, m) 5.84 (1H, dq, 15.0, 7.0) 
7´ 18.4 CH3 1.78 (H, d, 7.0
†
) 1.76 (3H, br d, 7.0) 
Data referenced in Mestrenova using DMSO-d6 or acetone-d6 
signal, respectively. 
a
 multiplicities deduced from DEPT-135 experiments 
d
 measured in DMSO-d6 
e
 measured in acetone-d6 
†
 overlapped 
 
Acetosellin (4): Red-orange amorphous powder (104 mg, 41.6 mg/L).             20D  
+264 (c 0.1, MeOH) [Nasini et al. [182]:  20D  +283 (c 0.1, MeOH)]. ECD (c 0.25 mg/mL, 
MeOH): λmax ( ε) 335 (- 8.1); 214 (+ 9.5) nm;
  1H-/13C-NMR-data see tables 4.6 and 4.7 and 
figures 8.26-8.34 in the appendix. HR-ESI-MS m/z 412.1762 [M+NH4]
+; 395.1483 [M+H]+ 
(calcd. for C23H23O6
+, 395.1489); 377.1385 [M-H2O+H]
+ (calcd. for C23H21O5
+, 377.1384). 
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4.4.3  5´,6´-DIHYDROXYACETOSELLIN 
 
Compound 7 (see fig. 4.15) was obtained as the main constituent of a fraction during the 
isolation process of acetosellin (4), eluting with approximately 55% MeOH (see sections 
4.4.1 and 3.2.6.2). Structure elucidation was performed using mainly 1D- and 2D-NMR 
measurements. The molecular mass of 428 (Δ = 34 u) already led to the assumption that 
compound 7 might be a dihydroxylated derivative of acetosellin (4). The exact mass 
confirmed the molecular formula to be C23H25O8, while the hypsochromic shift (Δ = 25 nm) 
pointed to the shortening of the conjugated polyenic system. Indeed, 13C- and 1H-NMR 
spectra showed that the alkene signals of C-5´/H-5´ as well as C-6´/H-6´ were missing, 
compared to the spectra of acetosellin (4). In turn, two signals indicative of hydroxymethine 
functions appeared at δ 3.71/4.06 (1H-NMR) and δ 71.7/77.4 (13C-NMR). Through HMBC and 
COSY correlations, the side chain was proven to be hydroxylated at C-5´ and C-6´, leading 
to a vicinal diol partial structure. Comparison of the chemical shift values of all C- and H-
atoms confirmed the core structure to be identical with acetosellin (4). However, the absolute 
configuration of C-5´ and C-6´ could not be resolved during this study. In order to elucidate 
the relative configuration, synthesis of an acetonide at C-5´and C-6´ and subsequent 
comparison of 1H-NMR coupling constants with literature data could be pursued [185,186]. 
For the absolute configuration, Mosher´s method [185,187] or X-ray crystallography [188] 
could be employed. Nevertheless, the configuration at C-8 and C-3 is believed to be identical 
to acetosellin (4), since compound 7 shows the same Cotton effect in the CD-spectrum and 
is most probably is derived from the latter by oxidation of the terminal double bond (see fig. 
8.44 in the appendix and section 5.1.2 for the discussion). 
 
Fig. 4.15: Structure of 5´,6´-dihydroxyacetosellin (7) showing COSY and key HMBC correlations.  
 
 
COSY 
HMBC 
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Table 4.8: NMR-data of 5´,6´-dihydroxyacetosellin (7), measured in MeOH-d4 at 600 MHz (
1
H-NMR) 
and 125 MHz  (
13
C-NMR), respectively.  
Carbon No. δC [ppm]
a,c
 δH [ppm]
c
, (J [Hz]) 
1 65.5, CH2 
4.40 (1 Ha, dt, 17.1; 3.3);                                    
4.78 (1 Hb, dd, 2.4; 17.1) 
3 75.5, CH 3.72 (1H, m) † 
4 33.3, CH2 
2.72 (1 Ha, br d, 17.6);                                               
2.90 (1 Hb, m) 
5 146.6, qC   
6 118.5, qC   
7 157.5, qC   
8 86.6, qC   
9 197.4, qC   
10 129.0, qC   
11 168.3, qC   
12 110.6, qC   
13 157.8, qC   
14 117.8, CH 6.93 (1 H, s) 
15 146.9, qC   
16 28.4, CH3 1.88 (1 H, s) 
17 65.4, CH2 3.75 (2H, m) 
†
 
1´ 131.0, CH 7.18 (1 H, d, 15.2) 
2´ 136.5, CH 6.75 (1 H, dd, 10.2; 15.2) 
3´ 132.5, CH 6.62 (1 H, dd, 10.2, 15.2) 
4´ 138.0, CH 6.08 (1 H, dd, 6.5, 15.2) 
5´ 77.4, CH 4.06 (1 H, m)  
6´ 71.7, CH 3.75 (2H, m) 
†
 
7´ 18.9, CH3 1.22 (3 H, d, 6.4) 
Data referenced in Mestrenova using MeOH-d4 signal. 
a
 multiplicities deduced from DEPT-135 experiments 
c
 measured in MeOH-d4 
†
 overlapped 
5´,6´-Dihydroxyacetosellin (7): Yellow amorphous powder (6 mg, 2.4 mg/L).  20D  +149.5 (c 
0.47, MeOH). UV (CH3OH) λmax [nm] (ε [L·mol
-1·cm-1) 206 (25691), 315 (10816) nm; ECD (c 
0.3 mg/mL, MeOH): λmax ( ε) 332 (- 8.2), 216 (+ 5.2) nm; IR (νmax) 3357, 2914, 2850, 1738, 
1694, 1614, 1453, 1261 cm-1. 1H-/13C-NMR-data see table 4.8. LC-ESI-HRMS m/z 411.1453 
[M-H2O+H]
+ (calcd. for C23H23O7
+, 411.1438), 429.1553 [M+H]+ (calcd. for C23H25O8
+, 
429.1544), 446.1794 [M+NH4]
+ (calcd. for C23H28NO8
+, 446.1809). 
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4.4.4   STUDIES ON THE BIOSYNTHESIS OF ACETOSELLIN (4) 
 
The biosynthesis of azaphilones has been studied in a variety of fungi, most notably in the 
genera Penicillium and Monascus (both Aspergillaceae) [189–193]. Monascus species are of 
great interest, since their azaphilonoid pigments (MAzP = Monascus azaphilone pigments 
[194]) – mainly produced by M. ruber, M. purpureus and M. pilosus – are used in south east 
Asia as food colorants and are consumed for their alleged health benefits [195]. Traditionally, 
these species are used for the fermentation of rice, leading to the production of red mold rice 
(RMR, red yeast rice, ang-kak, red koji). RMR is of special importance not only for its 
azaphilonoid pigments, but for its content of the cholesterol-lowering drug lovastatin [195]. 
From a toxicological point of view, the capability of the aforementioned genera to produce 
citrinin as well – a cytotoxic azaphilonoid lacking the extended side chain – is of great 
concern for the food industry [196].  
As of 2015, the full genomes of five different strains in the genus Monascus have been 
sequenced [197]. On the basis of genomic data and labeling studies, a hypothesis was 
established that azaphilonoids with a side chain similar to acetosellin (4) are derived from 
two distinct polyketide chains. During biosynthesis, an esterification and a following 
Knoevenagel condensation are responsible for the connection of both parts. Thus, a lactone 
ring is formed. [177,198–202]. However, the biosynthesis of acetosellin (4) could not be 
resolved in former studies. One attempt by Plitzko et al. [184] failed due to degradation of the 
cultivated strain and a resulting cessation of acetosellin (4) production.  
During this study, a successful attempt was made to elucidate the incorporation of precursors 
by feeding [1-13C]acetate. The results will be discussed in the following section.  
 
4.4.4.1 DETERMINATION OF CULTIVATION CONDITIONS FOR THE 
LABELING EXPERIMENT WITH E. NIGRUM 
 
In order to achieve efficient incorporation of the [1-13C]acetate, experiments on the time 
course of acetosellin (4) production were performed at the beginning. The resulting data are 
necessary to plan the time points of [1-13C]acetate addition and to estimate the optimal date 
for harvesting and extraction of the culture. Additionally the consumption of [1-13C]acetate 
could be reduced by maximizing the yield of the desired product.   
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To determine the optimal duration of fermentation, E. nigrum strain 800 was cultivated and 
extracted as depicted in section 3.1.5.1. The extracts were semi-quantitatively compared via 
LC-ESI-MS. According to the LC-MS results, the maximum yield of acetosellin (4) deploying 
strain 800 was obtained between two and three weeks (see table 4.9).  
However, the optimal production of acetosellin (4) was observed in test cultures using strain 
749 grown on CDA for four weeks. As can be seen in table 4.4, an approximately threefold 
increase in acetosellin (4) production could be achieved. Based on these results, strain 749 
growing on CDA was chosen as the production system. 
Tab. 4.9: Results of the semi-quantitative analysis of acetosellin (4) production by LC-MS for cultures 
of E. nigrum strains 800 and 749. Data were calculated from the TIC by using a mass range from 394 -
396 (fig. 8.47 in the appendix). Strain 800 was grown on MEN medium, strain 749 was cultivated on 
CDA. The cultures were extracted with EtOAc after the indicated cultivation period. 
E. nigrum strain Cultivation time [weeks] Peak area [mAU·s] 
800 1 8.0 x 10
7
 
800 2 1.7 x 10
8
 
800 3 1.7 x 10
8
 
800 4 9.8 x 10
7
 
800 5 4.8 x 10
7
 
749 4 5.7 x 10
8
 
 
 
Experiences from past cultivations showed that E. nigrum grows slower on CDA than on the 
tested complex media. Therefore, the peak of acetosellin (4) production was expected to 
occur later. A cultivation time of three instead of two weeks was scheduled as compromise in 
order to yield more product and keep cultivation time limited.  
However, strain 800 was still considered for the investigation of new secondary metabolites 
(see section 4.5). 
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4.4.4.2 CULTIVATION AND FEEDING OF E. NIGRUM STRAIN 749 WITH [1-
13C]ACETATE 
 
For fermentation, feeding of [1-13C]acetate and extraction of E. nigrum strain 749 the protocol 
mentioned in section 3.1.5.2 was followed, yielding 111 mg of crude extract.  
During the cultivation, exudation of reddish or purple pigments into the medium could be 
observed. A similar pigmentation was observed for the mycelium, except for young hyphae at 
the growing front. Additionally, single guttation droplets with orange to dark reddish color 
appeared at the agar plugs, which were used for the inoculation (see fig. 4.16). Above all, 
phenotype and growth rate were comparable to cultures of strain 749 on pure CDA medium 
without NaOAc supplementation. In this way, a deleterious effect of precursor addition on the 
fungus could be excluded already during cultivation.  
 
  
Fig. 4.16: Growth and appearance of a labeling culture of E. nigrum strain 749 after 3 days (a) and 
after 21 days of cultivation in Fernbach flasks (b). Edge length of agar plugs was ca. 1 cm. 
 
A tentative evidence for successful labeling is given by the LC-ESI-MS data of the crude 
extract: The chromatogram shows a prominent peak eluting at 18.21 minutes (see fig. 8.48), 
of which the mass (m/z = 395) and UV data (λmax = 340.0 nm) correspond to previous 
measurements with unlabeled acetosellin (4). Additionally, the typical pattern for 13C-labeled 
metabolites can be identified in the mass spectrum, where the incorporation of at least six 
13C-atoms is shown. The remaining 13C-atoms could probably not be resolved due to limited 
sensitivity of the LC-MS instrument.  
 
b a 
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4.4.4.3 ISOLATION AND ANALYSIS OF 13C-LABELED ACETOSELLIN (4) 
 
The isolated substance was analyzed via 1H-NMR and 13C-NMR measurements (see tab. 
4.10 and fig. 4.17). In order to exclusively see the 13C-enriched atoms, a small number of 
scans (194 scans) was carried out for the 13C-NMR spectrum. Through comparison of data 
from the original substance and the 13C-labeled compound, incorporation of eleven [1-
13C]acetate units could be confirmed. The alternating labeling pattern complemented this 
observation.  
Tab. 4.10: NMR spectroscopic data of 
13
C-labeled acetosellin (4), measured in MeOH-d4 at 300 MHz 
or 75 MHz for 
13
C-NMR, respectively. The 
13
C enriched carbons are in bold print. 
Carbon 
No. 
δC  
[ppm] 
δH [ppm]  
(J in Hz) 
δC [ppm]
a
 
1 65.5, CH2 
a 4.76, d (17.2) 
b 4.38, d (17.2) 
65.5, CH2 
3 75.4, CH 3.73, m 75.4, CH 
4 33.3, CH2 
a 2.89, m 
b 2.70, d (17.6) 
33.3, CH2 
5 146.7, qC  146.7, qC 
6 118.2, qC  118.2, qC 
7 157.5, qC  157.4, qC 
8 86.6, qC  86.6, qC 
9 197.4, qC  197.3, qC 
10 128.8, qC  128.8, qC 
11 168.3, qC  168.3, qC 
12 110.3, qC  110.3, qC 
13 157.6, qC  157.5, qC 
14 117.3, CH 6.91, s 117.2, CH 
15 147.0, qC  146.9, qC 
16 28.5, CH3 1.86, s 28.6, CH3 
17 65.3, CH2 3.73, m 65.3, CH2 
1‘ 129.7, CH 7.08, d (15.0) 129.7, CH 
2‘ 137.3, CH 6.74, dd (9.9, 15.0) 137.2, CH 
3‘ 131.1, CH 6.43, m 131.1, CH 
4‘ 137.9, CH 6.46, m 137.9, CH 
5‘ 132.9, CH 6.23, dd (9.9, 15.0) 132.9, CH 
6‘ 133.3, CH 5.90, dq (15.0, 7.0) 133.3, CH 
7‘ 18.6, CH3 1.84, m 18.6, CH3 
a
: unlabeled acetosellin (4) 
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Fig. 4.17: Structure of acetosellin (4) with 
13
C labeling pattern. Bold dots indicate incorporated 
13
C-
atoms. The dashed red lines indicate the two different polyketide units, from which the product 
presumably originates. 
 
4.4.4.4 SIGNIFICANCE OF THE 13C-LABELING PATTERN  
 
After analysis of the NMR spectroscopic data from the feeding experiment with  sodium [1-
13C]acetate, eleven 13C-enriched carbons and a pattern of [1-13C]acetate incorporation into 
acetosellin (4) as depicted in fig. 4.17 were revealed. Thus, the pattern proposed by Plitzko 
in 2007 [184] could be confirmed.  
As a consequence of the incorporation pattern, following conclusions can be drawn: The 
biosynthesis of the pentaketide unit starting from C-17 through to C-1 forms ring B and C. 
During the synthesis, two hydroxylations would have to take place to form the hydroxy 
groups at C-8 and C-17. Condensation between C-10 and C-5 would lead to the formation of 
ring B, whereas the C-ring would likely be the result of acetal formation and subsequent 
dehydratation (see section 5.1.2 for a detailed scheme and further explanations). The 
methyl group at C-8 presumably arises from methylation via S-adenosyl methionine (SAM) 
already during chain elongation.  
This notion is supported by two observations: First, methylation of polyketides by SAM takes 
place at the methylene carbon in α-position to the thiolester of the growing chain [203]. In the 
case of acetosellin (4), C-8 does not show 13C-labeling and consequently must have 
originated from a methylene group during chain elongation. C-16 of the methyl group neither 
is part of the polyketide backbone nor does it show 13C-labeling. Second, the same 
methylation pattern and the responsible methyltransferases have been reported as part of 
the biosynthetic gene clusters of citrinin, azanigerone and the azaphilonoid Monascus 
pigments [177,201,202]. 
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The biosynthesis of the hexaketide unit starting from C-7’ through to C-11 and the 
interconnection with the pentaketide probably leads to the formation of ring A and D. During 
synthesis, the keto groups at C-6’, C-4’ and C-2’ would have to be reduced to form a 
conjugated triene with double bonds at C-6’, C-4’ and C-2’. The carbonyl group at C-13 is 
enolized. 
Both polyketide units would be interconnected at two positions. First, the hydroxy group at C-
8 and the carboxylic group at C-11 would undergo an esterification. An additional 
Knoevenagel condensation between C-12 and the keto group at C-7 would form the γ-
lactone ring D, yielding epicocconone (8). Another aldol condensation between C-6 and the 
keto group at C-15 would build the aromatic ring A, leading to the final product, acetosellin 
(4). 
 
4.5  OTHER SECONDARY METABOLITES FOUND IN THIS STUDY 
 
4.5.1.  POLYKETIDES 
 
4.5.1.1 EPICOCCOLIDE B (9) 
 
 
Fig. 4.18: Structure of epicoccolide B (9). 
Epicoccolide B (9) was isolated twice from E. nigrum strain 800 following the protocol 
described in section 3.2.6.5. Through comparison of LC-MS data, epicoccolide B (9) could 
be shown to be present in cultures of strain 800 grown on malt extract under different 
conditions. Through HR-MS measurements of crude extracts from strain 749 grown on CDA 
(Czapek-Dox agar) medium, compound 9 was also identified. Furthermore, it is excreted into 
guttation droplets by strain 749, growing on this medium (see section 4.7 for details). 
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Structure elucidation of epicoccolide B (9) was accomplished through comparison of 
literature data [183,204] with 1H- and 13C-NMR measurements, mass spectrometry and UV-
data.  
 
Epicoccolide B (9): yellow solid (first isolation: 1.3 mg, 4 mg/mL; second isolation: 4.8 mg, 
3.4 mg/mL); UV (CH3OH), λmax [nm] (taken from HPLC-separation): 363, 307, 241; 
1H NMR 
(300 MHz, DMSO-d6) δ 10.39 (s, H-8), 9.46 (s, H-16), 7.46 (s, H-3), 2.57 (s, H3-9), 2.00 (s, 
H3-17); 
13C NMR (75 MHz, DMSO-d6) δ 194.8 (C-16, CH), 190.1 (C-8, CH), 151.8 (C-2, qC), 
151.6 (C-14, qC), 150.2 (C-12, qC), 142.4 (C-7a, qC), 141.1 (C-6, qC), 136.5 (n.d.), 132.7 
(C-13, qC), 127.3 (C-5, qC), 125.0 (C-10, qC), 122.9 (C-3a, qC), 118.8 (C-15, qC), 116.9 (C-
4, qC), 112.6 (C-11, qC), 109.0 (C-3, CH), 12.8 (C-17, CH3), 11.1 (C-9, CH3); LC-ESI-MS m/z 
359 [M+H]+ (calcd. for C18H15O8
+, 359.1). 
 
4.5.1.2  (3R,4S)-4-HYDROXYMELLEIN (10) 
 
 
Fig. 4.19: Structure of (3R,4S)-4-hydroxymellein (10). 
 
Retention time, mass fragments and UV maxima obtained by LC-ESI-MS analysis of the 
flash fractions 4 and 5 already indicated that these fractions contained 4-hydroxymellein (10, 
see also section 3.2.6.4), an isocoumarin that was isolated from previously from another 
strain of E. nigrum in this institute [205]. Comparison of 1H NMR and 13C NMR spectra (see 
appendix) with literature data confirmed the structure. The optical rotation determined for 10 
matched the literature data for (3R,4S)-4-hydroxymellein (10) [206,207]. 
 
(3R,4S)-4-hydroxymellein (10): amorphous solid (2.0 mg);  TDα  = -27.6 (c 0.001); 
1H NMR 
(300 MHz, DMSO-d6) δ 10.87 (s, 8-OH), 7.61 (dd, J = 7.7, 8.0 Hz, H-6), 7.05 (d, J = 7.7 Hz, 
H-7), 6.94 (d, J = 8.4 Hz, H-5), 6.13 (br s, 4-OH) 4.55 (m, H-3, H-4), 1.39 (d, J = 4.8 Hz, H3-
11); 13C NMR (75 MHz, DMSO-d6) δ 168.1 (C-1, qC), 160.5 (C-8, qC), 143.7 (C-10, qC), 
136.6 (C-6, CH), 116.5 (C-7, CH), 116.2 (C-5, CH), 106.9 (C-9, qC), 79.8 (C-3, CH), 69.5 (C-
4, CH), 17.7 (C-11, CH3); LC-ESI-MS m/z 195 [M+H]
+ (calcd. for C10H10O4
+, 195.07). 
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4.5.1.3 EPICOCCONE (11) 
 
 
Fig. 4.20: Structure of epicoccone (11). 
 
Fractionation of the crude extract from E. nigrum strain 749 – grown on MES – yielded 2.7 
mg of compound 11 (see section 3.2.6.1 for details). The 13C-NMR spectrum already 
indicated the presence of six aromatic carbons and one carbonyl group, pointing to the 
presence of an orsellinic acid derivative. Comparison of the NMR spectral data with 
published data from Abdel-Lateff et al. [205,208] proved the structure to be identical with the 
phthalide epicoccone (11), which was isolated before from the culture of the marine-derived 
strain Epicoccum sp. 353.  
Epicoccone (11): greyish-white solid: 1H NMR (300 MHz, MeOH-d4): δ 5.15 (s, H2-3), 2.44 
(s, H-8); 13C NMR (75 MHz, MeOH-d4): δ 174.6 (C-1, qC), δ 146.2 (C-6, qC), δ 141.4 (C-5, 
qC), δ 138.0 (C-4, qC), δ 127.9 (C-4a, qC), δ 118.3 (C-7, qC), δ 114.0 (C-7a, qC), δ 68.0 (C-
3, CH2), δ 9.7 (C-8, CH3); LC-ESI-MS m/z 195 [M-H]
- 151 [M-H-CO2]
- (calcd. for C9H9O5
+: 
195.0). 
 
4.5.1.4 1F4-1-6 (12) 
 
 
Fig. 4.21: Structure of 1F4-1-6 (12). 
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The molecular mass of compound 12 (see fig. 4.21, for details of the isolation see section 
3.2.6.1) was deduced to be C17H24O8 by high resolution mass spectrometry, implying six 
degrees of unsaturation. UV absorption maxima (265 nm, 304 nm) pointed to the presence of 
an aromatic moiety. Indeed, 13C-NMR data (recorded in MeOH-d4) showed characteristic 
resonances for five aromatic carbon atoms (see table 4.13), of which one (C-2) was strongly 
deshielded and thus hypothesized to carry a hydroxyl-substituent. Since one signal from the 
aromatic moiety could not be observed in MeOH-d4, additional 1D- and 2D-NMR 
measurements were undertaken in acetone-d6, revealing the presence of an aromatic carbon 
atom (C-4). The chemical shift value (δ 160.5) is in a similar range as for C-2. Accordingly, a 
dihydroxy phenyl partial structure was assumed. Since only one singlet in the downfield 
region (H-3) was observed in the 1H-NMR, three further substituents had to be attributed to 
the ring system. Extensive 2D-NMR measurements confirmed a spin system consisting of 
the aromatic moiety, substituted with two hydroxy functions, two methyl groups and one 
carboxylic ester group. HMBC correlations and comparison of the chemical shift values with 
calculated values, proved the partial structure to be 5-methyl orsellinic acid. The second spin 
system – connected to the 5-methyl orsellinic acid moiety – was revealed to be a linear 
pentitol mainly by its COSY correlations, while the ester bond between C-1´ and C-7 was 
established by HMBC correlations (see fig. 4.22). Finally, the third spin system (C-6´, C-7´, 
C-8´) showed HMBC correlations to C-5´and C-6´, thus allowing to conclude the presence of 
an acetonide substructure. However, the configuration at the three chiral centers (C-2´, C-3´, 
C-4´) could not be resolved, since the substance was lost during an attempt to hydrolyze the 
ester function. 
Literature search did not reveal a report about this specific compound. However, in 2012 
Talontsi et al. [209] reported the isolation of paeciloside A (see fig. 5.11) in the fungal strain 
Paecilomyces sp. CAFT156 (Trichocomaceae, Eurotiales), including its absolute 
configuration. Comparison of the NMR-data to compound 12 show a similar pattern and thus 
confirm the structure. For paeciloside A, weak activity against gram-positive bacteria and 
cytotoxicity against Artemia salina were demonstrated.  
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Fig. 4.22: Structure of 1F4-1-6 (12) showing COSY and key HMBC correlations.  
 
Tab. 4.13a: NMR-Data for 1F4-1-6 (12), obtained in MeOH-d4. 
Carbon No. δC [ppm] 
a,c
 δH [ppm] 
c
, (J [Hz]) COSY 
c
 HMBC 
b,c
 
1 108.1, qC       
2 161.3, qC       
3 101.0, CH 6.25 (1 H, s) 8 1,2,5,7 
4 n.d.       
5 117.4, qC       
6 141.0, qC       
7 172.6, qC       
8 11.5, CH3 2.10 (3 H, s) 3,9 1,4
*
,5,6 
9 19.0, CH3 2.45 (3 H, s) 8 2,5,6 
1´ 67.1, CH2 
a: 4.40 (1 H, dd, 5.9; 11.2);  
b: 4.45 (1H,dd, 7.0, 11.2) 
  
7,2´,3´ 
7,2´,3´ 
2´ 69.6, CH 4.14
†
 (1 H, m) 1´,3´ 1´,4´ 
3´ 73.1, CH 3.60 (1 H, dd, 1.7; 8.0) 4´ 1´,4´ 
4´ 76.7, CH 4.23 (1 H, dt, 8.0; 6.0) 3´ 5´,6´ 
5´ 68.2, CH2 
a: 4.00 (1 H, dd, 6.0, 8.4);  
b: 4.15
†
 (1 H, m) 
4´ 
4´,6´ 
4´,6´ 
6´ 110.4, qC       
7´ 25.6, CH3 1.37 (3 H, s)   6´ 
8´ 27.1, CH3 1.40 (3 H, s)   6´ 
 
referenced in Mestrenova using MeOH-d4 signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances 
c
 measured in MeOH-d4 (300 MHz) 
n.d. = not detected, signal was observed solely in acetone-d6. 
†
 overlapped 
 
 
COSY 
HMBC 
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Tab. 4.13b NMR-Data for 1F4-1-6 (12), obtained in acetone-d6. 
Carbon No. δC [ppm] 
a,d
        δH [ppm] 
d
; (J [Hz])           
1 107.1, qC   
2 161.0, qC   
3 101.0, CH 6.32 (1 H, s) 
4 160.5, qC   
5 117.0, qC   
6 141.4, qC   
7 172.0, qC   
8 11.6, CH3 2.07 (3 H, s) 
9 19.1, CH3 2.44 (3 H, s) 
1´ 67.2, CH2 
a: 4.40 (1 H, m)  
b: 4.45 (1H, m) 
2´ 69.2, CH 4.14
†
 (1 H, m) 
3´ 72.8, CH 3.60 (1 H, dd, 2.0; 8.2) 
4´ 76.3, CH 4.17
†
 (1 H, m) 
5´ 67.7, CH2 
a: 3.97 (1 H, dd, 5.8; 8.4)  
b: 4.07 (1 H, dd, 6.2; 8.4) 
6´ 109.5, qC   
7´ 25.6, CH3 1.27 (3 H, s) 
8´ 27.1, CH3 1.32 (3 H, s) 
 
referenced in Mestrenova using MeOH-d4 signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances 
d
 measured in acetone-d6 (500 MHz) 
†
 overlapped 
1F4-1-6 (12): pale yellow solid (2.4 mg):  TDα  = +20.0 (c 0.18); UV (CH3OH), λmax [nm] (ε 
[L·mol-1cm-1]): 304 (11448), 265 (21046); IR (νmax) 3345, 2927, 1704, 1644, 1608 cm
-1; 1H and 
13C NMR (tab. 4.13); HR-ESI-MS m/z 379.1362 [M+Na]+ (calcd. for C17H24NaO8
+: 379.1363). 
 
4.5.2   TERPENOIDS 
 
4.5.2.1 EPICARONIC ACID (13) 
 
 
Fig. 4.23: Structure of epicaronic acid (13). 
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Epicaronic acid was isolated from an extract of strain 800, following the method described in 
section 3.2.6.5. The 1D- and 2D-NMR measurements revealed the presence of 15 carbon 
atoms, including four methyl, four methylene, one methine group and six quaternary centers 
(see table 4.14).    
The chemical shift values for C-4 (δ 201.3) and C-11 (δ 170.1) pointed to the presence of a 
ketone and a carboxylic acid moiety. 
 
The 1H-1H COSY spectrum revealed two spin systems: H2-2 and H2-3 as well as H2-7, H2-8, 
H-10 and H3-15. The small proton coupling constant between H-10 and H3-15 indicated a 
long-range coupling through the 9,10Δ double bond and therefore the presence of one sp2-
hybridized quaternary carbon, i.e., C-9. The double bond between C-9 and C-10 was 
confirmed to be E-configured through NOESY correlations between H-10 and H2-8/H3-14. 
 
1H-13C HMBC indeed proved C-9 to be the quaternary center between C-8, C-10 and C-15. 
Additionally, this measurement confirmed most of the acyclic fragment reaching from C-7 to 
C-15. Furthermore, a six-membered carbon cyclic moiety with the methyl groups C-12 and 
C-13 both attached to the sp3 quaternary carbon C-1, a keto function (C-4, δ 201.3) and the 
methyl group C-14 attached to the sp2 quaternary carbon C-5, could be established. The 
HMBC correlations (see fig. 4.24) originating from H2-7, H2-8, H3-12, H3-13 and H3-14 
suggested a connection of the acyclic fragment with the six-membered carbon ring at C-6.  
Finally, the quaternary carbon C-11 had yet to be assigned to the structure. A chemical shift 
value of C-11 in the 13C NMR (δ 170.1) pointed to a carboxylic acid moiety. Since the signal 
of C-9 was shifted downfield (δ 160.2) and an HMBC correlation of H3-15 to C-11 was 
observed, the conclusion was that C-11 is connected to C-10. 
The final proof of the proposed structure was achieved through UV, IR and MS analyses. 
The UV spectrum showed two maxima at 217 and 244 nm; the IR spectrum suggested the 
presence of alkenes (1644 cm-1) as well as at least one carbonyl group (1694 cm-1). HR-ESI-
MS analysis confirmed the chemical formula to be C15H22O3. 
Despite extensive search, no literature describing compound 13 could be found, rendering 
this a new metabolite, named epicaronic acid. 
 
 
Fig. 4.24: Structure of epicaronic acid (13) showing key COSY and HMBC correlations. 
HMBC 
NOESY 
COSY 
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Table 4.14: NMR-data for epicaronic acid (13) in MeOH-d4. 
No. δC δH (mult, J in Hz) COSY HMBC 
1 38.3, qC    
2 37.6, CH2 1.89 (2 H, m) 3 1,4,6,7 
3 35.1, CH2 2.52 (2 H, t, 6.9) 2 1, 2,4 
4 201.3, qC    
5 132.2, qC    
6 166.4, qC    
7 30.2, CH2 2.50 (2 H, m) 8 1,5,6,8,15 
8 40.4, CH2 2.35 (2 H, m) 7 6,7,9,10,15 
9 160.2, qC    
10 117.1, CH 5.79 (1 H, q, 1.5) 8, 15 15 
11 170.1, qC    
12 27.1, CH3 1.26 (3 H, s)  1,2,6,7 
13 27.1, CH3 1.26 (3 H, s)  1,2,6,7 
14 11.7, CH3 1.82 (3 H, s)  2,4,5,6,8,12,13 
15 18.8, CH3 2.26 ( 3 H, d, 1.5) 8,10 8,9,10 
 
referenced in Mestrenova using MeOH-d4 signal. 
a
 multiplicities deduced from DEPT-135 experiments 
b
 numbers refer to 
13
C resonances 
 
 
Epicaronic acid (13): yellowish solid (2.7 mg); UV (CH3OH) λmax [nm] (ε [L·mol
-1·cm-1) 246 
(7055), 217 (7124); IR (νmax) 2926, 1694, 1644, 1443, 1354, 1201, 1137, 1087, 649 cm
-1; 1H 
and 13C NMR (tab. 4.14); HR-ESI-MS m/z 273.1461 [M+Na]+ (calcd for C15H22O3Na
+, 
273.1467). 
 
4.5.2.2 TRICINONOIC ACID (14) 
 
 
Fig. 4.25: Structure of tricinonoic acid (14). 
Comparison of the 1D-NMR data (see appendix), molecular mass and the optical rotation 
proved the structure of 14 (see fig. 4.25) to be tricinonoic acid [210], which was found before 
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in an endophytic Fusarium tricinctum (Nectriaceae, Hypocreales) . A second report 
mentioned the occurrence in an Hamigera species (Trichocomaceae, Eurotiales) [211]. 
 
Tricinonoic acid (14): light brown solid (1.5 mg);  TDα  = +7.3 (c 0.0004, MeOH); 
1H NMR 
(300 MHz, MeOH-d4) δ 6.06 (d, J = 15.7 Hz, H-5), 5.50 (dd, J = 9.2, 15.7 Hz, H-6), 4.97 (br s, 
H2-12), 2.53 (m, H2-3), 2.50 (m, H2-2), 2.45 (m, H2-9), 2.14 (s, H3-11), 1.82 (m, H-7, H2-8), 
1.64 (m, H-13), 0.95 (d, J = 6.6 Hz, H3-14), 0.91 (d, J = 6.6 Hz, H3-15); 
13C NMR (75 MHz, 
MeOH-d4) δ 212.2 (C-10, qC), 177.6 (C-1, qC). 146.2 (C-4, qC), 134.5 (C-5, CH), 133.0 (C-6, 
CH), 114.6 (C-12, CH2), 51.0 (C-7, CH), 42.6 (C-9, CH2), 34.5 (C-2. CH2), 33.6 (C-13, CH), 
30.0 (C-11, CH3), 28.7 (C-3, CH2), 21.2 (C-14, CH3), 19.7 (C-15, CH3); LC-ESI-MS m/z 253.1 
[M+H]+ (calcd. for C15H25O3, 253.18). 
 
4.5.3.  FLAZIN (15) 
 
 
Fig. 4.26: Structure of flazin (15). 
Fractionation of the crude extract of E. nigrum strain 800, grown on MEN, afforded 1.2 mg of 
flazin (15, see fig. 4.26). Comparison of the NMR-results and the molecular mass with data 
reported by Shabaan et al. [212] proved the structure to be flazin. However, flazin was 
already found to be a constituent of the pure medium: 
In order to distinguish medium-derived background signals from fungal metabolites, two 
extracts were prepared during this study. A: 2 L MES medium (after autoclaving). B: 40 g of 
commercial malt extract (without autoclaving). Extraction was performed as described in 
section 3.1.5.1.  
LC-ESI-MS analysis (see appendix) and 1H-NMR measurement of non-autoclaved malt 
extract already showed the typical retention time, molecular mass, UV spectrum and 1H NMR 
resonances for flazin, indicating its presence in commercial malt extract. 
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Flazin (15): yellow solid: 1H NMR (300 MHz, DMSO-d6): δ 8.84 (s, H-4), 8.42 (d, J = 8.4 Hz, 
H-5), 7.83 (d, J = 8.0 Hz, H-8), 7.65 (t, J = 7.6 Hz, H-7), 7.42 (d, J = 3.0 Hz, H-4´), 7.35 (t, J = 
7.5 Hz, H-6), 6.63 (d, J = 3.4 Hz, H-3´), 4.68 (s, H2-6´); 
13C NMR (75 MHz, DMSO-d6): δ 
168.4 (C-10, qC), δ 159.1 (C-2´, qC), δ 153.1 (C-5´, qC), δ 143.3 (C-8a, qC), δ 134.3 (C-1, 
qC), δ 133.7 (C-9a, qC), δ 131.7 (C-3, qC), δ 130.7 (C-7, CH), δ 123.9 (C-5, CH), δ 122.8 (C-
4a, qC), δ 122.8 (C-4b, qC), δ 122.4 (C-6, CH), δ 117.6 (C-4, CH), δ 114.7 (C-8, CH), δ 
112.9 (C-4´, CH), δ 111.1 (C-3´, CH), δ 57.8 (C-6´, CH2); HR-ESI-MS m/z 309.0868 [M+H]
+ 
(calcd. for C17H13N2O4
+: 309.0870). 
 
4.6  BIOACTIVITIES OF THE ISOLATED METABOLITES 
 
4.6.1  INHIBITION OF CEREBROSIDE-SULFOTRANSFERASE (CST) 
 
During this work, small molecules were tested by Isabell Zech (working group Prof. 
Gieselmann, Institute for Biochemistry and Molecular Biology, University of Bonn) for their 
inhibitory activity against hCST using a radioactivity-based assay (see section 3.5.3 for the 
method). Epipyrones (1-3) showed significant inhibition of this enzymatic target, with an IC50-
value of 61.4 µM (see fig. 4.27).  
 
 
Fig. 4.27: Inhibitory activity of epipyrones (1-3) on human cerebroside sulfotransferase (hCST). The 
assay was performed in duplicates on three days, respectively. The mean values are given with the 
standard deviation. Assay performed by I. Zech (working group Prof. Gieselmann). 
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Since epipyrones (1-3) were the first inhibitory compounds on this target, more in-depth 
studies on structure-activity relationships (SAR) were attempted. The structural similarity of 
the C-glycosyl moiety in epipyrones (1-3) with the physiological substrate prompted us to 
undertake a semisynthetic derivatization of epipyrones (1-3). Therefore the C-galactosyl 
moiety was acetylated as described in sections 3.4 and 4.3.2. The two products 5 and 6 
were both probed for their effect on hCST activity (see fig. 4.28 and fig. 4.29): At the 
concentrations tested – 100 µM and 200 µM – compound 5 exhibited diminished inhibitory 
potential (100 µM: 61.3%; 200 µM: 42.3% residual activity), compared to epipyrones (1-3) 
(100 µM: 43.3%; 200 µM: 10.2% residual activity). This was also seen for compound 6 
(88.4% residual activity at 100 µM) and confirmed that acetylation of the C-galactosyl-moiety 
decreases the activity towards hCST in comparison with epipyrones (1-3, 18.2% residual 
activity).  
Since acetylation of the C-galactosyl moiety in epipyrones (1-3) leads to a marked decrease 
of inhibitory activity on hCST, a correlation between this moiety and bioactivity on this target 
seems obvious.  
In order to rule out the possibility that  only the C-glycosyl unit is necessary to inhibit the 
enzyme, pure β-D-galactose was tested (see appendix). However, no inhibitory activity was 
observed (see fig. 8.87 in appendix).  
Finally, a search for analogous substances to the epipyrones (1-3) was performed via the 
database ´Zinc´ [213]. One of the compounds – citreoviridin C (see fig. 4.28) – was found to 
exhibit comparable activity as epipyrones (1-3, IC50 = 58.56 µM, see fig. 8.88 in appendix for 
details). Citreoviridins are polyketides of fungal origin, found in Penicillium spp. [214] and 
Aspergillus spp. [215].  
 
 
Fig. 4.28: Structures of β-D-galactose and citreoviridin C [215], both tested for their inhibitory effects 
against hCST. 
In conclusion, the galactosyl moiety in the epipyrones (1-3) is crucial for the bioactivity, 
probably as a hydrophilic head group, but it is not solely responsible for the observed 
β-D-galactose citreoviridin C 
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inhibitory activity at the hCST. The two hydrophilic end portions, connected by a rigid 
polyenic spacer are common structural features of both inhibitors, epipyrones (1-3) and 
citreoviridin C. The exact role of different structural moieties remains unknown. Further 
studies would be needed to reveal the complete structure activity relationships.  
After succeeding in characterizing the first inhibitor for the hCST, i.e., epipyrones (1-3), more 
secondary metabolites from E. nigrum were tested for their inhibitory potential (see fig. 4.31).  
Compounds 10, 13, 14 and 15 showed weak or no inhibition of hCST at a concentration of 
100 µM.  
While acetosellin (4) showed a stronger inhibitory activity (11.9% residual activity) when 
compared to epipyrones (1-3), the results for compound 4 were not reproducible when 
retested with a second sample of compound (4). This led to the assumption that the 
observed inhibition may have been an experimental artefact. Another explanation could be 
the instability of acetosellin (4), which became apparent during purification by HPLC (see 
section 3.2.6.2).  
Overall, the importance of natural products in the search for inhibitors of hCST could be 
demonstrated, since epipyrones (1-3) were proven to be the first inhibitors of this target. 
Further work will be needed to establish molecular tools or lead structures for research and 
therapy. 
  
Fig. 4.29: Inhibitory activity of epipyrones (1-3) and epipyrone tetraacetate (5) on human cerebroside 
sulfotransferase (hCST). The assay was performed in triplicates. For the positive control, the assay 
was carried out without inhibitor. The mean values are given with the standard deviation. Assay 
performed by I. Zech (working group Prof. Gieselmann). 
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Fig. 4.30: Inhibitory activity of compound 6 (epipyrone triacetate) on human cerebroside 
sulfotransferase (hCST) at a concentration of 100 µM, compared with that of epipyrone (1-3). 
Inhibitory activity is given as residual activity of the tested enzyme in %. Assay was performed in 
duplicates on two days, respectively. The mean values are given with the standard deviation. Assay 
performed by I. Zech (working group Prof. Gieselmann). 
 
Fig. 4.31: Inhibitory activity of compounds epipyrones (1-3), acetosellin (4), hydroxymellein (10), 
epicaronic acid (13), tricinonoic acid (14), flazin (15) on human cerebroside sulfotransferase (hCST) at 
a concentration of 100 µM. Inhibitory activity is given as residual activity of the tested enzyme in %. 
Assay was performed in duplicates on two days, respectively. The mean values of are given with the 
regarding standard deviation. Assay performed by I. Zech (working group Prof. Gieselmann). 
 
4.6.2  INHIBITION OF CYSTEINE AND SERINE PROTEASES 
 
During this project, secondary metabolites were tested by the working group of Prof. 
Gütschow (Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn) for their 
inhibitory activity against different proteases (see section 3.5.4 for the methods). While 
acetosellin (4), epicaronic acid (13) and flazin (15) did not show any activities towards serine 
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or cysteine proteases at concentrations of 20 µM, epipyrones (1-3) exhibited potent inhibition 
of selected target enzymes (see tab. 4.15, fig. 4.32 and fig. 4.33; inhibition curves for 
epipyrones in fig. 8.89 - 8.91 in the appendix): The IC50 values range from 4.63 to 11.4 µM 
for HLE (human leukocyte elastase), cathepsin K and S. Interestingly, cathepsins B and L 
were not inhibited by epipyrones (1-3). This observation is intriguing, since the latter both are 
found ubiquitously in the human body, in contrary to cathepsins K and S (see section 1.4): 
Cathepsin K is mainly synthesized by osteoclasts, while antigen presenting cells are the 
main producers of cathepsin S, though additional cell types have been attributed to the latter 
quite recently [116]. Additionally, the digestive enzymes – trypsin and chymotrypsin – were 
not inhibited. 
 
Tab. 4.15: Activities of the tested compounds against cysteine and serine proteases: Shown are the 
IC50 values, inhibitory constants (Ki) in brackets. Compounds 4, 13, 15 were assayed at a final 
concentration of 20 µM in all assays. Compounds 1-3, 5 and 6 were assayed in following 
concentrations: Against HLE, six concentration were tested. For cathepsins B and L, compounds 5 
and 6 were tested at 10 µM, epipyrones (1-3) were tested at 20µM. For cathepsins K and S, 
compounds 5 and 6 were tested at 20 µM, epipyrones (1-3) were tested with six concentrations.  
Comp. Enzymes 
 trypsin
2
 
chymo-
trypsin
2
 
HLE 
2
 cath. B 
2
 cath. L 
2
 cath. K 
2
 cath. S 
2
 
1-3 - - 
4.63±0.64 
(1.62±0.23) 
- - 
11.4±1.8 
(0.795±0.123) 
6.61±0.42 
(3.80±0.24) 
5 - - 
5.19±0.77 
(1.82±0.27) 
- - 64
1
 29
1
 
6 - - 
10.0±2.1 
(3.52±0.73) 
- - 54
1
 83
1
 
4 - - - n.i. - n.i. n.i. 
13 - - - n.i. - n.i. n.i. 
15 - - - n.i. - n.i. n.i. 
 
cath. = cathepsin;   
n.i. = not investigated. 
´-´ = no inhibitory activity found. 
1 
When only one concentration was measured to calculate the IC50 value, then the data are shown    
   without standard error and inhibitory constant (see section 3.5.4 for the methods). 
2 
Shown are the values of duplicate measurements under the assumption of competitive inhibition [µM    
± standard error] (the mode of inhibition was not examined in the experiments). 
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In accordance with the previous observations on hCST (human cerebroside sulfotransferase, 
see section 4.6.1), acetylation of epipyrones (1-3) leads to a diminished activity toward the 
protease targets (see fig. 4.32 and fig. 4.33). While the activity on HLE seems to be weakly 
affected, the inhibitory activity towards cathepsins K and S was strongly decreased. Apart 
from that, epipyrone tetraacetate (5) has the advantage that it is a single defined molecule, 
which apparently does not isomerize at its C-glycosyl moiety, contrary to epipyrones (1-3). 
 
Fig. 4.32: Inhibition of cathepsins K and S by epipyrones (1-3), epipyrone triacetate (6) and epipyrone 
tetraacetate (5). Shown are the IC50 values. For epipyrones (1-3), six measurements (0 – 25 µM) were 
performed in duplicate. For compounds 5 and 6, the IC50 was determined based on two 
measurements at 20 µM and subsequent non-linear regression analysis. The assays were all 
performed in the working group of Prof. Gütschow. 
 
Fig. 4.33: Inhibition of neutrophil elastase (HLE) by epipyrones (1-3), epipyrone triacetate (6) and 
epipyrone tetraacetate (5). Shown are the IC50 values. For all compounds, six measurements at 
different concentrations were performed in duplicate.  Error bars display the standard error, which has 
been calculated based on non-linear regression analysis. The assays were all performed in the 
working group of Prof. Gütschow. 
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4.6.3  OTHER BIOACTIVITIES 
4.6.3.1 CYTOTOXICITY 
 
Resazurin-based assay 
At a concentration of 30 µM there was no cytotoxicity in the resazurin-based cell viability 
assay for acetosellin (4) and epicoccolide B (9) (see fig. 4.34 and 4.35; for details see 
section 3.5.1.1). 
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Fig. 4.34: Cell viability measured with acetosellin (4) using the resazurin assay. Displayed are mean 
values of 4 replicates. Etoposide was taken as the positive control. 
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Fig. 4.35: Cell viability measured with epicoccolide B (9) using the resazurin assay. Displayed are 
mean values of 4 replicates. For data of single measurements see appendix. Etoposide was taken as 
the positive control. 
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MTT-based assay: 
Epipyrones (1-3) did not show cytotoxic or antiproliferative effects against four different 
human or murine cell lines at a concentration of 37 µg/mL (= 60.4 µM). For the method see 
section 3.5.1.2. 
 
4.6.3.2  ANTIMICROBIAL ACTIVITIES 
 
Antibacterial activity 
Epipyrones (1-3), acetosellin (4), epicoccolide B (9), epicaronic acid (13), tricinonoic acid (14) 
and (3R,4S)-4-hydroxymellein (10) were subjected to agar diffusion assays. None of the 
tested compounds displayed antibacterial activity (see section 3.5.2.1 for the tested strains).  
 
Antifungal activity 
Since epipyrones (1-3) were previously found to exert antifungal activity against plant 
pathogens [175,216], a wide array of fungal strains was tested for inhibitory activity in an 
agar diffusion assay (see section 3.5.2.2 for the method and table 4.16). 50 µg of 
epipyrones (1-3) were applied per test disk. Antifungal activity was observed mainly for 
dermatophytic ascomycetes from the genera Arthroderma and Trichophyton (both 
Arthrodermataceae, Onygenales). This is noteworthy, since these two genera are 
phylogenetically related. None of the tested mucoralean (Mucor indicus, Actinomucor 
elegans, Cunninghamella elegans) or basidiomycetous fungi (Rhodotorula glutinis, 
Sporidiobolales) showed inhibition by epipyrones (1-3). Fungi from the Hypocreales 
(Fusarium spp.), Eurotiales (Penicillium spp, Aspergillus spp.) or Chaetothyriales (Exophiala 
spp., Cladophialophora spp.) or Pleosporales (Pleospora sp.) did not show significant 
inhibition or only slight inhibition by epipyrones (1-3), the only exception being Exophiala 
phaeomuriformis. However, the sensitivity of dermatophytes to epipyrones (1-3) could not be 
scientifically interpreted.  
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Tab. 4.16: Agar diffusion assay with epipyrones (1-3). The size of the halo (no growth zone) around 
the filter paper with 50 µl DMSO (control) or 50 µl epipyrones-solution (1 mg epipyrones/ml DMSO) at 
two time points.  
Strain Strain number 
Inhibition zone in mm 
after 2-3 days 
Inhibition zone in mm after 6-7 
days
***
 
Ascomycota:    
Arthroderma obtusum CBS 633.82 2.00±0 1.16±0.23 
Artroderma otae CBS 282.63 0±0 0±0 
Arthroderma racemosum CBS 633.82 0.37±0.12 0.32±0.37 
Arthroderma 
vanbreuseghemii 
CBS 449.74 - 0.63±0.29 
Aspergillus fumigatus CBS 418.64 - 0.38±1.01 
Candida albicans CBS 6431 0±0 0±0 
Candida albicans CBS 8758 0±0 0±0 
Cladophialophora carionii CBS 160.54 - 0±0 
Exophiala jeanselmii CBS 507.90 0.84±0.22 - 
Exophiala phaeomuriformis CBS 131.80  2.22±0.74
 
Fusarium andiyazi CBS 134430 0±0 0±0 
Fusarium petroliphilum CBS 135955 0±0 0±0 
Fusarium verticillioides CBS 135801 0±0 0±0 
Fusarium sp. WLD1-6 0±0 0±0 
Meyerozyma guillermondii 18.6AIII 0±0 0±0 
Microsporon gypseum CBS 130939 1.18±0.38  
Penicillium chrysogenum 18.6FII 0±0 0±0 
Pleospora sp.  CBS 134305 - 0.375±1.1 
Trichophyton erinacei CBS 344.79 2.00±0.32  
Trichophyton 
mentagrophytes 
CBS 101546 4.44± 0.45 5.0±0.71 
Trichophyton 
mentagrophytes 
CBS 120357 1.35± 0.42  
Trichophyton verrucosum CBS 134.66 0±0 0±0 
Trichophyton violaceum CBS 119447 - 0.10±0.13 
Basidiomycota:    
Rhodotorula glutinis CBS 20 1.18±0.24 0.45±0.42 
Mucorales:    
Actinomucor elegans CBS 100.13 0±0 0±0 
Mucor indicus CBS 120585 0±0 0±0 
Cunninghamella elegans WLD1-4 0.83±0.33 0±0 
- = no growth observed at that time point, 
*** 
Mean values are given with the respective standard 
deviation. 
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Anti-HIV testing 
Epipyrones (1-3) were also assayed for inhibitory activity against HIV-1 using the EASY-HIT 
assay [154] (see section 3.5.3). No inhibitory activity was observed (see fig. 4.36). 
 
Fig. 4.36: Effect of epipyrones (1-3) on the ability of HIV-1 to infect HeLa-derived cells. The y-axis 
displays the rate of infection of the susceptible cells, while the x-axis shows the final concentration of 
epipyrones (1-3). Experiments were done in four replicates (n = 4). No inhibitory activity can be 
attributed to epipyrones (1-3).  
 
4.6.3.3 NUCLEAR RECEPTORS (LXR, PPAR) 
 
Epipyrones (1-3) were tested against five nuclear receptors (LXRα, LXRβ, PPARα, PPARγ, 
PPARδ). Only PPARγ was activated at a final concentration of 125 µM (see fig. 4.37), while 
all other receptors did not show significant activation at the same concentration. 
Nevertheless, the observed activity on the PPARγ receptor is not pronounced enough for 
further tests on these targets.  
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Fig. 4.37: Agonist activity of epipyrones (1-3) at the PPARγ-receptor in comparison with a negative 
control (DMSO), with a concentration range between 7.81 – 125 µM. Values are given relative to the 
activity, which is obtained by activation with the agonist rosiglitazone. The assay was carried out in 
triplicate. Error bars display the standard deviation. For the method see section 3.5.5. 
 
4.6.3.4 EXTRACELLULAR AΒ-42 PRODUCTION AND INHIBITION OF 
PROTEIN KINASES 
 
No activity of epipyrones (1-3) was observed towards Aβ-42 production or protein kinase 
activity in the assays of ManRos Diagnostics (see section 3.5.6 for the methods).  
 
4.6.3.5 BINDING OF EPIPYRONES (1-3) TO A MODEL MEMBRANE 
 
In this assay, performed in the working group of Prof. Bendas (Institute of Pharmaceutical 
Chemistry, University of Bonn), the ability of epipyrones (1-3) to bind to or to integrate into a 
phospholipid-bilayer was studied. The purpose of this experiment was to get insights into a 
possible generic mode of action for epipyrones (1-3), which would be an explanation for the 
different bioactivities. For this purpose a model membrane, bound to a surface acoustic wave 
sensor (SAW) was used (see section 3.5.7 for the method). The oscillation on its surface, 
called Love shear wave, was observed and interaction of the test compound with the model 
membrane was indicated by a phase shift and changes in the amplitude.  
Upon injection of epipyrones (1-3) onto the SAW sensor, a phase shift (observed as a peak) 
occurs, which points to adsorption onto the membrane, while the overall rise of the curve 
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indicates that epipyrones (1-3) do not elute completely from the membrane after cessation of 
the injection but instead keep on binding to it (see fig. 4.38). The decreased amplitude of the 
detected shear wave during injection indicates an adsorption of epipyrones (1-3) rather than 
an integration into the membrane, since the latter would lead to an increased amplitude (see 
fig. 4.39).   
As can be seen from the measured phase shift and change in amplitude of the Love-shear 
wave, epipyrones (1-3) bind to the model membrane at a physiological pH (pH 7.4). These 
data indicate that epipyrones (1-3) are able to bind to plasma membranes at physiological 
conditions and thus could perturb membrane organization or function of membrane proteins 
or receptors (see section 5.1.1 for discussion). 
 
Fig. 4.38: Phase shift (in degrees [deg]) of the Love-shear wave through application of epipyrones-
containing solution (increasing concentrations of epipyrones (1-3), in PBS buffer at pH 7.4, from 10
-15
 
to 10
-6
 M). Green arrows at the bottom indicate the beginning of the injection, black arrows indicate 
termination of the injection. Blue arrows indicate preparation for the injection. The measurement was 
carried out in 5 consecutive channels.  
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Fig. 4.39: Change in the amplitude of the Love-shear wave through application of epipyrones-
containing solution (increasing concentrations of epipyrones (1-3), in PBS buffer at pH 7.4, from 10
-15
 
to 10
-6
 M). Green arrows at the bottom indicate the beginning of the injection, black arrows indicate 
termination of the injection. Blue arrows indicate preparation for the injection. The measurement was 
carried out in 5 consecutive channels. 
 
4.7 GUTTATION FLUIDS – QUALITATIVE AND QUANTITATIVE ANALYSIS 
 
4.7.1  INTRODUCTION 
 
The aim of the herein described experiments was to alter the production of different 
secondary metabolites in an efficient, simple way and to assess the applicability of guttation 
droplets to monitor these metabolic changes. The increase in the production of guttation fluid 
was a further aim, in order to get a sufficient amount for in-depth chemical analyzes. 
Furthermore, they can be analyzed chemically without the need of extraction or purification. 
Thus, their analysis could provide a time- and cost-saving tool for drug discovery in fungi, 
since they were shown to harbor a wide array of primary and secondary metabolites (see 
section 1.5). Additionally, they are interesting from an ecological perspective. The exudation 
of reasonable amounts of secondary metabolites implicates that guttation droplets exert 
important functions for the producing strain. However, their role has not been elucidated 
clearly. Thus, the study of their metabolite content could also shed light on the reasons of 
their production. In the following section the experimental setup and the results will be 
described, for the methods see section 3.6, for the discussion see section 5.2.  
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4.7.2  CULTIVATION AND PHENOTYPE 
 
E. nigrum strain 749 was cultivated on Czapek-Dox agar with variation of two parameters: 
Illumination and supplementation with trace metals (Zn2+ + Cu2+), giving four distinct 
fermentation conditions (see table 4.17). For each condition, ca. 10 - 25 single cultures were 
prepared and the cultivation was repeated three times (see section 3.6 for details on the 
method). Liquid droplets are drawn with a syringe after 14 and 28 days, respectively. The 
cultures were extracted on day 30. 
 No additives Trace metals
*
 
Darkness Experiment 1 Experiment 2 
Continuous 
illumination 
Experiment 3 Experiment 4 
 
Table 4.17: Setup of the cultivation experiments, altering illumination (artificial white light) and trace 
metal supplementation. 
*Concentration of trace metals (applied as ZnSO4 and CuSO4; final concentration in the medium):  
c(Zn
2+
) = 35 µM; c(Cu
2+
) = 20 µM 
 
As can be seen from the photos (see fig. 4.40), variations in the cultivation conditions 
provoke a major change in culture morphology, pigmentation and guttation. While the 
morphology of the mycelium is influenced mainly by the trace metal content, illumination 
primarily affects pigmentation and guttation. This also applies to the production of the main 
metabolites, as will be pointed out in the next section (section 4.7.3). Following observations 
were made regarding the phenotype of E. nigrum strain 749: 
Morphology: Mycelium on Czapek-Dox agar supplemented with trace metals shows a 
tomentose (cottony) growth, while a powdery morphology can be observed without trace 
metals. Light does not seem to have a significant influence.                               
Pigmentation: In contrast to the morphology, pigment production is susceptible to changes 
of illumination and trace metal content. Without additives, reddish-violet pigmentation is more 
pronounced under continuous illumination, while it is quite faint in darkness. Trace metal 
addition leads to an inverted correlation: Production of orange pigments is much stronger in 
darkness and decreases under light. These observations are probably related to the 
metabolite content of the extracts and guttation droplets (see section 4.7.3). 
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Guttation: The spatial distribution, onset of production and metabolite content differ with 
each of the four variations of cultivation conditions. While guttation on medium without trace 
metals occurs already a few days after inoculation (during the first week of cultivation), the 
amount on day 14 is high and is similar on day 28. The overall volume of guttation droplets is 
higher as with trace metal supplementation (see appendix, table 8.3c). However the volume 
of droplets could not be measured accurately, since it was not possible to collect the liquid 
exhaustively. Thus, the data for the droplet volume are approximations.  
Additionally, trace metals lead to a delayed onset of guttation production (later than one 
week after inoculation) and the volume increases over time comparing the drawn droplets 
from day 14 and day 28. Remarkably, without additives the droplets mainly occur in the 
center of the mycelium on the agar plug, which was used for the inoculation of the cultures. 
Trace metal addition leads to droplet formation scattered mainly in the middle section or 
nearer the growing zone 
 No additives Trace metals (Cu2+, Zn2+)* 
Darkness 
  
Continuous 
illumination 
  
Fig. 4.40: Phenotypic plasticity of strain 749 as exemplified by photos of 14 day old cultures with a 
typical habit, grown on CDA (Czapek-Dox agar) or CDT (Czapek-Dox agar supplemented with trace 
metals).  
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4.7.3 SECONDARY METABOLITE CONTENT IN E. NIGRUM STRAIN 749 
 
4.7.3.1 QUALITATIVE ANALYSIS OF MINOR CONSTITUENTS  
 
The metabolic content of the extracts and guttation fluid of E. nigrum strain 749 was first 
analyzed for known metabolites from E. nigrum mainly by high resolution LC-MS and 
comparison with own or literature data. Mass to charge ratio of the pseudomolecular ions as 
well as fragmentation pattern were taken for this purpose. In this way, epipyrones (1-3) and 
acetosellin (4) were identified as main constituents of extracts and guttation fluid. 
Additionally, the presence of 5´,6´-dihydroxyacetosellin (7) and epicoccolide B (9) could be 
proven in the guttation fluid and the extracts of strain 749 grown on Czapek-Dox agar. 
Furthermore, epicocconone (8) was found via high resolution LC-MS in extracts and guttation 
droplets [see fig. 8.92-8.94 in the appendix for MS-data of epicocconone (8)]. 
Epicocconone (8): HR-ESI-MS m/z 411.1454 [M+H]+; ESI-MS/MS m/z 393; 375; 317; 249; 
163.  
 
4.7.3.2 QUALITATIVE AND QUANTITATIVE ANALYSIS OF THE MAJOR 
CONSTITUENTS  
 
The quantification of the main constituents, epipyrones (1-3) and acetosellin (4), in guttation 
droplets and extracts of E. nigrum strain 749 was achieved with the DAD-data from LC-MS 
measurements, while 1H-NMR was used additionally for the extracts in order to underpin 
these results (see appendix, fig. 8.3, fig. 8.4 and tables 8.3a – 8.3e). Serial dilutions of the 
two compounds were employed as standard solutions (see section 3.6 for the method, fig. 
3.4a and fig. 3.4b for linearity of values from the standard solutions).  
The data for the extracts clearly showed that production of epipyrones (1-3) and acetosellin 
(4) is influenced differentially by constant illumination and trace metal content (see fig. 4.41). 
Under optimal conditions (without trace metal addition), acetosellin mean concentration (per 
Liter medium) was found to be 0.165 mM (with illumination) or 0.264 mM (without 
illumination). For epipyrones, the concentrations are at  0.187 mM (with illumination) or 0.308 
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mM (without illumination) under its respective optimal production conditions (with trace metal 
addition). 
Without trace metals, mainly acetosellin (4) is produced, while addition of trace metals favors 
the synthesis of epipyrones (1-3). The effect of illumination is not as pronounced, but still an 
effect on the metabolism can be observed: Epipyrones (1-3) production favors darkness, 
while the effect on acetosellin (4) biosynthesis is not as clear, since the variation without 
illumination is much higher than with illumination.  In general, the variability of metabolism 
among the replicate cultures is remarkable. Specifically, the results for acetosellin (4) vary 
conspicuously throughout the experiments. However, it can be concluded that both factors – 
illumination and trace metals – have a remarkable effect on the production of these two 
major secondary metabolites.  
Based on the above mentioned observations, one would expect a similar pattern in the 
guttation droplets according to the cultivation conditions. Indeed, acetosellin (4) appears 
mainly on medium without trace metal supplementation, while epipyrones (1-3) production is 
still increased by TMS addition without illumination. Thus, an influence of trace metals can 
still be observed, while the effect of illumination is not as pronounced. Surprisingly, there are 
some remarkable differences to the extracts: The concentration ranges are different to the 
extracts. Epipyrones (1-3) are exuded generally in high concentrations (between 0.23 – 2.00 
mM; see fig. 4.43). Acetosellin (4) levels are much lower (between 0.00 – 0.09 mM; see fig. 
4.42). Even under optimal production conditions for acetosellin (4), concentrations of 
epipyrones (1-3) are higher in the droplets.  
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Fig. 4.41: Concentrations of the main metabolites – epipyrones (1-3) and acetosellin (4) – per Liter 
Czapek-Dox medium, from 3 replicate cultivations, together with the standard error of the mean and 
significance (Mann-Whitney test; *: p ≤ 0.05). For the extraction method see section 3.6. TMS = 
supplementation with trace metal solution. Yellow light bulbs indicate fermentation under continuous 
illumination with white light, while colorless light bulbs indicate fermentation in darkness. 
 
In general, levels of 1-3 are elevated compared to the extracts. In contrary, concentrations of 
4 are lower in the guttation droplets than in the extracts under its optimal production 
conditions. This implies a mechanism or effect, which favors exudation of epipyrones (1-3) 
over acetosellin (4). Alternatively, the latter could have been reabsorbed into the hyphae (see 
section 5.2 for possible reasons).  
No profound differences could be found for the metabolite concentrations after 14 days 
compared to the concentrations after 28 days (see fig. 4.42 and 4.43). Taking into account 
the variability between replicate cultures, this observation shows that the concentration of 
epipyrones (1-3) and acetosellin (4) stays relatively constant throughout the cultivation 
period. Thus, the time point of droplet harvesting does not seem to be crucial for the analysis 
of the secondary metabolite content.   
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Fig. 4.42: Concentrations of acetosellin (4) in the guttation droplets from 3 replicate cultivations, 
together with the standard error of the mean and significance (Mann-Whitney test; *: p ≤ 0.05).                   
† 
For these cultures, the guttation droplets could only be collected twice because of insufficient 
production of droplets. TMS = supplementation with trace metal solution. Yellow light bulbs indicate 
fermentation under continuous illumination with white light, while colorless light bulbs indicate 
fermentation in darkness. 
 
Fig. 4.43: Concentrations of epipyrones (1-3) in the guttation droplets from three replicate cultivations, 
together with the standard error of the mean and significance (Mann-Whitney test; *: p ≤ 0.05). 
† 
For 
these cultures, the guttation droplets could only be collected twice because of insufficient production of 
droplets. TMS = supplementation with trace metal solution. Yellow light bulbs indicate fermentation 
under continuous illumination with white light, while colorless light bulbs indicate fermentation in 
darkness. 
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In order to get an idea about the influence of the two trace metals (Cu2+ and Zn2+) for on 
secondary metabolism, an additional experiment was pursued: Five cultures of strain 749 
were prepared on Czapek-Dox agar with supplementation of only one trace metal, either 
Cu2+ (CDA+Cu2+) or Zn2+ (CDA+Zn2+), respectively. The respective concentrations were 
identical to the concentrations in CDT medium (Czapek-Dox medium with trace metal 
supplementation, see section 3.1.3 for details). Cultivation was carried out without 
illumination. For each experiment, CDA+Cu2+ and CDA+Zn2+, the five cultures were pooled 
and extracted together.  
Semi-quantitative comparison of the MS data with data from Czapek-Dox agar (CDA) and 
Czapek-Dox agar with trace metal solution (CDT) shows a remarkable difference for the two 
major metabolites (see fig. 4.44 and fig. 4.45). Compared to simple CDA, Zn2+-
supplementation abolishes acetosellin (4) production, while Cu2+ strongly increases 
acetosellin (4) biosynthesis. Addition of both ions together, as mentioned before, 
downregulates its production.  
The observations for epipyrones (1-3) are different. The selected ion chromatogram (see fig. 
8.98 in the appendix) presumably shows the isomers of the C-glycosyl- and polyenic moiety. 
This results in a complicated peak pattern, which could not completely be analyzed during 
this thesis. The data suggest, however, that the supplementation of neither Cu2+ nor Zn2+ 
alone is sufficient to upregulate production of epipyrones (1-3) to a degree, which was 
observed with both metals in combination. Surprisingly, even cultivation without any metal 
content is superior in this respect. Additionally, no guttation droplets (for Zn2+) or only minute 
amounts (for Cu2+; 13 µL total volume) could be harvested.  
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Fig. 4.44: Selected ion chromatogram of different culture extracts from strain 749, showing the mass 
of acetosellin (4) (m/z 395.1489 [M+H]
+
, the selected range was 395.140-395.156). Analysis was 
performed using LC-HR-ESI-MS system C (see section 3.3.2). Colored lines represent following 
extracts (CDA = Czapek-Dox agar, CDT = Czapek-Dox agar with trace metal solution, all cultivations 
carried out under darkness under the same conditions): blue: CDA; red (baseline): CDA+Zn
2+
; 
green: CDA+Cu
2+
; pink: CDT 
 
Taken together, the results show that Epicoccum nigrum strain 749 reacts sensitively on 
trace metal content and illumination by differentially controlling the production of epipyrones 
(1-3) and acetosellin (4), respectively. The differences are also reflected by the phenotype, 
specifically by culture morphology, pigmentation and guttation pattern. Strikingly, not only the 
production of secondary metabolites seems to be tightly regulated: The concentration of the 
aforementioned metabolites in the guttation droplets diverges from the pattern observed for 
the extracts. The reason is not clear, but it might also be an active regulation process. This 
will be further discussed later (see section 5.2).  
The metabolites found in the guttation droplets render these fluids interesting targets for the 
quick and cost-efficient chemical analysis of fungal secondary metabolism. The workup 
process for LC-MS measurements is very simple and high metabolite concentrations 
facilitate the evaluation. Nevertheless, not every metabolite found in extracts could be clearly 
identified in the guttation droplets and this study could not show, whether specific secondary 
metabolites (e.g., apolar compounds) are not exuded at all. Future studies could address 
these questions. Furthermore, the ecological reasons for the intense secretion of specific 
natural products as droplets onto the mycelium would be fruitful research subjects. 
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5 DISCUSSION 
 
5.1  CHEMICAL STRUCTURES AND BIOACTIVITIES 
 
5.1.1  EPIPYRONES (1-3) 
 
C-glycosylated secondary metabolites are quite rare in fungi, even more so when the C-
glycosyl moiety is attached to a pyrone functionality. This renders epipyrones (1-3) highly 
distinctive and intriguing molecules.  In terms of biosynthesis, epipyrones (1-3) are probably 
polyketide-derived compounds (see fig. 5.1). The pyronepolyene backbone would thus be 
constructed by 12 acetate units and 4 methylation reactions, of which one methyl  group 
would be oxidized to a carboxyl group. Following the cyclization of the 2-pyrone (= α-pyrone) 
moiety, glycosylation would occur at position 3, which is a typical position due to its high 
electron density [217]. Glycosylation reactions are carried out by glycosyltransferases using 
nucleoside diphosphate sugars as donor [218].  
 
 
Fig. 5.1: Putative schematic path to epipyrones biosynthesis, exemplified for epipyrone A (1).        
NDP-galactose = nucleoside diphosphate linked to a galactose unit; SAM = S-adenosyl methionine. 
 
Epipyrones (1-3) are not the only compounds of this class from E. nigrum. As can be seen 
from fig. 5.2, two more isomers were described, i.e., ´compound 1´ (named as in the patent 
by Villas-Boas et al., where it was described) [219] and orevactaene [220].  
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The distinctive feature of the specific isomers lies in the C-glycosylated 2-pyrone motif. In 
orevactaene the glycosyl moiety is rearranged to form a pyran partial structure with the 
hydroxy function at C-4 of the 2-pyrone ring. In ´compound 1´ the 2-pyrone gives way to a 
bicyclic highly oxygenated ring system, which might be seen as an artefact from oxidation of 
orevactaene.  
 
 
 
Fig. 5.2: Comparison of two further pyronepolyene C-glycosides from E. nigrum with epipyrone A (1), 
which were published before: Orevactaene and ´compound 1´.  
 
Apart from that, only a few cases of C-glycosylated secondary metabolites from fungi could 
be found via literature search, particularly concerning 2- or 4-pyrones with an unsaturated 
side chain: While 2-pyrones and polyenes occur widely in nature [221–224], the C-glycosyl 
partial structure is highly distinctive. C-glycosides have mainly been described in plants, 
where phenolic secondary metabolites are often glycosylated to yield O-/ N-/ S-/ or C-
glycosides [225,226]. The aglycones usually are  flavonoids, anthranoids or gallic acid 
derivatives. A number of C-glycosylated natural products were also reported in bacteria and 
even in insects or mammals [227].  
Concerning fungi, fig. 5.3 shows the examples, which were found for C-glycosides with a 
backbone similar to that of epipyrones (1-3). Despite extensive literature search, no bacterial 
or fungal pyronepolyenes with a fully conjugated side chain connected to a C-glycosylated 2-
pyrone moiety could be found. Instead, in all of the shown cases, the olefinic chain is partly 
saturated and a deoxy sugar forms the glycosyl unit.  
 
´compound 1´ 
orevactaene 
epipyrone A (1) 
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Fig. 5.3: Structures of C-glycosylated 2-pyrones with an unsaturated side chain:  
Neofusapyrones (deoxyneofusapyrone; 7-desmethyldeoxyneofusapyrone and neofusapyrone; from 
Fusarium sp. FH-146 and Verticillium dahliae, both Hypocreales) [228,229]  
Dactylfungin A (found in Dactylaria parvispora, Helotiales) [230]  
YM202204 (R = H) and S39163/F-1 (R = Me) (found in Phoma sp. Q60596, Pleosporales) [231,232].  
 
Much more examples can be found for 2-pyrones with an unsaturated side chain, which lack 
a glycosyl unit. Fig. 5.4 only shows a few of them, with leptomycin A being a bacterial 
metabolite from a Streptomyces strain. From these examples, the high degree of 
functionalization of the side chain can be seen (regarding the degree of unsaturation, 
oxygenation and methylation pattern). 
An interesting fact about both – glycosylated and non-glycosylated compounds – is that they 
often exert antifungal activity, usually without showing significant inhibition of bacteria and no 
or low cytotoxicity (i.e., neofusapyrone, fusapyrone, desmethyldeoxyneofusapyrone, 
dactylfungin A, YM-202204, S39163/F-1, leptomycins [175,219,229–231,233–235]). This is 
specifically true for epipyrones (1-3, see section 4.6.3.2 for bioactivities):  Antifungal activity 
was described before against phytopathogens (i.e., Botrytis cinerea and Lecanicillium 
muscarium [175]) and observed during this study mainly for ascomycetes, specifically those 
belonging to Arthrodermataceae (´dermatophytes´).  
 
R = H: YM202204; R = Me: S39163/F-1 
Dactylfungin A 
R
1
 = Me, R
2
 = H:   
 
Deoxyneofusapyrone                            
R
1
 = H, R
2
 = H:      7-Desmethyldeoxyneofusapyrone         
R
1
 = Me, R
2
 = OH: Neofusapyrone 
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Fig. 5.4: Structures of 2-pyrones with an unsaturated side chain: 
Alternapyrone (isolated from Alternaria solani, Pleosporales) [17,236] 
Citreomontanine (found in Penicillium sp. CR07, Eurotiales) [237,238] 
Leptomycin A (found in Streptomyces sp. ATS1287, Actinomycetales, Bacteria) [235] 
 
Additionally, epipyrones (1-3) did not exhibit cytotoxic effects on different human cell lines, 
nor did they show antibacterial activities. Instead, potent effects on specific cellular human 
targets were noticed: The strongest activities were observed against specific cysteine and 
serine proteases (see section 4.6.3), followed by inhibition of human cerebroside 
sulfotransferase (hCST) and a minor activity at the nuclear receptor PPARγ. Inhibition of NF-
κB (IC50 = 50 µM), Influenza virus H1N1 (101.3 µM) and telomerase (67 µM) have been 
described for epipyrones (1-3) before [176]. For the isomers ´compound 1´ and orevactaene 
(see fig. 5.3), antifungal and anti-HIV-activity (inhibition of binding of the regulatory protein 
Rev to RRE, IC50 = 3.6 µM) are known, respectively [219,220].  
Taken together, our data suggest that epipyrones (1-3) selectively inhibit specific serine and 
cysteine proteases but still show considerable affinity towards other targets. These multiple 
activities could be the consequence of at least one common mechanism.  
One explanation for the pleiotropic effects could be the amphiphilic structure, with a 
hydrophilic C-glycosyl unit and the apolar alkylic moiety, which lies beside the carboxylic acid 
group. Indeed, the herein described studies on the interaction of epipyrones (1-3) with a 
model membrane (see section 4.6.6) confirm the amphiphilic character of epipyrones (1-3) 
at physiological pH. The adsorption onto the membrane surface could be important at least 
at high compound concentrations: Compounds with phenolic structures or amphiphilic 
Leptomycin A 
Citreomontanine 
Alternapyrone 
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character have been shown to interact with cell membranes and protein surfaces, thereby 
exerting different effects like modification of enzyme activities, perturbation of membrane 
structure and membrane fluidity or agglomeration of proteins [239–243].  
In vivo, epipyrones (1-3) could also act as antioxidants, since polyenic substances can easily 
be oxidized under physiological conditions [243]. Antioxidant activity is also one explanation 
for the antifungal activity. Since reactive oxygen species (ROS) are crucial for differentiation 
processes in fungi, antioxidants are able to hamper the development of fungi [138,244,245]. 
Additionally, antioxidant activity is an important factor for the fungus to counteract abiotic 
stress factors. The herein reported strain 749 was isolated from a marine alga. The high salt 
concentration in marine environments leads to oxidative stress and is counteracted by 
various organisms through production of antioxidant compounds or enzymes [246–248]. This 
role is also supported by the upregulation of epipyrones-production under high salinity of the 
medium, which was shown during this work (see section 4.3.1). The 2-pyrone moiety 
confers an additional cue on possible modes of action mainly against serine and cysteine 
proteases: These partial structures are able to undergo transesterification reactions with 
nucleophilic residues (e.g., alcohol or thiol residues of serine and cysteine) at the active site 
of enzymes like serine proteases and thus act as suicide inhibitors [249].  
However, the proposed modes of action remain to be proven and would be interesting 
subjects for future studies. The same is true for the ecological significance of epipyrones´-
production. In any case, since E. nigrum produces epipyrones (1-3) in high amounts and the 
production is tightly regulated (i.e., by trace metals and light or osmotic stress), the 
production must be highly important for the survival of the producing fungus. 
 
5.1.2  ACETOSELLIN (4) 
 
The results given in sections 4.4.4.3 and 4.4.4.4 strengthen the hypothesis that two 
separate polyketide units lead to the formation of acetosellin (4). Similar findings for other 
azaphilonoids lending support to the conclusions will be considered herein. Finally, a 
hypothetical biosynthetic scheme will be discussed in this section.  
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5.1.2.1 BIOSYNTHESIS OF OTHER AZAPHILONOID METABOLITES 
 
Labeling studies on ochrephilone from Penicillium multicolor built the starting point for the 
theory of acetosellin (4) being formed by condensation of two polyketide-derived chains by 
Plitzko (fig. 5.5) [184,193]. However, structural similarity is more obvious between acetosellin 
(4) and the azaphilonoid pigments derived from Monascus spp. (Monascus azaphilone 
pigments = MAzPs): In the case of monascorubrin, monascoflavin and PP-V, the 
condensation of a hexaketide – forming the azaphilonoid core structure - with an acyclic 
pentaketide chain was proposed [177,192,199,250]. Any one of them showed a comparable 
incorporation pattern through feeding of 13C- or 14C-labeled acetate as precursor.  
 
Fig. 5.5: Acetosellin (4) from E. nigrum, together with azaphilones isolated from Monascus spp. 
(monascorubrin, monascoflavin, PP-V) and Penicillium multicolor (ochrephilone). They show high 
structural similarity and a similar pattern of acetate incorporation after labeling studies. For details see 
text.  
More recent findings on the genetic level outline that biosynthetic gene clusters (BGCs) - 
harboring  polyketide synthase (PKS) and fatty acid synthase (FAS) genes as well as 
tailoring enzymes - are responsible for the formation of MAzPs [200,201]. The azaphilone 
partial structure is synthesized by a non-reducing fungal polyketide synthase with a reductive 
release domain (NR-fPKS-R) [202,251,252]. The acyclic tail, a 3-oxo-fatty-acyl chain, is 
provided by a canonical fatty acid synthase, called MpFAS2.  
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Interestingly, data from Balakrishnan et al. obtained with M. purpureus [252] indicate that this 
FAS is dedicated solely to secondary metabolite synthesis and the deletion mutant did not 
show an altered cellular fatty acid content. Additional genes (outside of the BGC) coding for 
FASs were found, which were hypothesized to take part in primary metabolism. In 
Aspergillus nidulans, a similar combined PKS-FAS gene cluster was analyzed before. This is 
responsible for the production of the carcinogenic xanthone derivative sterigmatocystin [253]. 
Brown et al. proved the FAS to be responsible for the supply of a hexanoyl starter unit. Like 
in M. purpureus, deletion of the regarding FAS gene seemingly did affect neither production 
of long-chain fatty acids for primary metabolism nor growth of the regarding strain.   
Before the hexa- and the pentaketide units can be joined to form the azaphilonoid core 
structure, a crucial oxygenation reaction takes place: AzaH (in Aspergillus niger, or the 
homologue MppF in Monascus purpureus) - a monooxygenase -  dearomatizes the 2-methyl 
orcinaldehyde partial structures of the hexaketide unit (see fig. 5.6). Thereby, the typical 
pyran-quinone partial structure is formed [202,251].  
Esterification of the MpFAS2 product with the newly formed tertiary alcohol of the hexaketide 
unit can now be undertaken with the help of the acyltransferase MppB (see fig. 5.6). 
Knockout mutants of the genes coding for MpFAS2 or MppB, consequently, are incapable of 
producing Monascus azaphilone pigments. Formation of the γ-lactone moiety finally leads to 
the production of monascorubrin.  
Azaphilonoid compounds forming a lactone moiety with an extended side chain also occur in 
other fungal genera: Compounds like the bulgarialactones (fig. 5.7) isolated from the wood-
inhabiting ascomycete Bulgaria inquinans (Bulgariaceae) [254,255] and the pitholides 
isolated from the invertebrate-derived fungus Pithomyces sp. (Didymellaceae) [256] are 
examples for this subgroup with a linear tricyclic core structure. Angular azaphilones have 
also been isolated, e.g., the deflectins from Aspergillus deflectus (Aspergillaceae) [257]. 
Discussion 
 114 
 
Fig. 5.6: Biosynthetic origin of monascorubrin as proposed by Balakrishnan et al. [251].  
 
In the case of the bulgarialactones A-D, the side chain harbors a conjugated trienic partial 
structure and a vinylogous carboxylic acid function, which renders the side chain highly 
similar compared to epicocconone (8). The distinctive feature of the bulgarialactones is the 
isobutyl end group, which is replaced by a methyl group in epicocconone (8). 
A remarkable feature, shared by acetosellin (4) and bulgarialactone D, is the reduced pyran 
moiety. Acetosellin (4), however, is the only known metabolite of that kind with an additional 
aromatic ring supposedly formed by another intramolecular condensation. This raises the 
question why an azaphilonoid compound of this type was not observed in cultures of B. 
inquinans, although the formation of bulgarialactone-derived congeners with an aromatic ring 
would be conceivable.  
Both features – the aromatic moiety and the partially reduced pyran moiety – would make for 
interesting subjects of future investigations: None of the aforementioned studies did address 
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the biosynthesis or reaction leading to such a structure. A hypothesis on the mechanism will 
be provided in the following section.  
 
Fig. 5.7: Structures of different azaphilones with an extended side chain attached to a γ-lactone 
moiety: bulgarialactones A-C, isolated from Bulgaria inquinans [254] and bulgarialactone D, isolated 
from B. inquinans ICRM-184 [255]. Pitholide A, isolated from a Pithomyces sp. [256]. Deflectin 1b from 
Aspergillus deflectus [257]. 
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5.1.2.2 HYPOTHETICAL SCHEME FOR THE BIOSYNTHESIS OF 
ACETOSELLIN (4) 
Based on the findings mentioned above, following hypothesis on the biosynthesis of 
acetosellin (4) is proposed (see fig. 5.8):  
As in the case of azanigerones and the MAzPs [202,251,252], two separate units would form 
the starting point - a pentaketide and an acyclic hexaketide. However, a hypothetical BGC 
would most probably not encompass a FAS as in the case of the MAzPs, but instead two 
different PKS genes as for azanigerones: The functionalities of the linear side chain cannot 
be introduced by a canonical FAS [203]. Instead, the programming of a PKS would allow for 
generation of the observed substitution pattern. In this case, a highly reducing PKS (HR-
PKS) could synthesize the triene partial structure during the first three cycles under aid of the 
following three domains: KR (ketoreductase), DH (dehydratase), ER (enoylreductase). The 
following two steps would add the β-ketoacid functionality.  
Contrary to the hexaketide, the pentaketide could be formed in a similar manner as was 
shown for azanigerones, by a non-reducing PKS (NR-PKS) [202]. The methyl group at C-8 
most likely originates from the action of a C-methyl transferase (CMeT), which uses S-
adenosyl methionine as a cofactor. CMeT enzymes usually act, while the nascent polyketide 
chain is attached to the acyl carrier protein (ACP). The methylene group in α-position of the 
thiolester is methylated after the elongation step [203]. However, whether the oxidation at C-
17 – leading to the hydroxymethylene function – takes place during the chain elongation or 
later by the action of tailoring enzymes, is not clear. 
Following the chain elongation, the first cyclization leads to a 3-methyl orcinaldehyde moiety, 
which is then dearomatized by a monoxygenase. The resulting tertiary alcohol is crucial for 
the synthesis of the lactone moiety later on.  
In the next step, pyran-ring formation could be achieved via acetal formation. Finally, C-3 is 
reduced, ending up with the ultimate precursor for the esterification reaction.  
The esterification and following Knoevenagel condensation of both ketide units would lead to 
the putative precursor epicocconone (8), a metabolite also reported for E. nigrum [258]. 
Based on the consideration that a precursor-product relationship between epicocconone (8) 
and acetosellin (4) is apparent [184], the last step of acetosellin (4)  biosynthesis would be 
another cyclization, leading to the aromatic ring and therefore the final product. The driving 
force could be an oxidoreductase with NADPH as a cofactor. In Monascus purpureus YY-1, 
genes for oxidoreductases were identified. The authors attribute the gene products to pyran-
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ring reduction of the monascin precursor [200]. However, in the case of M. purpureus, 
reduction does not induce a further cyclization step. This is probably due to a lack of an 
electrophilic function in the alkylic side chain.  
Taken together, a biosynthetic pathway as shown in fig. 5.8 seems conceivable. But since 
the genome of E. nigrum is not known and no other putative precursors have been isolated, 
the exact biosynthetic sequence remains elusive. Furthermore, epicocconone (8) is still to be 
proven as the direct precursor of acetosellin (4), as it could not be isolated during this project. 
This may owe to the fact that the cultures were extracted at room temperature during this 
study: During the first study on epicocconone (8), parts of the cultivation and extraction 
reportedly were carried out at +4°C [258]. 
Finally, compound 7 most probably is derived from acetosellin (4) by oxidation of the terminal 
double bond to yield the epoxide, which could be hydrolyzed (see fig. 5.9). This leads to the 
question, whether the oxidation is induced enzymatically or spontaneously in- or outside the 
cell. Oxidation reactions leading to the formation of epoxides at double bonds of polyenes 
are widespread in nature, specifically in carotenoids.  Spontaneous (non-enzymatic) and 
enzymatic epoxidation were observed and are an important part of the antioxidant function of 
carotenoids in plants [243,259].  
The characteristic masses of 7 were observed in crude extracts of strain 749 growing on 
CDA medium, as well as in guttation droplets of strain 749 on the same substrate. 
Nevertheless, the abiotic or biosynthetic origin remains to be elusive.  
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Fig. 5.8: Proposed biosynthetic route to acetosellin (4) via epicocconone (8) following the 
condensation of two polyketide-derived chains (named A and B). This scheme is based on findings 
from MAzPs and azanigerone [194,200,202,251], combined with labeling results obtained during the 
present study. However, none of the biosynthetic steps has been proven in E. nigrum. SAM = S-
adenosyl methionine, NADPH = nicotinamide adenine dinucleotide phosphate (reduced form). 
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Fig. 5.9: Proposed route for the oxidation of acetosellin (4) at the terminal double bond via a 
hypothetical epoxide to yield the vicinal diol (7). It is currently not known, whether the oxidation is 
mediated by an enzyme or happens spontaneously in or outside the cell. 
 
5.1.2.3 BIOLOGICAL EVALUATION AND POSSIBLE APPLICATIONS IN THE 
FUTURE 
 
Past investigations showed that the class of azaphilones in general is highly diverse in terms 
of structure as well as biological activities. They were found to show antimicrobial and 
cytotoxic effects, anti-inflammatory, antioxidant activities as well as inhibition of different 
enzymes and the growth of tumor cells [177,178]. Thus, metabolites from Monascus spp., 
such as those shown in Fig. 5.2, were reported to show anti-inflammatory effects [260,261]. 
Bulgarialactones A and B were found to show activities against Bacillus brevis, B. subtilis 
and Micrococcus luteus as well as being nematicidal [254]. Bulgarialactone D is strongly 
active against Staphylococcus aureus [178]. 
4 
7 
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The pitholides have not been reported to show biological activities [256], whereas the 
deflectins showed antibacterial effects against gram-positive and –negative bacteria, the 
authors also mention a weak antifungal activity [257]. 
In two reports, from Nasini et al. and Talontsi et al. [182,183], antimicrobial activity for 
acetosellin (4) was mentioned. Both describe weak or moderate activity towards gram-
positive bacteria. Antifungal activity was not found.  
During this study, antimicrobial activity could not be attributed to acetosellin (4), though a 
panel of 30 microbes was tested. Neither yeasts, nor gram-positive or –negative bacteria 
were inhibited. Additionally, no cytotoxic effect was found in HEK cells at a concentration of 
30 µM. Testing against different cysteine and serine proteases did also not show an 
inhibitory activity at a concentration of 20 µM.  
No clear answer can be given for the discrepancy of activities. However, details on the test 
procedure have only been described by Talontsi et al., but not by Nasini et al. 
Furthermore, it became apparent during the work on acetosellin (4) that it easily degrades 
during the chromatographic process. Purification of the compound under aid of HPLC was 
hampered by its instability. Obviously, quick isolation and purification procedures – e.g., flash 
chromatography – under mild conditions are necessary to yield sufficient amounts of a pure 
product. Exclusion of light would be preferable, but is difficult to maintain, especially for 
bioactivity testing.  
 
5.1.3  OTHER POLYKETIDES 
 
Compound 10 (see fig. 5.10) was hypothesized by Abdell-Lateff [208] to be a simple 
condensation product of a pentaketide chain. Compounds 9, 11 and 12, as well as 
paeciloside A presumably originate from a well-known building block (fig. 5.11): 5-
methylorsellinic acid, which is a polyketide-derived phenolic metabolite [262]. While orsellinic 
acid and its derivatives occur widely in fungi [262,263] and lichens [264–266], methylation at 
C-5 is less common. Nevertheless, 5-methylorsellinic acid was found to be the precursor in 
the biosynthesis of mycophenolic acid (see fig. 5.11), which was the lead structure for the 
development of mycophenolate-mofetil, an important immunosuppressive drug  [267].  
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Fig. 5.10: Structures of epicoccolide B (9), (3R,4S)-4-hydroxymellein (10), epicoccone (11) and     
1F4-1-6 (12).  
The second putative building block, involved in biosynthesis of compound 12 and paeciloside 
A is derived from a pentitol (see fig. 5.12). Pentitols are part of the intermediary (primary) 
metabolism, which are produced in large amounts by fungi as storage metabolites [268,269]. 
Xylitol and D-arabinitol – both are pentitols – were found in fungi and are mainly produced by 
conversion of D-glucose in the pentose phosphate pathway [270,271]. In paeciloside A, the 
pentitol unit was identified as D-arabinitol, which matches the above mentioned distribution of 
this specific polyol in fungi. Unfortunately, the exact nature of the polyol-precursor of 
compound 12 could not be identified, since an attempt to elucidate its absolute configuration 
of compound 12 resulted in the loss of the compound. However, the acetonide substructure 
of compound 12 is most likely an artefact from the VLC fractionation process, during which 
acetone was used.  
10 
11
9 
12 
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Fig. 5.11: Comparison of the structures of 5-methylorsellinic acid, mycophenolic acid, 1F4-1-6 (12) 
and paeciloside A. 
Based on the biosynthetic studies undertaken for mycophenolic acid [267], a biosynthetic 
scheme is proposed for 1F4-1-6 (12) and epicoccone (11). Methylation probably takes place 
during chain elongation by S-adenosyl methionine (SAM). Subsequent cyclization leads to 
formation of 5-methylorsellinic acid. A following esterification reaction with a pentitol would 
finally lead to production of compound 12. The final precursor for compound 11 was 
hypothesized to be flavipin [183], a dialdehyde found originally in Aspergillus flavipes and 
later in E. nigrum.  
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Fig. 5.12: Possible biosynthetic route to epicoccone (11) and 1F4-1-6 (12). 
 
5.1.4  ISOPRENOIDS - TRICINONOIC ACID AND EPICARONIC ACID 
 
Despite epicaronic acid (13) being a new metabolite, similar secondary metabolites have 
been described before, e.g., the sesquiterpenoid phellilin A, isolated from the mycelium of 
Phellinus linteus (Hymenochaetaceae, Basidiomycota, fig. 5.13). The key difference to 13 is 
the ring closure between C-8 and C-13, resulting in a cyclopentane partial structure [272]. 
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Fig. 5.13: Structure of phellilin A, isolated from Phellinus linteus as described in [272], retinal [273] and 
apotrisporin C [274], compared to compound 13. 
 
From the viewpoint of biosynthesis, compound 13 likely is an apocarotenoid. Thus,  
synthesis by oxidative degradation of a carotenoid can be assumed. The production of 
carotenoids was repeatedly described for E. nigrum [275–277]. Apocarotenoids are widely 
distributed in plants and fungi, functioning as pollinator attractants, fruit or vegetable flavors, 
antifungal compounds and as regulatory or sexual hormones [278].  
In two genera of the former phylum Zygomycota, i.e., Phycomyces (Mucoromycotina) and 
Mortierella (Mortierellomycotina), the trisporoids were found to act as sex hormones 
[279,280]. Byproducts of trisporoid formation – apotrisporins (see fig. 5.13) – are believed to 
serve as regulators for sex hormone production [274].  
Furthermore, apocarotenoid production in plants was proven to be induced by infection with 
mycorrhizal symbionts. Thus, they are probably involved in the regulation of mycorrhizal 
symbioses [281]. Even retinal (see fig. 5.13), which is known to be the basis of human 
vision, was found in the Ascomycota, e.g., Fusarium fujikuroi [273].  
However, the ecological role and biosynthesis of compound 13 have not been subjects of 
further investigations, yet. A possible biosynthetic route (see fig. 5.14) could follow a similar 
scheme as for the trisporoids [282]. It would start with oxidative cleavage of β-carotene (step 
I), which has already been isolated in E. nigrum before [276]. The product aldehyde could be 
further oxidized at C-4 and C-11 (step II). Finally the double bond at C-7/C-8 could undergo 
hydration (step III) to yield compound 13.  
13 
phellilin A 
retinal 
apotrisporin C 
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Fig. 5.14: Possible schematic biosynthetic route to epicaronic acid (13). 
 
 
Finally, tricinonoic acid (14) is an irregular sesquiterpene, which supposedly emerged from 
oxidative cleavage of the regular sesquiterpene germacrene D (see fig. 5.15) [210].  
 
β-carotene 
13 
step I 
step II 
step III 
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Fig. 5.15: Possible biosynthetic route to tricinonoic acid (14) and tricindiol according to Bashyal et al. 
[210]. 
 
5.1.5  BETA-CARBOLINES – ARTEFACTS FROM THE MEDIUM 
 
Flazin (15) (fig. 5.16) is a highly fluorescent β-carboline alkaloid reported from marine 
Streptomyces spp. [212], Japanese sake, rice vinegar and soy sauce [283]. It was also 
reported in fruiting bodies of the basidiomycete Suillus granulatus by Tang et al. During their 
study, weak anti-HIV activity was found for flazin [284]. 
 
 
Fig. 5.16: Hypothetical reaction scheme for the formation of flazin from the supposed ingredient of 
malt extract L-tryptophan and the sugar artefact 5-hydroxymethylfurfural (5-HMF) under conditions of 
autoclaving. 
Synthetic reactions of L-tryptophan and glucose led to the formation β-carboline alkaloids via 
Pictet-Spengler condensation [285] and derivatives of flazin could be synthesized in the 
laboratory using derivatives of L-tryptophan and 5-hydroxymethylfurfural (5-HMF) as 
reactants [284]. Since 5-HMF was found during NMR analysis of autoclaved pure malt 
extract based medium in high concentration, the possibility of flazin being an artefact 
emerging from the reaction of the mentioned educts under conditions of autoclaving seems 
possible (fig. 5.16).  
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5.2 GUTTATION – PATTERNS OF PRODUCTION AND METABOLITE 
CONTENT 
 
Though E. nigrum is a known producer of guttation droplets [286], their constituents have not 
been studied to the best of my knowledge. Moreover, the ecological significance and 
regulation of the secretion of secondary metabolites into guttation droplets have not been 
clearly proven in fungi [131,133].  
During this study, a set of four different growth conditions – involving alteration of illumination 
and trace metal content – was used to assess the differential production of guttation droplets 
and their respective secondary metabolite content in E. nigrum. Firstly, Czapek-Dox agar 
(CDA) enhances secondary metabolism, compared to nutrient-rich media (e.g., malt extract 
agar, see section 4.2). Second, depending on the trace metal supplementation and 
illumination, major differences in the concentrations of  specific secondary metabolites were 
recognized in the fungal extract. Pure CDA and CDA supplemented with Cu2+ alone, lead to 
upregulation of acetosellin (4) production (see fig. 4.41 and 4.44). Acetosellin (4) is therefore 
proposed to be an antioxidant, which counteracts oxidative stress. Epipyrones (1-3) are 
synthesized mainly under supplementation with Cu2+ in combination with Zn2+ in darkness. 
Thus, the application of different trace metal ions and illumination for the control of fungal 
secondary metabolism was shown to be a useful tool in the fungus E. nigrum strain 749.  
Regarding the guttation droplets, variation of the culture conditions resulted in enhanced 
production volumes on CDA without trace metal supplementation. Furthermore, the exudates 
harbor high concentrations of the main metabolites. Concentration levels of epipyrones (1-3) 
were even much higher than in the extracts, while acetosellin (4) showed decreased 
concentrations in the guttation droplets [mean values in the guttation fluids: for epipyrones 
(1-3) between 0.23 – 2.00 mM, for acetosellin (4) between 0.00 – 0.09 mM, see fig. 4.42 and 
4.43]. Additionally, an effect of trace metals on the metabolite concentration was also shown 
for guttation droplets, while the effect of illumination is less pronounced. However, no 
significant effect of the time point of exudate harvesting (after 14 days or after 28 days) could 
be found.  The generally high level of exuded epipyrones (1-3), as opposed to acetosellin (4), 
could imply the presence of regulatory processes, which control secretion and/or 
reabsorption of the regarding secondary metabolites.  
These data clearly show that guttation droplets can be used for the qualitative analysis of 
fungal secondary metabolism during its cultivation. The effect of changed cultivation 
conditions is reflected by the analytic data for the guttation droplets, though with limitation, 
since epipyrones (1-3) were generally exuded in high concentrations. This, however, evens 
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out the differences found in the extracts to some extent. Thus, the data for the guttation 
droplets do not allow a precise prediction on the quantitative metabolite content in the fungal 
mycelium due to different rates of excretion for each metabolite. 
Finally, the high concentrations of the main secondary metabolites in guttation droplets are 
noteworthy from an ecological standpoint. They are sufficient to exert biological effects upon 
other organisms, since inhibitory activity on different enzymes was detected for epipyrones 
(1-3) already in the micromolar range (see section 4.6). Consequently, a defensive role of 
the exuded metabolites can be assumed.  
 
Possible roles of illumination and trace metal ions  
The influence of light on developmental processes and metabolism in fungi has been studied 
in a wide range of fungi. Thus, different types of receptors were found for blue or UV-A light 
(white collar-1 receptors and cryptochromes, both FAD-dependent), green (type I 
rhodopsins, retinal-dependent) and red light (phytochromes, bilin-dependent) [25,287]. 
Interestingly, fungal secondary metabolism reacts differently on light. In this respect, 
Aspergillus nidulans is among the most thoroughly studied fungi. Depending on the 
illumination, A. nidulans differentially produces specific secondary metabolites. Under light, 
Bayram et al. [25] found that antioxidant pathways are upregulated (e.g., catalase, 
superoxide dismutase, melanin) together with the production of certain secondary 
metabolites (e.g., terrequinone, a bisindolylbenzoquinone). Additionally, asexual reproduction 
is induced.  
In darkness, however, sexual reproduction prevails in A. nidulans. Differential upregulation of 
secondary metabolites was also observed (e.g., polyketides like sterigmatocystin, emodin). 
The aim of such a differential production strategy could be to channel resources for the 
production of a single or just a few metabolites. Thus, high concentrations of a metabolite are 
accumulated in a short time [200].  
The switch in secondary metabolism and sexual/asexual development is in part conferred by 
the trimeric velvet complex (consisting of the proteins VeA, VelB and LaeA). Illumination by 
red light leads to binding of the red light-receptor (FphA) to a VeA/VelB heterodimer. 
Thereby, the translocation of VeA/VelB into the nucleus and the following buildup of the 
velvet complex are inhibited. As a consequence, asexual sporulation and the production of 
different secondary metabolites are induced. During dark periods, the VeA/VelB complex is 
translocated into the nucleus, where it forms a trimer with the methyl transferase LaeA, which 
epigenetically activates a wide array of genes. Thus, sexual development and the production 
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of specific secondary metabolites is induced. These light dependent processes – light 
perception and signal forwarding through the velvet complex – are partly highly conserved 
among fungi [25,287–289]. 
This being said, only few information could be found in the literature regarding the reaction of 
E. nigrum on altered illumination. Former reports noted that asexual sporulation is enhanced 
under white or near UV-light, though the response was largely dependent on the specific 
strain. The growth rate of the mycelium did not respond to different intensities of white light 
[290,291]. In another study, the pronounced production of red pigments in darkness 
compared to white light was mentioned. However, the authors were not able to identify the 
pigment(s) [292].  
In E. nigrum strain 749, the production of epipyrones (1-3) seems to be regulated not only by 
the substrate, but also by illumination. This compound is preferably produced in darkness. To 
the best of my knowledge, this is the first time that such a correlation is reported for E. 
nigrum. The observations are in accordance with the results obtained before from A. 
nidulans, that different secondary metabolites may be produced mostly upon specific 
conditions or life stages. Epipyrones (1-3) may primarily exert their function in darkness as 
antioxidant or antifungal compounds. Such a janus-faced role as antioxidant and defensive 
(highly bioactive) compound has been documented for a number of fungal mycotoxins or 
pathways (e.g., trichothecenes, aflatoxins, lovastatin) [293–295].  
 
Numerous studies were published on the role of different heavy metal ions on fungal 
physiology and metabolism. The same is true for the acquisition of trace metals through 
bioweathering of rocks by fungi [296]. However, the effect of trace metals on secondary 
metabolism was not studied as thoroughly. In general, insufficient supply with trace metals 
induces the formation of siderophores. These are able to bind different polyvalent metal 
cations [e.g., Fe(III), Cu(II), Cr(III)] with high affinity. Structurally, they most often show 
hydroxamate moieties or phenolic structures [297]. High concentrations of heavy metals, in 
turn, have different implications: They can induce the secretion of enzymes and secondary 
metabolites around the fungal mycelium in high concentrations [296]. More interestingly, the 
positive effect of Zn2+, Cu2+ and Fe3+ was shown on the production of mycotoxins, namely 
zearalenone and aflatoxin B1, by Fusarium graminearum and A. flavus, respectively 
[23,298]. Ding et al. elicited the production of a new meroterpenoid by addition of Co2+ to the 
culture medium of an Aspergillus sp. Remarkably, the strain was isolated from a marine 
hydrothermal vent [299]. 
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During this study, CuSO4 and ZnSO4 were applied as trace metal solution. Low 
concentrations of Cu2+ are needed as cofactor in a number of fungal oxidoreductases like 
laccases and superoxide dismutases (SOD) [300]. On the other hand, free Cu2+ induces 
oxidative stress in cells of different organisms, i.e., fungi and plants, probably due to lipid 
peroxidation and alteration of membrane permeability [300–302]. Thus, high concentrations 
of > 1 mM (depending on the fungus) exert toxic effects due to membrane leakage and 
alteration of enzyme function [303]. Already in physiological concentrations, it is also able to 
elicit the production of antioxidant enzymes and secondary metabolites. This is the case for 
the production of the (antioxidant) mycotoxin citrinin by Penicillium verrucosum [24]. 
Interestingly, upregulation of citrinin production implies downregulation of another mycotoxin, 
namely zearalenone.  
In the marine-derived fungi Aspergillus clavatus and A. sclerotiorum, Jiang et al. were even 
able to elicit the production of secondary metabolites in a dose-dependent manner by 
increasing concentrations of copper in the medium [304]. The mentioned literature data give 
further hints on the regulation of secondary metabolism in E. nigrum: Since the production of 
acetosellin (4) is markedly increased by addition of Cu2+, this could be a further hint to the 
hypothesis that it is an antioxidant metabolite. On the other hand, acetosellin (4) production 
was also elevated without the addition of trace metals. Thus, it could act as a metal chelating 
metabolite due to its phenolic structure, which lies in β-position to the keto group of a lactone 
moiety.  
Similar to copper, the physiological role of Zn2+ also lies in its catalytic action in the active 
side of numerous enzymes, e.g., Zn-SOD, aldolases, transcription factors (zinc finger 
proteins) or alcohol dehydrogenase [305]. Even a Zn-dependent polyketide cyclase was 
found in a bacterial polyketide synthase gene cluster [306]. High Zinc concentrations (> 2 
mM, depending on the fungus) show toxic effects against different fungi probably due to 
oxidative stress and disruption of iron- and sulfur-metabolism [307,308]. Regarding the role 
of zinc for the production of the two main metabolites in E. nigrum strain 749, no hypothesis 
can be provided. Nevertheless, it seems clear that optimal production of epipyrones (1-3) 
requires zinc and copper.  
To date, it is not clear, how and why E. nigrum strain 749 delegates its metabolic resources 
in the observed ways. This includes the question, why the fungal secondary metabolism 
reacts so sensitively on the addition of trace metals on CDA. This, however, could be 
explained with the employed agar medium. CDA is a minimal medium, i.e., it contains a 
limited set of defined chemicals, partly in an unfavorable form (see section 3.1.3 for details). 
In previous studies, a link was found between increasing nutrient availability and diminished 
metal toxicity [309–311]. Consequently, secondary metabolism is linked to nutrient depletion 
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or the absence of preferred nutrient sources in different fungi [200,312]. The unfavorable 
nutrient composition of this medium is also reflected by poor growth and strong secondary 
metabolism of E. nigrum on CDA medium during this study.  
At the beginning of this study, malt extract agar was used as a nutrient-rich complex medium 
(see section 4.3.1) in order to assess the secondary metabolism of E. nigrum. On this 
medium, the secondary metabolism and its trace metal-dependent shift was not as 
pronounced as with CDA. This could be a sign that the unfavorable nutrient composition of 
CDA hampers the ability of the fungus to balance its metabolism. As a consequence, the 
fungus could delegate a huge part of its resources to its secondary metabolism at the 
expense of its primary metabolism. A correlation of nutrient depletion in the medium and 
strongly upregulated secondary metabolism was found for Monascus purpureus. Cultivation 
under carbon starvation resulted in a strong production of azaphilonoid pigments [200].  
Interestingly, unfavorable nutrient composition and nutrient depletion are believed to be the 
rule rather than the exception in nature [10,309,313–315]. In other words, the seemingly 
extreme reaction of E. nigrum on the applied culture conditions on CDA could give a hint on 
its metabolism in the natural environment. 
 
Guttation droplets 
The herein described metabolite concentrations in the guttation droplets (see section 4.7) 
lead to the question, how the fungus exudes such high concentrations of secondary 
metabolites. Literature data suggest that either the secretion of secondary metabolites is 
regulated by the fungus and may thus be achieved by an active transport mechanism, i.e., 
exocytosis or by membrane transporters. In this scenario, the osmotic pressure - exerted by 
the secreted compounds - could lead to additional water outflow from the cytoplasm. This 
view may be reflected by the observation in Oudemansiella melanotricha (syn. Xerula 
melanotricha, Agaricales, Basidiomycota) that the plasma membrane below the cell wall is 
strongly folded at the sites of guttation. Thus, an increase of the surface for transmembrane 
transporters for the exudation process might be achieved. Interestingly, through electron 
microscopy the presence of channels in the cell wall was observed, through which the 
exudate can be released from the periplasmic space [316]. However, a folded plasma 
membrane does not exclude the possibility of a pressure-driven process (see below). 
Furthermore, the involvement of active transporters was only shown for secretion of 
secondary or primary metabolites by fungi into the medium or inside of glands from plants 
[124,125,317].  
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A study by Kikuchi et al. gives a hint on the possible involvement of aquaporins in the 
secretion processes: In the fungus Rhizophagus clarus (Glomeromycota), translocation of 
solutes - i.e., polyphosphates - from the fungal hyphae to plant roots was found to be 
mediated by aquaporins. They facilitate water flow through the membrane and thus generate 
a mass flow of the cytoplasm, partially facilitated by tubular vacuoles. Polyphosphate can in 
this way be transported along the source-sink gradient and secreted by specific transporters, 
which are found adjacent to the aquaporins [318]. A source-sink relation due to transpiration 
is most likely also the driving force behind guttation in plants, which usually form guttation 
droplets at the leaf margin. Such a gradient could even help to explain the spatial distribution 
of guttation droplets in E. nigrum: Excretion of water or cytoplasmic contents could force an 
intrahyphal mass flow in direction of the guttation spot (see below).  
The most convincing hypothesis on the guttation mechanism seems a pressure-driven 
outflow through the plasma membrane, which is one of the theories for guttation in plants. In 
this case, different solutes and water would pass the membrane directly without a 
translocator [319]. The increasing turgor pressure would be conveyed by the central vacuole. 
Further support for this hypothesis comes from the fact that mature or central parts of the 
fungal mycelium (i.e., near the point of inoculation) are often highly vacuolated [320,321]. 
Guttation in E. nigrum strain 749 preferably occurred in aged parts of the mycelium. 
Finally, three mechanisms would be conceivable for the secretion process:  
(1) Aquaporins together with additional transporters might help to secrete different solutes. 
MFS (major facilitator superfamily) or ABC (ATP-binding cassette) transporters are amongst 
the transmembrane proteins, which could aid in this process. Their involvement in secretion/ 
excretion processes was proven for several fungal secondary metabolites (e.g., gliotoxin, 
trichothecenes) [124,322,323]. However, the weakness of this explanation lies in the wide 
range of compounds, which were found in guttation droplets of plants and fungi.  
(2) A vesicle-mediated secretion or exocytosis (granulocrine release). The involvement of 
specialized vesicles was proposed for exocytosis of aflatoxins in A. parasiticus [125].  
(3) Increased permeability of the plasma membrane could lead to the diffusion of solutes and 
water through the plasma membrane. This explanation would be in accordance with the 
chemical diversity observed in guttation fluids in the literature. However, no evidence could 
be found for this type of secretion for fungal exudates. 
The fact that acetosellin (4) concentration is comparatively low in the guttation droplets could 
be explained by two different mechanisms: It could be either reabsorbed into the cell after 
secretion. This possibility was already proven for citrinin, which can be reabsorbed and 
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degraded by the producing fungus [324]. Alternatively, secretion could be hampered due to 
its higher lipophilicity compared to epipyrones (1-3) [calculated log D values at pH 7: log 
D(epipyrones) = -1.38; log D(acetosellin) = 6.35; calculation performed by ACD/Labs Version 
11.02 (©1994-2016 ACD/Labs)]. Low polarity could lead to stronger binding to cell structures, 
e.g., the plasma membrane [243]. Furthermore, it could be stored in other compartments 
than epipyrones (1-3). Finally, the latter could be the preferred substrate for special 
transporters, e.g. MFS- or ABC-transporters (see above). 
Assuming the hypothesis of a source-sink gradient, the question remains, why the guttation 
droplets are mainly formed in central or aged parts of the mycelium: Production of large 
guttation droplets was recognized in the center of the mycelium on Czapek-Dox agar without 
trace metal supplementation. On all media, guttation was not observed at the growing edge 
of the mycelium, but only in central regions with high pigmentation. Following the 
abovementioned data, this could be explained by two phenomena: First, by the high 
vacuolation in hyphae during idiophase or senescence, coupled with cytoplasmic streaming 
in this direction; second, by intense production of secondary metabolites in the secretion 
spots. Both – advanced developmental stages and secondary metabolism – are correlated to 
oxidative stress [295,325,326]. High secondary metabolite content in the mycelium, in turn, 
was linked by Figueroa et al. with guttation droplet production in P. restrictum [136]. 
An increased membrane permeability in the central mycelial portions, leading to guttation, 
could be explained with oxidative stress. It was proven to increase the permeability of the 
plasma membrane through lipid peroxidation and to cause electrolyte leakage [327–329]. A 
pressure-driven filtration process – i.e., eccrine release – could thus be facilitated. 
Nevertheless, on medium with Cu2+ supplementation, which is supposed to impose oxidative 
stress on cells, only small amounts of guttation droplets were observed. This makes it more 
complex to link oxidative stress and spatial distribution of the droplets.  
 
The content of specific primary and secondary metabolites in guttation droplets from plants 
[135,330], bacteria [129] and fungi [133,136,331–335] was investigated in just a few studies. 
This is surprising since their analysis can be achieved in a straightforward manner. 
Nevertheless, different studies confirm the data from this work regarding the presence of 
secondary metabolites in guttation droplets. Sun et al. and Aliferis et al. studied primary 
metabolites in Suillus bovinus (Boletales, Basidiomycota) and simple phenolic metabolites in 
Rhizoctonia solani (asexual form of Thanatephorus cucumeris, Cantharellales, 
Basidiomycota), respectively [119,335]. Their results showed that guttation droplets in these 
species contain a wide array of primary metabolites, e.g., sugars, amino acids, sugar 
Discussion 
 134 
alcohols and fatty acids. R. solani even exudes different organic acids, mostly phenolic 
substances, like ferulic acid, ellagic acid, gallic acid. Antioxidant activity was also published 
for exudates from S. bovinus, though they have not been characterized chemically [132].  
Regarding secondary metabolites, mainly Penicillium spp. were studied due to the ample 
amount of exudates, which they regularly produce in axenic culture. Also, their specific 
coloration is an important taxonomic feature [286]. Thus Wang et al. showed in a study on 
Penicillium citreonigrum that guttation droplets can be a prolific source of secondary 
metabolites, among them azaphilones and meroterpenoids [331]. They also showed that 
epigenetic modifiers can be used to increase the number of secondary metabolites in the 
fungus and consequently in the droplets. These studies lend support to the observation that 
in E. nigrum strain 749 different secondary metabolites were found, while the complex 
chromatograms even suggest the presence of a wide array of non-identified metabolites. The 
complexity also reflects the wide spectrum of secondary metabolites, which have been found 
in E. nigrum in this work and before [336].  
Further support for the remarkable concentration of epipyrones (1-3) found in guttation 
droplets (see fig. 4.42 and 4.43 in section 4.7) during this work comes from following 
studies. Both analyzed the mycotoxin concentration in exudates. In the first study, the 
concentrations of ochratoxins A and B in Penicillium nordicum and P. verrucosum (both 
Aspergillaceae, Eurotiales) were shown to be significantly higher than in the underlying 
mycelium and culture medium [133]. Ochratoxins are highly nephrotoxic isocoumarin 
derivatives, which are often found in staples [337]. In another study, Gareis et al. assessed 
guttation droplets from different strains of Stachybotrys chartarum (Stachybotryaceae, 
Hypocreales) for their mycotoxin concentration and bioactivity. Using mass spectrometry and 
an MTT-assay, they found that the droplets are highly cytotoxic due to their content in 
different trichothecenes, i.e., sesquiterpenes containing an epoxy function [334].  
Thus, it can be concluded that guttation droplets are an important means for the exudation of 
highly bioactive substances. Also, data from this study and from the aforementioned work on 
P. nordicum show that guttation might just be one side of a two-sided secretion strategy, 
since the main metabolites were also found in the medium. The ecological relevance is also 
underpinned by the work of Figueroa et al. They reported on the identification of different 
polyhydroxyanthraquinones in exudates of P. restrictum [136]. Interestingly, these 
compounds exhibited inhibitory activity on the quorum sensing of methicillin-resistant 
Staphylococcus aureus (MRSA), which gives a hint on their ecological potential. They could 
also link the production of guttation droplets to high local concentrations of the mentioned 
metabolites by MS-Imaging.  
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These studies clearly show that exudates probably have a significant impact on the 
surrounding microbiota and on fungivores. The high concentration of epipyrones (1-3) and 
other secondary metabolites could thus be seen as a means to control the microbial 
community structure and maybe even to defend the fungus against fungivory. The latter was 
shown for guttation droplets of A. nidulans, which act to deter collembolans (syn. springtails, 
Folsomia candida) from feeding on the fruiting bodies [137].  
Further studies on the regulation of secondary metabolism in E. nigrum, especially on 
genome and transcription level, could give more insights into the underlying mechanisms of 
guttation and its ecological roles. Electron microscopy and MS-imaging could also serve as 
powerful tools for the understanding of guttation and its correlation with secondary 
metabolism.  
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6 SUMMARY 
 
Members of the kingdom of fungi belong to one of the most diverse life forms on earth. This 
is also reflected by the ability of these organisms to synthesize a huge array of secondary 
metabolites with unusual scaffolds and potent bioactivities. The latter also explain the 
application of many fungal products in therapy, e.g., lovastatin, cyclosporine A, mycophenolic 
acid. 
In order to find new chemical entities for medicinal use, increasingly remote or inaccessible 
areas are explored for yet not investigated fungal species or strains. Therefore, two marine-
derived strains of Epicoccum nigrum – strain 749 and strain 800 –  were chosen as target 
organisms for this work. They were subjected to different culture conditions in order to elicit 
the production of bioactive natural products.   
In this way, a total of 12 compounds, mostly of polyketide origin, but with different scaffolds 
were isolated and identified based on the extensive use of a range of analytical techniques, 
especially NMR spectroscopy. Three of them are new chemical entities, i.e., 5´,6´-
dihydroxyacetosellin, 1F4-1-6, epicaronic acid, and one, i.e., tricinonoic acid was not found in 
E. nigrum before. 
The unusual structure of acetosellin suggested, that its biosynthesis may proceed via the 
condensation of two separate polyketide-derived moieties, a biosynthetic peculiarity that is 
rarely seen in nature. In order to verify this hypothesis, E. nigrum cultures were incubated 
with 13C-labeled sodium acetate, and the resulting labeling pattern of the respective 
metabolite analyzed by NMR. The results indeed proved that acetosellin is the product of two 
separate polyketide synthases. These are postulated to synthesize a bicyclic core and an 
acyclic polyketide unit, which subsequently are condensated to form the unique 
naphthoquinone part of this metabolite.   
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Figure 6.1: Structures of metabolites isolated from E. nigrum. For acetosellin, the acetate units as 
analyzed by incubation with [1-
13
C]acetate are shown in bold with bold dots indicating incorporated 
13
C-1-atoms from [1-
13
C]acetate. 
The bioactivities of these natural products were foremost assessed against human enzymatic 
targets. Thus, epipyrones were proven to be the first inhibitors of human cerebroside 
sulfotransferase (hCST), an enzyme implicated in the lysosomal storage disease 
metachromatic leukodystrophy, with an IC50 of 61.4 µM. Even though this activity is rather 
weak, this molecule can in future studies serve as a lead structure for the development of 
more potent inhibitors. Of special interest is also, that epipyrones exert potent and selective 
effects on cysteine- and serine-proteases, namely human leukocyte elastase (HLE) with an 
IC50 of 4.63 µM, cathepsin S (IC50 = 6.61 µM) and cathepsin K (IC50 = 11.4 µM). Interestingly, 
trypsin, chymotrypsin, as well as cathepsins B and L were not inhibited, showing that there is 
a high degree of selectivity. The C-glycosyl moiety of epipyrones is an extraordinary 
chemical feature of these compounds, but also responsible for the chemical interconversions 
between epipyrones A-C. The glycosyl part of epipyrones was thus semi-synthetically 
1F4-1-6 Epicaronic acid 
R = 1-C-(β-galactopyranosyl): Epipyrone A 
R = 1-C-(α-galactofuranosyl): Epipyrone B 
R = 1-C-(β-galactofuranosyl): Epipyrone C 
R =  Acetosellin 
 
R = 5´-6´-Dihydroxy-                 
acetosellin 
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modified by acetylation, yielding a chemically stable tetra-, and a triacetate as major 
products. These, however, showed markedly diminished potency toward the aforementioned 
enzymes.  
During cultivation, E. nigrum strain 749 forms guttation droplets, i.e., exudates. This is highly 
dependent on growth conditions, e.g., the addition of trace metals and illumination. Not only 
the production of guttation droplets is influenced, but also the type and concentration of 
secondary metabolites. In order to shed light on the regulation of this process, the levels of 
the major secondary metabolites – epipyrones and acetosellin – were analyzed in the 
guttation droplets and compared to those in extracts from the mycelium and cultivation 
medium. Thus, trace metal addition, i.e., Cu2+ and Zn2+, led to a pronounced production of 
epipyrones, of which the concentration is even more elevated, when the culture is not 
illuminated. Under optimal conditions, the concentration of epipyrones is 0.31 mM (per Liter 
medium) in the mycelium and medium extracts and 2.0 mM in the droplets. In contrast, 
acetosellin was best synthesized without trace metals. Acetosellin levels in the guttation 
droplets were always much lower than those for epipyrones, i.e. <0.09 mM.  
In conclusion, E. nigrum is a producer of promising enzyme inhibitors, which may serve as 
the basis for the development of drug candidates. The herein described results concerning 
biosynthesis and differential production of secondary metabolites will support future studies 
with the respective compounds. 
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8 APPENDIX 
 
The resulting genetic sequences of the herein described fungal strains: 
 E. nigrum strain 749: 
TGTACTTTTGGACGTCGTCGTTATGAGTGCAAAGCGCGAGATGTACTGCGCTCCGAAATCAATACGCCGGCT
GCCAATTGTTTTAAGGCGAGTCTACACGCAGAGGCGAGACAAACACCCAACACCAAGCAGAGCTTGAAGGTA
CAAATGACGCTCGAACAGGCATGCCCCATGGAATACCAAGGGGCGCAATGTGCGTTCAAAGATTCGATGATT
CACTGAATTCTGCAATTCACACTACTTATCGCATTTCGCTGCGTTCTTCATCGATGCCAGAACCAAGAGATCC
GTTGTTGAAAGTTGTAACTATTATGTTTTTTCAGACGCTGATTGCAACTGCAAAGGGTTTGAATGTTGTCCAAT
CGGCGGGCGGACCCGCCGAGGAAACGAAGGTACTCAAAAGACATGGGTAAGAGGTAGCAGACCGAAGTCT
ACAAACTCTAGGTAATGATCCTTCCGCAGGTTC 
 E. nigrum strain 800:  
TGTACTTTTGGACGTCGTCGTTGTGAGTGCAAAGCGCGAGATGTACTGCGCTCCGAAATCAATACGCCGGCT
GCCAATTGTTTTAAGGCGAGTCTACACGCAGAGGCGAGACAAACACCCAACACCAAGCAGAGCTTGAAGGTA
CAAATGACGCTCGAACAGGCATGCCCCATGGAATACCAAGGGGCGCAATGTGCGTTCAAAGATTCGATGATT
CACTGAATTCTGCAATTCACACTACTTATCGCATTTCGCTGCGTTCTTCATCGATGCCAGAACCAAGAGATCC
GTTGTTGAAAGTTGTAACTATTATGTTTTTTCAGACGCTGATTGCAACTGCAAAGGGTTTGAATGTTGTCCAAT
CGGCGGGCGGACCCGCCGAGGAAACGAAGGTACTCAAAAGACATGGGTAAGAGGTAGCAGACCGAAGTCT
ACAAACTCTAGGTAATGATCCTTCCGCAGGTTCA 
Further sequences used for the phylogenetic tree: 
 Gliomastix murorum strain 469 
ACCTGCGGAGGGATCATTACCGAGTTGCAAAACTCCCAAACCCACTGTGAACCAATACCACTGTTGCTTCGG
CGGACACGCCCCGGGCGCACCTCCTCAGGGGGGTGTGCCCCGGAACCAGGCGCCCGCCGGGGGACCGAA
ACCTCTGTATTTACCATTTGAGTACTCTGAGTGTGATTTACAAAATCAAAATTAAAACTTTCAACAACGGATCT
CTTGGCTCTAGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGCGAATTGCAGAATTCAGTGAATCA
TCGAATCTTTGAACGCACATTGCGCCCGCCAGTATTCTGGCGGGCATGCCTGTCTGAGCGTCGTTTCGACCC
TCGCGCCCGGCTTCTGTCGGGGGCGGTGTTGGGGATCGGCCACACCCTTTACTGGGCGGCCGTCCCCTAA
ATCCAGTGGCGACCACGCTGTAGCCTCCCCTGCGTAGTACTAAAACCACCTCGCAGGCGGAGAGCGGTGCG
GCCCGCCGTAAAACCCCCCAACTT 
 
 Phoma betae strain 815 
CCGTAGGTGAACCTGCGGAAGGATCATTACCAATATGAAAGCGGGTGGGGAGCCACAGAAGTTGGGGCCCT
CGTGGCTCTACTTCTGCCCCATCTGTCTGAATATTCACCCATGTCTTTTGCGTACCCATTGTTTCCTTGGCGG
GCTTGCCCGCCAACAGGACATTATTAAACCTTTTGTAATTGCAGTCAGCGTCAGAAATAACTTAATAGTTACAA
CTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAGTGTGAATTG
CAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCTTGGTATTCCATGGGGCATGCCTGTTC
GAGCGTCATTTGTACCCTCAAGCTCTGCTTGGTGTTGGGTGTTTGTCTCTTCCGGGAGACTCGCCTCAAAAC
Appendix 
 162 
AATTGGCAGCCGGCATATTGGTATCGGAGCGCAGCACAAGTCGCGCTTCTGTCCATATTTGTTGGCATCCAG
CAAGACC 
 Phoma exigua (syn. Boeremia exigua) strain PB5 
CCGTAGGTGAACCTGCGGAAGGATCATTACCTAGAGTTGTAGGCTTTGCCTACCATCTCTTACCCATGTCTTT
TGAGTACCTTCGTTTCCTCGGCGGGTCCGCCCGCCGATTGGACAAACTTAAACCCTTTGTAATTGAAATCAG
CGTCTGAAAAAACATAATAGTTACAACTTTCAACAACGGATCTCTTGGTTCTGGCATCGATGAAGAACGCAGC
GAAATGCGATAAGTAGTGTGAATTGCAGAATTCAGTGAATCATCGAATCTTTGAACGCACATTGCGCCCCTTG
GTATTCCATGGGGCATGCCTGTTCGAGCGTCATTTGTACCTTCAAGCTCTGCTTGGTGTTGGGTGTTTGTCTC
GCCTTTGCGTGTAGACTCGCCTTAAAACAATTGGCAGCCGGCGTATTGATTTCGGAGCGCAGTACATCTCGC
GCTTTGCACTCATAACGACGACGTCCAAAAAGTAC 
Additional sequences of different Epicoccum nigrum strains taken from GenBank for assembly of the 
phylogeny (GenBank accession numbers are given): 
JX402194.1, JX402182.1, JX402191.1, KF164404.1, KC305160.1, KF574877.1, KC222840.1, KC568289.1 
 
Tab. 8.1a: Inhibitory activity on neutrophil elastase (HLE, see section 3.5.4 for the method) of a crude 
extract from E. nigrum strain 749 grown on MES (malt extract agar with artificial sea water) under 
continuous illumination with white light. Activity is given as residual activity in %. Number of replicates 
N = 4. SD = standard deviation, abs/min = Absorption of the cleaved chromophore/minute.  
 
Conc. 
[µg/ml] 
Abs/min. SD N Rest activity [%] 
 
0 0,0057 0,0005 4 100,00 
 
2 0,0044 0,0007 4 77,19 
 
4 0,0034 0,0009 4 59,65 
 
6 0,0027 0,0007 4 47,37 
 
8 0,0024 0,0006 4 42,11 
 
10 0,0019 0,0004 4 33,33 
       
 
Tab. 8.1b: Data as for Tab. 8.1a, extract from E. nigrum strain 749 grown on MEA (malt extract agar).  
 
Conc. 
[µg/ml] 
Abs/min. SD N Rest activity [%] 
 
0 0,0081  - 8 100,00 
 
2 0,0036 0,0004 4 44,44 
 
4 0,0025 0,0005 4 30,86 
 
6 0,0016 0,0003 4 19,75 
 
8 0,0012 0,0003 4 14,81 
 
10 0,0008 0,0003 4 9,88 
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Fig. 8.1: Comparison of the TWC (total wavelength count) from LC-MS runs of crude extracts from E. 
nigrum strain 749 (for the method see section 3.3.2). The red rectangle indicates the time frame, in 
which epipyrones (1-3) elute, the green rectangle highlights acetosellin-derived peaks. Lightbulbs 
indicate continuous illumination with white light. MEA = malt extract agar; ASW = artificial sea water; 
CDA = Czapek-Dox agar; TMS = trace metal solution. 
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      + TMS 
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Fig. 8.2: Comparison of the TWC (total wavelength count) from LC-MS runs of crude extracts from E. 
nigrum strain 800 (for the method see section 3.3.2). The green rectangle indicates the time, at which 
acetosellin elutes (on CDA with TMS, no acetosellin was detected). Lightbulbs indicate continuous 
illumination with white light. MEA = malt extract agar; ASW = artificial sea water; CDA = Czapek-Dox 
agar.  
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[1] 
 
 
 
 
[2] 
 
 
 
 
Fig. 8.3: Comparison of the composition of two extracts from E. nigrum strain 749 on:  
[1] CDA (Czapek-Dox agar), under continuous illumination with white light.  
[2] CDT (Czapek-Dox agar with trace metal solution), grown in darkness. 
Shown are the UV-data (TWC and the selected UV-spectrum of the respective main metabolite) 
obtained during an LC-ESI-MS run.  
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Fig. 8.4: Comparison of the 
1
H-NMR experiments of (in MeOH-d4 and recorded at 300 MHz):  
[1] E. nigrum strain 749 grown on CDA (Czapek-Dox agar), under continuous illumination.  
[2] Acetosellin (4) 
[3] E. nigrum strain 749 grown on CDT in darkness (Czapek-Dox agar with trace metal solution). 
[4] Epipyrones (1-3) 
[1] 
[2] 
[4] 
[3] 
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Fig. 8.5: 
1
H-NMR of epipyrones (1-3) in MeOH-d4, measured at 300 MHz. 
 
Fig. 8.6: 
13
C-NMR of epipyrones (1-3) in MeOH-d4, measured at 75 MHz. 
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Fig. 8.7: DEPT-135 of epipyrones (1-3) in MeOH-d4. 
 
Fig. 8.8: HSQC of epipyrones (1-3) in MeOH-d4, measured at 300 MHz. 
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Fig. 8.9: COSY of epipyrones (1-3) in MeOH-d4, measured at 300 MHz. 
 
Fig. 8.10: HMBC of epipyrones (1-3) in MeOH-d4, measured at 300 MHz. 
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Fig. 8.11: NOESY of epipyrones (1-3) in MeOH-d4, measured at 300 MHz. 
 
Fig. 8.12: 
1
H-NMR of epipyrone tetraacetate (5) in MeOH-d4, measured at 600 MHz. 
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Fig. 8.13: 
13
C-NMR of epipyrone tetraacetate (5) in MeOH-d4, measured at 150 MHz. 
 
Fig. 8.14: DEPT-135 of epipyrone tetraacetate (5) in MeOH-d4. 
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Fig. 8.15: HSQC of epipyrone tetraacetate (5) in MeOH-d4, measured at 600 MHz. 
 
Fig. 8.16: COSY of epipyrone tetraacetate (5) in MeOH-d4. 
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Fig. 8.17: HMBC of epipyrone tetraacetate (5) in MeOH-d4, measured at 600 MHz. 
 
Fig. 8.18: ROESY of epipyrone tetraacetate (5) in MeOH-d4, measured at 600 MHz. 
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Fig. 8.19: 
1
H-NMR of epipyrone triacetate (6) in MeOH-d4, measured at 600 MHz. 
 
Fig. 8.20: 
13
C-NMR of epipyrone triacetate (6) in MeOH-d4, measured at 150 MHz. 
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Fig. 8.21: DEPT-135 of epipyrone triacetate (6) in MeOH-d4. 
 
Fig. 8.22: HSQC of epipyrone triacetate (6) in MeOH-d4, measured at 600 MHz. 
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Fig. 8.23: HMBC of epipyrone triacetate (6) in MeOH-d4, measured at 600 MHz. 
 
Fig. 8.24: NOESY of epipyrone triacetate (6) in MeOH-d4, measured at 600 MHz. 
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Fig. 8.25: LC-ESI-MS experiment of a crude extract made from the agar medium. The mycelium of E. 
nigrum strain 749, grown on Czapek-Dox agar with continuous illumination, was separated from the 
medium prior to the extraction. As can be deduced from retention time and mass (tR = 17.15 min; m/z 
= 412; 395; 377), acetosellin (4) was found to be exuded into the medium.  
 
 
Fig. 8.26: 
1
H-NMR of acetosellin (4) in MeOH-d4, measured at 300 MHz. 
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Fig. 8.27: 
13
C-NMR of acetosellin (4) in MeOH-d4, measured at 75 MHz. 
 
 
Fig. 8.28: DEPT-135 of acetosellin (4) in MeOH-d4, measured at 75 MHz. 
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Fig. 8.29: COSY of acetosellin (4) in MeOH-d4. 
 
 
Fig. 8.30: HSQC of acetosellin (4) in MeOH-d4. 
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Fig. 8.31: HMBC of acetosellin (4) in MeOH-d4. 
 
 
Fig. 8.32: 
1
H-NMR of acetosellin (4) in acetone-d6, measured at 300 MHz. 
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Fig. 8.33: 
1
H-NMR of acetosellin (4) in DMSO-d6, measured at 300 MHz. 
 
Fig. 8.34: 
13
C-NMR of acetosellin (4) in DMSO-d6, measured at 75 MHz. 
Fig. 8.35: CD spectrum of acetosellin in MeOH. 
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Fig. 8.36: 
1
H-NMR of 5´,6´-dihydroxyacetosellin (7) in MeOH-d4 at 600 MHz. 
 
Fig. 8.37: 
13
C-NMR of 5´,6´-dihydroxyacetosellin (7) in MeOH-d4 at 125 MHz. 
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Fig. 8.38: DEPT-135 of 5´,6´-dihydroxyacetosellin (7) in MeOH-d4 at 600 MHz. 
 
Fig. 8.39: HSQC of 5´,6´-dihydroxyacetosellin (7) in MeOH-d4 at 600 MHz. 
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Fig. 8.40: COSY of 5´,6´-dihydroxyacetosellin (7) in MeOH-d4 at 600 MHz. 
 
Fig. 8.41: HMBC of 5´,6´-dihydroxyacetosellin (7) in MeOH-d4 at 600 MHz. 
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Fig. 8.42: UV-spectrum of 5´,6´-dihydroxyacetosellin (7) in MeOH. 
 
Fig. 8.43: IR-spectrum of 5´,6´-dihydroxyacetosellin (7) in MeOH. 
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 Fig. 8.44: CD spectrum of 5´,6´-dihydroxyacetosellin in MeOH. 
  
 
Fig. 8.45: Comparison of 
1
H-NMR spectra from 
13
C-labeled acetosellin ([1]) and unlabeled ([2]) 
acetosellin (4) in MeOH-d4. 
[2] 
[1] 
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Fig. 8.46: Comparison of 
13
C-NMR spectra from 
13
C-labeled acetosellin ([1]) and unlabeled ([2]) 
acetosellin (4) in MeOH-d4. Signals are marked following the numbering in fig. 4.16. 
 
Fig. 8.47: LC-ESI-MS data sheet for a crude extract of E. nigrum strain 800 cultivated on MEN 
medium (malt extract agar supplemented with NaOAc and artificial sea water) under continuous 
illumination. Extraction was carried out after one week of cultivation using EtOAc.  
[2] 
[1] 3 
     5 
      15 
7
13
9 
11 
1 
2´ 
4´   
   6´   
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Fig. 8.48: LC-ESI-MS data sheet for the crude extract of the [
13
C]-labeled culture of E. nigrum strain 
749 showing the total ion chromatogram (TIC), the isotopic pattern of [
13
C]-enriched acetosellin (4), the 
total wavelength chromatogram (TWC) and the DAD spectral data for acetosellin (4) (from top to 
bottom). 
 
 
Fig. 8.49: 
1
H-NMR of epicoccolide B (9) in DMSO-d6. 
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Fig. 8.50: 
13
C-NMR of epicoccolide B (9) in DMSO-d6. 
 
Fig. 8.51: DEPT-135 of epicoccolide B (9) in DMSO-d6. 
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Fig. 8.52: 
1
H-NMR of (3R,4S)-4-hydroxymellein (10) in MeOH-d4. 
 
Fig. 8.53: 
13
C-NMR of (3R,4S)-4-hydroxymellein (10) in MeOH-d4. 
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Fig. 8.54: 
1
H-NMR of epicoccone (11) in MeOH-d4. 
 
Fig. 8.55: 
13
C-NMR of epicoccone (11) in MeOH-d4. 
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Fig. 8.56: DEPT-135 of epicoccone (11) in MeOH-d4. 
 
Fig. 8.57: 
1
H-NMR of 1F4-1-6 (12) in MeOH-d4. 
 
Fig. 8.58: 
13
C-NMR of 1F4-1-6 (12) in MeOH-d4. 
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Fig. 8.59: DEPT-135 of 1F4-1-6 (12) in MeOH-d4. 
 
Fig. 8.60: HSQC of 1F4-1-6 (12) in MeOH-d4. 
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Fig. 8.61: COSY of 1F4-1-6 (12) in MeOH-d4. 
 
Fig. 8.62: HMBC of 1F4-1-6 (12) in MeOH-d4. 
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Fig. 8.63: 
1
H-NMR of 1F4-1-6 (12) in acetone-d6. 
 
Fig. 8.64: 
13
C-NMR of 1F4-1-6 (12) in acetone-d6. 
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Fig. 8.65: HSQC of 1F4-1-6 (12) in acetone-d6. 
 
Fig. 8.66: COSY of 1F4-1-6 (12) in acetone-d6. 
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Fig. 8.67: HMBC of 1F4-1-6 (12) in acetone-d6. 
 
Fig. 8.68: UV-spectrum of 1F4-1-6 (12) in MeOH. 
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Fig. 8.69: IR-spectrum of 1F4-1-6 (12). 
 
Fig. 8.70: 
1
H-NMR of epicaronic acid (13) in MeOH-d4. 
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Fig. 8.71: 
13
C-NMR of epicaronic acid (13) in MeOH-d4. 
 
Fig. 8.72: DEPT-135 of epicaronic acid (13) in MeOH-d4. 
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Fig. 8.73: COSY of epicaronic acid (13) in MeOH-d4. 
 
Fig. 8.74: HSQC of epicaronic acid (13) in MeOH-d4. 
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Fig. 8.75: HMBC of epicaronic acid (13) in MeOH-d4. 
 
Fig. 8.76: NOESY of epicaronic acid (13) in MeOH-d4. 
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Fig. 8.77: UV-spectrum of epicaronic acid (13) in MeOH. 
 
Fig. 8.78: IR-spectrum of epicaronic acid (13). 
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Fig. 8.79: 
1
H-NMR of tricinonoic acid (14) in MeOH-d4. 
 
Fig. 8.80: 
13
C-NMR of tricinonoic acid (14) in MeOH-d4. 
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Fig. 8.81: DEPT-135 of tricinonoic acid (14) in MeOH-d4. 
 
Fig. 8.82: 
1
H-NMR of flazin (15) in DMSO-d6. 
 
Fig. 8.83: 
13
C-NMR of flazin (15) in DMSO-d6. 
Appendix 
 205 
 
Fig. 8.84: LC-ESI-MS data sheet for the crude extract of pure malt extract showing the total ion 
chromatogram (TIC), the mass signal for flazin (m/z 309 [M+H]
+
), the total wavelength chromatogram 
(TWC) and the DAD spectral data for flazin (from top to bottom). 
 
Fig. 8.85: Raw data of the resazurin-based cell viability assay, performed with acetosellin (4) in a 
concentration range of 0.1 µM – 30 µM. 0.3% DMSO was used as control.  
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Fig. 8.86: Raw data of the resazurin-based cell viability assay, performed with epicoccolide B (9) in a 
concentration range of 0.1 µM – 30 µM. 0.3% DMSO was used as control.  
 
Tab. 8.2: Effect of compounds 1-3, 4, 6, 10, 13, 14, 15 on human cerebroside sulfotransferase 
(hCST). Inhibitory activity is given as residual activity of the tested enzyme in %. Assay was performed 
in duplicates on two days, respectively. 
Tested compound Residual activity [%] 
Epipyrone triacetate (6) 88.43 ± 5.9 
Flazin (15) 46.36 ± 7.1 
Acetosellin (4)* 11.86 ± 5.7 
Epicaronic acid (13) 53.44 ± 3.4 
Tricinonoic acid (14) 57.08 ± 2.3 
(3R,4S)-4-Hydroxymellein (10) 88.72 ± 3.4 
Epipyrones (1-3) 18.21 ± 6.8 
* Activity on first testing. Acetosellin did not show inhibitory activity after repeated testing on hCST.  
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Fig. 8.87: Assay for inhibitory activity of pure β-D-galactose on human cerebroside transferase. The 
assay was repeated four times. Error bars indicate standard deviation. No significant inhibition could 
be observed. The positive control was carried out without inhibitor.  
 
 
Fig. 8.88: Inhibitory activity of citreoviridin C on human cerebroside sulfotransferase (hCST). The 
assay was performed in duplicates, of which the mean values of are given.  
 
Fig. 8.89: Inhibitory activity of epipyrones (1-3) on cathepsin K.  The assay was performed in 
duplicates for each concentration. 
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Fig. 8.90: Inhibitory activity of epipyrones (1-3) on cathepsin S. The assay was performed in 
duplicates for each concentration. 
 
 
Fig. 8.91: Inhibitory activity of epipyrones (1-3) on human leukocyte elastase (HLE). The assay was 
performed in duplicates for each concentration. 
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Fig. 8.92: Part of chromatogram showing the presence of epicocconone (8) in guttation droplets on 
mycelium of E. nigrum strain 749, grown on Czapek-Dox agar under continuous illumination with white 
light. Analysis was performed  by LC-HR-ESI-MS in positive mode. Data were viewed with MZmine 
2.21. 
 
 
Fig. 8.93: Mass spectrum and fragmentation of epicocconone (8), analyzed in the extract of E. nigrum 
strain 749, grown on Czapek-Dox agar under continuous illumination with white light,  by LC-HR-ESI-
MS in positive mode. Data were viewed with MZmine 2.21. 
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Fig. 8.94: Part of chromatogram showing the presence of epipyrones (1-3), acetosellin (4), 5´6´-
dihydroxyacetosellin (7), epicocconone (8) and epicoccolide B (9) in guttation droplets on mycelium of 
E. nigrum strain 749, grown on Czapek-Dox agar under continuous illumination with white light. 
Analysis was performed  by LC-HR-ESI-MS in positive mode. Data were viewed with MZmine 2.21. 
  
Fig. 8.95: Selected ion chromatogram showing the relative abundance of epipyrones (1-3) and 
acetosellin (4) in guttation droplets on mycelium of E. nigrum strain 749, grown on CDT (CDA with 
trace metal solution, upper chromatogram) in darkness and CDA (Czapek-Dox agar, lower 
chromatogram) under continuous illumination with white light. Analysis was performed  by LC-HR-ESI-
MS in positive mode. Data were viewed with MZmine 2.21. 
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Fig. 8.96: Total wavelength chromatograms showing the relative abundance of epipyrones (1-3, green 
box) and acetosellin (4, red box) in extracts from E. nigrum strain 749, grown on Czapek-Dox agar 
with or without trace metal solution (first replicate cultivation). Analysis was performed  by LC -ESI-MS 
in positive mode. TMS = supplementation with trace metal solution. Yellow light bulbs indicate 
fermentation under continuous illumination with white light, while colorless light bulbs indicate 
fermentation in darkness. 
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Fig. 8.97a: Example for DAD data for standard solution of epipyrones (1-3) with a concentration of 0.1 
mg/mL, used for the quantification of extract and guttation droplets. 
 
Fig. 8.97b: Example for DAD data for standard solution of acetosellin (4) with a concentration of 0.1 
mg/mL, used for the quantification of extract and guttation droplets. 
 
 
Fig. 8.98: Selected ion chromatogram of different culture extracts from strain 749, showing the mass 
of epipyrones (1-3) (m/z 613.3007 [M+H]
+
, selected range 613.290 - 613.350). Analysis was 
performed using LC-HR-ESI-MS system C (see section 3.3.2). Colored lines represent following 
extracts (CDA = Czapek-Dox agar, CDT = Czapek-Dox agar with trace metal solution, all cultivations 
carried out under darkness under the same conditions): ): pink: CDA; red: CDA+Zn
2+
; blue: 
CDA+Cu
2+
; green: CDT 
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Tab. 8.3a: Raw data for the quantification of epipyrones (1-3) and acetosellin (4) in the extracts of E. 
nigrum strain 749 on Czapek-Dox agar (see section 4.7). 
Experiment/ 
replicate No. 
Trace metals/ 
illumination 
Volume of 
agar 
Total mass 
of 
epipyrones 
[mg]  
Concentration 
of epipyrones 
per L agar 
[mM] 
Total mass 
of acetosellin 
[mg]  
Concentration 
of acetosellin 
per L agar [mM] 
1 
No/Yes 2.5 8.12 0.005 129.89 0.132 
No/No 1.1 24.95 0.037 338.20 0.780 
Yes/Yes 0.7 11.62 0.027 21.36 0.077 
Yes/No 2.5 207.42 0.135 0.00 0.000 
2 
No/Yes 1.9 32.50 0.028 217.35 0.290 
No/No 1.8 40.46 0.037 1.79 0.003 
Yes/Yes 1.9 381.57 0.328 0.00 0.000 
Yes/No 1.7 571.21 0.548 0.00 0.000 
3 
No/Yes 1.7 13.09 0.013 49.02 0.073 
No/No 1.5 16.65 0.018 6.54 0.011 
Yes/Yes 2.1 264.31 0.205 1.98 0.002 
Yes/No 2 293.47 0.239 0.00 0.000 
 
Tab. 8.3b: Mean values of the concentration of epipyrones (1-3) and acetosellin (4) in the extracts of 
E. nigrum strain 749 on Czapek-Dox agar with standard error of the mean (SEM) (see section 4.7). 
Trace 
metals/illumination 
Mean epipyrones [mM] ± 
SEM 
Mean acetosellin [mM] ± 
SEM 
No/Yes 0,015 ± 0.007 0,165 ± 0.065 
No/No 0,031 ± 0.006 0,264 ± 0.258 
Yes/Yes 0,187 ± 0.087 0,027 ± 0.025 
Yes/No 0,308 ± 0.124 0,000 ± 0.000 
 
Tab. 8.3c: Volumes of collected guttation droplets of E. nigrum strain 749 on Czapek-Dox agar (see 
section 4.7). Guttation droplets from all cultures of a specific fermentation condition. The mean values 
with standard error of the mean (SEM) are given from three replicate experiments. 
Collection 
date
†
 
Trace metals/ 
Illumination 
Total volume [µL] Volume per petri dish [µL] 
Mean volume per 
petri dish [µL] 
  
n = 1 n = 2 n = 3 n = 1 n = 2 n = 3 
 
14 No/Yes 166 646 234 6.6 34.0 13.8 18.1  
14 No/No 168 420 177 15.3 23.3 11.8 16.8  
14 Yes/Yes 0 26 254 0.0 1.4 12.1 4.5  
14 Yes/No 12 6 115 0.5 0.4 5.8 2.2  
28 No/Yes 36 494 234 1.4 26.0 13.8 13.7  
28 No/No 260 178 49 23.6 9.9 3.3 12.3  
28 Yes/Yes 0 8 365 0.0 0.4 17.4 5.9 
28 Yes/No 227 125 80 9.1 7.4 4.0 6.8 
†
Date of cultivation. n = experiment/replicate number (see tab. 8.3a). 
Appendix 
 214 
Tab. 8.3d: Raw data for the quantification of epipyrones (1-3) in the guttation droplets of E. nigrum 
strain 749 on Czapek-Dox agar (see section 4.7). The mean values with standard error of the mean 
(SEM) are given from three replicate experiments. 
Collection date† Trace metals/illumination c(epipyrone) [mmol/l] Mean value ± SEM 
  n = 1 n = 2 n = 3  
14 No/Yes 0.16 0.69 1.23 0.69 ±  0.31 
14 No/No 0.73 0.76 0.66 0.72 ± 0.03 
14 Yes/Yes * 0.2 0.57 0.39 ± 0.19 
14 Yes/No 0.24 4.43 1.32 2.00 ± 1.26 
28 No/Yes 0.14 0.51 0.92 0.52 ± 0.23 
28 No/No 0.27 0.29 0.12 0.23 ± 0.05 
28 Yes/Yes * 0.92 1.54 1.23 ± 0.31 
28 Yes/No 0.81 1.29 1.12 1.07 ± 0.14 
*No data recorded, since guttate production was too low for collection of droplets. 
†
Date of cultivation. 
n = experiment/replicate number (see tab. 8.3a). 
Tab. 8.3e: Raw data for the quantification of acetosellin (4) in the guttation droplets of E. nigrum strain 
749 on Czapek-Dox agar (see section 4.7). The mean values with standard error of the mean are 
given from three replicate experiments. 
Collection date† Trace metals/illumination c(acetosellin) [mmol/l] Mean value ± SEM 
  n = 1 n = 2 n = 3  
14 No/Yes 0.11 0.09 0 0.07 ± 0.03 
14 No/No 0.25 0.01 0 0.09 ± 0.08 
14 Yes/Yes * 0.01 0 0.01 ± 0.01 
14 Yes/No 0 0.01 0 0.00 ± 0.00 
28 No/Yes 0.11 0.15 0 0.09 ± 0.04 
28 No/No 0.22 0 0 0.07 ± 0.07 
28 Yes/Yes * 0 0 0.00 ± 0.00 
28 Yes/No 0 0 0 0.00 ± 0.00 
*No data recorded, since guttate production was too low for collection of droplets. 
†
Date of cultivation. 
n = experiment/replicate number (see tab. 8.3a). 
 
